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1.1 Cells of the immune system.
The cells of the immune system are made up of non-specific and specific elements. The non¬
specific components include killer cells (e.g natural killer (NK) cells and lymphokine activated
killer (LAK) cells), granulocytes, macrophages, dendritic cells and other phagocytic and/or
antigen presenting cells which may be both circulating or resident in tissue. The specific cells of
the immune system are the lymphocytes. In all species so far examined, the lymphocyte
population can be divided into subsets, T cells and B cells. The majority of T cells are produced
in the thymus and express a specialised T cell receptor for processed antigen, they can be divided
both phenotypically and functionally into subsets. B cells are produced in the bone marrow (or
Bursa of Fabricus in birds) and recognise antigen via surface immunoglobulins.
Before discussing the populations of lymphocytes, it is worth defining some of the molecules
used to describe the different populations. In order to characterise and co-ordinate the reactivity
of the increasing number of monoclonal antibodies, a series of Leucocyte Differentiation Antigen
Wbrkshops were organised (Bernard et al., 1984; Reinherz et al., 1986; McMichael, 1987;
Knapp,1990). Monoclonal antibodies which demonstrated identical patterns of cellular reactivity
and immunoprecipitated the same molecular weight components as visualised by SDS-PAGE were
grouped into clusters of differentiation (CD) and assigned a number.
CD3 was one of the first group of human T cell surface antigens identified by monoclonal
antibodies and the CD3 complex is intimately associated with the TCR on the surface of all T cells
(Clevers et al., 1988). CD3 is involved in signalling from the TCR and is comprised of three CD3
chains (y, 5 and e) and two further transmembrane polypeptides (£, and rj in a proportion of
receptors). The surface proteins CD4 and CD8 are transmembrane glycoproteins which are
expressed on mutually exclusive subpopulations of mature T lymphocytes (Maddon et al., 1985;
Maddon et al., 1987; Parnes, 1989). The expression of CD4 and CD8 on cells is tightly
correlated with the recognition of antigen in association with MHC class II and class I molecules
respectively. CD4 is a nonpolymorphic glycoprotein of Mr 55kDa. It interacts with a
nonpolymorphic determinant of MHC class II molecules on APC thereby increasing the avidity
of the interaction of T cell and APC (Doyle and Strominger, 1987). CD4 has also been shown to
associate with the TCR on cells involved in immune responses (Janeway, 1992). CD8 is a 70kDa
heterodimer of an a and (3 chain, though this protein can be found on populations of
lymphocytes as an a chain homodimer (e.g. intraepithelial lymphocytes). CD8 directly binds
MHC class I molecules thereby contributing to the cytotoxic activity of CD8-positive T cells
(Norment et al., 1988; Salter et al., 1989). A physical association between CD8 and the TCR has
also been demonstrated (Janeway, 1992).
CD22 is a lineage specific B lymphocyte molecule expressed in the cytoplasm of all B
lymphocytes including B cell progenitors. Surface expression is associated with B cell maturity
and antigenic responsiveness.
1.1.1 T lymphocytes.
Once exported from the thymus, T cells migrate to T cell specific areas of the spleen, lymph
nodes and other lymphoid organs. Many T cells continue in a migratory lifestyle, recirculating
out of lymphoid tissues into the lymphatics, then via the thoracic duct to the blood, and again into
lymphoid tissues through specialised sinuses or venules. A smaller proportion exits into
nonlymphoid tissues and eventually makes its way to lymphoid tissues via afferent lymphatics.
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This continual migration is believed to allow exposure, of a large proportion of the total pool of T
cells, to antigen which may be quite locally distributed. Under normal circumstances, the great
majority of the lymphocytes in a healthy individual are quiescent but following exposure to
antigen T cells are activated, divide and become effector cells. Activation of T cells occurs
primarily in the lymph nodes which drain the site of the infection and this leads to an expansion
of all antigen specific cell populations. Each daughter T cell has an identical antigen specificity
to that of its parent cell.
T cells play an important role in the function and regulation of the immune system. Once
activated they directly or indirectly kill invading bacteria or parasites, infected or damaged cells,
tumour cells and inopportunately, the bodies own cells. T cells regulate other T cells by cell-to-
cell contact or through the release of soluble factors such as cytokines. T cells also regulate B cell
function and are essential for expansion, differentiation and Ig class switching.
In all species so far examined, mature T cells can be divided into three subsets based on the
expression of the proteins CD4 and CD8. CD4-positive cells are predominantly regulatory
"helper cells" and react with foreign antigens associated with MHC class II molecules. These
antigens are usually peptides derived from exogenous proteins. CD4-positive cells do not express
CD8. CD8-positive T cells are mostly cytotoxic cells and react with antigens associated with MHC
class I molecules. These antigens are usually peptides derived from endogenous molecules.
CD8-positive cells do not express CD4. CD4-positive T cells and CD8-positive T cells use the a{3
dimer as their TCR. The third group of cells do not express CD4 or CD8 and do not use the a[}
dimer as their T cell receptor. Instead these cells express a yS TCR dimer. y8 T cells have not yet
been assigned any distinct function, nor have any presentational elements been identified which
are specific for yS T cells.
1.1.1.1 Helper T cells.
Helper T lymphocytes are generally the CD4-positive population though some CD8-positive T
cells and some yS T cells can carry out helper functions. The functional distinction of helper cells
is in the array of cytokines that they produce as a consequence of antigen-stimulated activation.
Cytokines act by binding to high-affinity receptors expressed on target cells and by inducing
biochemical signals within those cells that profoundly affect their behaviour.
CD4-positive T cells do not constitute a homogeneous class of cells and cytokine biology has
identified two subsets designated TH1 and TH2 helper T cells. When stimulated by receptor
engagement, CD4-positive T cells produce IL-2, but little or no IL-4 or IFNy (Swain et al., 1991).
These pre-helper T cells have the potential to develop into either a population of TH1 helper cells
or a population of TH2 helper cells. Much work has attempted to dissect the necessary steps of
development, this is reviewed by Paul and Seder (1994). There is evidence that the ligand
presented to CD4-positive T cells may itself regulate the TH1 or TH2 pattern of the responding
cells (Murray et al., 1989) and this may be dependent on the density of the ligand presented.
The cytokines IL-4, IL-5, IL-6, IL-10 and IL-13 are secreted by TH2 cells and act on B cells. IL-
4 acts as a costimulant of B cell growth and in the murine species also controls Ig class switching
from IgM to IgGl (IgG4 in humans), and IgM to IgE. IL-13 has a similar activity to that of IL-4
(Punnonen et al., 1993). IL-5 is important in the development of stimulated B cells into antibody
secreting cells (Hamaoka and Ono, 1986) and IL-6 and IL-10 promote Ig secretion. TH1 cells
produce the cytokines IL-2, IFNy and TNFfi. These cells cause T cell mediated inflammation and
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are well suited to induce enhanced microbicidal activity in macrophages and are therefore of
particular value in intracellular infections. IL-10 and IL-4, secreted by TH2 cells, oppose the
effects of IFNy and thus these cells may play a role in the control of self-inflicted injury due to
the effects of TH1 cells (Rapoport et al., 1993; Kuhn, 1993).
1.1.1.2 Cytotoxic T cells.
CTL play a major role in protection and recovery from viral, bacterial and parasitic infections.
CTL also mediate allograft rejection and are implicated in certain autoimmune diseases and
tumour immunity (Moller, 1983, 1988). Classically, CTL were described as those cells which
recognise antigen in the context of MHC class I molecules. This occurs in association with the
CD8 protein expressed on the surface of the target cell (Podack et al., 1991). MHC class II and
CD4 restricted cytotoxicity does occur however, as do cytotoxic y5 T cells. The first signal in
cytotoxicity is antigen recognition by the TCR. The CTL then become activated and carry out
their effector functions. A co-stimulatory signal for CD8 cells is not known though IL-1 is
thought to be the co-stimulatory signal for CD4 restricted cytotoxicity.
Cytolysis is known to be unidirectional with the effector T cell spared the lethal cytotoxic hit
delivered to the target cell (Fishelon and Berke, 1978; Zagury et al., 1979; Mueller and Tschopp,
1994). Two mechanisms for cytolysis have been identified, one based on the secretion of lytic
proteins and one which depends on cell-surface ligand-receptor interaction (Squier and Cohen,
1994). The first mechanism involves perforin and serine esterases which are contained within
cytoplasmic granules in CTL (Lu et al., 1992). Perforin has been demonstrated to form pores in
cell membranes analogous to the complement proteins (Joag et al., 1989). The second
mechanism involves the expression of the cell-surface protein Fas on the target cell and the ligand
for Fas on CTL (Walsh et al., 1994; Lowin et al., 1994)
1.1.1.3 y5T cells.
y5 T cells were not noticed by cellular immunologists in innumerable studies of humoral and cell
mediated immune responses. It was the discovery of rearranged genes other than Ig and ap TCR
rather than an observation of a new function which led to their discovery. The immunology of y5
T cells has since progressed in a reverse direction to that of ap T cells. From discovery of the y
and 5 genes, to the discovery of the TCR and discovery of a new class of lymphocyte. A
definitive function for y5 T cells has yet to be identified.
In 1984, monoclonal antibodies were raised against T cell clones and the subsequent
identification of the TCR for antigen was possible. These monoclonal antibodies
immunoprecipitated protein heterodimers of rearranged a and p gene transcripts (Allison et al.,
1982; Meucr et al., 1983; Acuto et al., 1983). cDNA's encoding the TCR p subunit were first
isolated by subtractive hybridisation and differential screening (Hedrick et al., 1984; Yanagi et
al., 1984) and subsequently, candidate cDNA's encoding a genes were cloned. One of these
genes did not have the consensus site for asparagine linked glycosylation and this cDNA
rearrangement was termed the ygene (Saito et al., 1984). The first evidence that a second
heterodimer existed followed analysis of cells with monoclonal antibodies raised against the ap
TCR molecule and monoclonal antibodies raised against the CD3 proteins (Brenner et al., 1986;
Bank et al., 1986; Weiss et al., 1986; Littman et al., 1987). It was shown that there was a small
percentage of peripheral blood CD3-positive T cells which did not express the aP TCR. These
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cells were shown to express a CD3-associated heterodimer of a y-chain with an unidentified chain.
Antibodies raised against synthesised y-chain peptides subsequently revealed the cell surface
expression of a second heterodimer, the y5 TCR (Brenner et al., 1986). The 8 gene was
subsequently found located within the TCR y locus and cloned (Chien et al., 1987). The products
of the y and 8 genes were shown to be expressed as cell surface heterodimers and cells bearing
this receptor represent a different class of T cells (Bank et al., 1986; Lanier et al., 1987)
There are few phenotypical and morphological differences between a[3 and y8 T cells. In all
species examined, yS T cells do not generally express the proteins CD4 and CD8 (Groh et al.,
1989; Hayward et al., 1989;. Miyawaki et al., 1990; Braakman et al., 1991; Inghirami et al.,
1990; Faure et al., 1989; Cron et al., 1989; Mackay et al., 1988; Evans, 1993). In addition, in
ruminants, yS T cells do not express the protein CD2 (Mackay et al., 1988a; Evans, 1993) but
uniquely express a protein called WC1 (previously referred to as T19). The WC1 molecule is the
only known unique surface protein expressed on yS T cells (MacKay et al., 1989; Clevers et al.,
1990).
1.1.2 B cells.
B cells are responsible for antibody formation; each B cell produces an antibody with a single
specificity (Awdeh et al., 1970). Antibodies are the antigen recognition molecules of the B cell
and largely recognise conformational epitopes of regions of complex molecules such as
glycoproteins (Warner, 1974). Antibody may be a secreted form or membrane-bound. The B
cell receptor for antigen is the membrane bound form of antibody. Activation of B cells in
peripheral lymphoid organs leads to the secretion of antibody by the plasma cell progeny of
these B cells. The antibodies are identical or closely related to the cell surface receptors present
on the B cell progenitors that were triggered (Tonegawa et al., 1981; Leder, 1982). Each type of
antibody plays a different role in the body (Spiegelbcrg, 1974; Davies et al., 1990). IgA
molecules are distributed in the serum and in secretory fluids from the salivary glands and
gastrointestinal system (Fisher et al., 1979). IgG proteins are the most abundant antibodies in the
scrum, while IgD molecules are found predominantly on the surface of B lymphocytes
(Spiegelberg, 1974). IgE antibodies are mediators of allergic responses and of immune reactions
to parasitic infections (Ishizada and Ishizada, 1975). IgM proteins occur in two forms, as a
receptor on the surface of B cells (Spiegelberg, 1974) or a secreted form in the serum, which is a
pentameric structure linked by an additional polypeptide called the J chain.
Antibodies consist of four polypeptide chains or multiples thereof. There are two mostly
unglycosylated light chains and two glycosylated heavy chains (Edelman, 1970; Porter, 1973).
In the mouse, light chains fall into two groups (k and X) while the heavy chains can be divided
into five classes (a, y, 8, e and p.). The genes encoding the heavy and light chain of antibodies are
made up from segments which have to be rearranged before the genes can be transcribed and
translated (Hanjo et al., 1989). The H gene is made from four distinct clusters of gene segments
encoding the variable (V), diversity (D), joining (J) and constant (C) regions. Light chains are
made from V J and C region segments. Light chains associate with any of the heavy chains to
produce IgA(a), IgG(y), IgD(8), IgE(e) and IgM(p) antibodies. The heavy chain used is
indicated in parenthesis. The amino terminal domains of the two chains are variable from
antibody to antibody and are the antigen binding site. The more carboxyterminal constant (C)
domains are involved in functions of the antibody which are unrelated to their antigen-binding
specificities. Many of the effector functions of antibodies are mediated by the binding of C
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domains to complement proteins or to Fc receptors expressed on other cells (Reid and Porter,
1981). Different classes of antibodies bind to different types of Fc receptor. Binding of antibody
to Fc receptors can induce antibody-dependent cellular cytotoxicity (ADCC), antigen uptake for
processing and presentation to T cells by antigen presenting cells, and immunoglobulin class
switching. ADCC is carried out by killer cells and is IgG dependent although other forms of
antibody can synergise with IgG to improve the ADCC responses.
1.2 Ontogeny of the immune system.
The immune system is built up from a small number of embryonic stem cells. These cells persist
throughout the life of an individual and replenish the immune system. Such cells have been used
experimentally as transplantable cells to regenerate parts of the immune system (Ikuta et al„
1992). The most primitive known progenitor of lymphoid cells is the pluripotent hematopoietic
stem cell (HSC). HSC express little or no surface markers which are characteristic of committed
blood cell lineages. However, in the human and mouse, these cells have been shown to include in
their progeny, yS T cells, ap T cells and precursors of inflammatory cells (Spangrude and
Wfcissman, 1988; Ikuta et al., 1990). In addition, HSC have the capacity to self-renew and have
been shown to protect lethally irradiated hosts following transplantation by the early and
sustained reconstitution of all blood cell types, including stem cells (Spangrude et al., 1988a).
During the ontogeny of the immune system, B cells progenitors are the first lymphocyte
committed precursors to be seen (Kantor and Herzenberg, 1993). These B-lineage precursors are
found in the embryonic part of the placenta and in embryonic blood at 10-14 days of gestation.
At this time, they then enter the stromal compartments of the bone marrow where B cell
differentiation takes place. At the same time, HSC committed to differentiate along T cell
lineages migrate from the bone marrow to the cortical regions of the thymus. The thymic stroma
contains elements of both ectodermal and endodermal origin which are important during the
thymic differentiation of thymocytes (Goldstein and MacKay, 1969; von Gaudecker, 1986). The
HSC seed the thymus and in a short time begin to express Thy-1 and CD5, characteristic of
mouse thymocytes (Ezine et al., 1987; Spangrude et al., 1988b, 1989). The process by which
stem cells develop into immunocompetent, exportable T lymphocytes is an elaborate one which
takes about three weeks (Shortman, 1992).
1.3 Thymic development of T cells.
The first major developmental event in T cell production occurs when HSC seed the thymus.
Under the influence of chcmoattractants such as (^-microglobulin (Dunon et al., 1990; Zijlstra et
al., 1990; Roller et al., 1990) and using homing receptors such as CD44 (Pgp-1) (Rothenberg
1992; O'Neill, 1989) the HSC localise at the thymic corticomedullary junction (Penit and
Vasseur, 1988). HSC then begin to express the thymic T-cell markers Thy-1 and CD44 (Nikolic-
Zugic, 1991). The cells are initially CD8-negative, TCR-negative, CD3-negative and express
moderate levels of CD4 (Wu et al., 1991a). These then become CD4-negative and express high
levels of HSA (Adkins et al., 1987; Rothenberg, 1992). Subsequent transient expression of
CD25 has been reported (Shimonkevitz et al., 1987). By 15 to 20 weeks of gestation, T cell
precursors expressing a[3 and yS TCR are present in the thymus (Wilson et al., 1992) and these
cells are now committed to their T cell lineage (Petrie et al., 1990). ap and y8 T cells develop
from the same precursor cell though rearrangements and surface expression of the yand 8 genes
precede those of the a and p genes (Raulet et al., 1985; Pardoll et al., 1987; Itohara et al., 1989).
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Using y8 TCR transgenic mice it was suggested that a(3 and yd T cell lineages segregate prior to
the expression of either TCR on the cell surface (Bonneville et al., 1989; Ishida et al., 1990). It
was also shown that yd T cells developed normally in ap T cell deficient mice (Mombaerts et al.,
1992) and that normal ap T cell development occurs without y8 T cells (Itohara et al., 1993).
Furthermore, nonproductive rearrangements of y genes are commonly found in ap T cells (Heilig
and Tonegawa, 1987). It is widely known that a variety of different cytokines intervene as
paracrine and autocrine growth and differentiation factors in intrathymic T-cell differentiation
(Barcena et al., 1991; Gutierrez-Ramos et al., 1991)
1.3.1 T cell receptor variable and constant genes.
The TCR loci, termed a, p, y and 8, consist of variable (V), joined (J), diverse (D - in the case of
the p and 5 loci) and constant (C) regions. These regions undergo somatic rearrangements and
generate functional genes. The rearrangements are mediated by processes similar to those that
control the rearrangement of immunoglobulin genes. This comprises both looping out and
deletion of gene segments (Fujimoto and Yamagishi, 1987; Okazaki et al., 1987; Lai et al., 1987)
and inversion (Malissen et al., 1986).
In the human and murine species the TCR y and 8 loci contain a limited number of germline V
and C segments. This is in contrast to the TCR a and P loci. In humans, 14 Vy genes (of which
only 7 or 8 are functional) belonging to four families have been identified along with 6 VS genes
(Moretta et al., 1991). The murine y locus encodes 7 Vy genes belonging to 5 families whilst the
8 locus encodes 8 individual V8 genes (Raulet, 1989). In the human species , some 700 V region
recombinations are possible for the yd heterodimer, whilst some 2500 ap TCR combinations are
thought possible (Davis and Bjorkman, 1988).
Despite the limited number of these germline V and C segments there is extensive junctional
diversity. The variability in the junctional region is due to the imprecision in the joining
processes and the addition of short stretches of nucleotides, called N regions, for both TCR y and
8 genes. N-nucleotide insertion in V-J joints is controlled by the expression of the terminal
deoxynucleotidyl transferase gene (Alt and Baltimore, 1992; Komori et al., 1993; Gilfillan et al.,
1993). Because of the N regions, the number of different junctional recombinations for the
human y8 heterodimer are higher than those of the ap heterodimer (Brenner et al., 1988; Davis
and Bjorkman, 1988). This limited V region repertoire of the y and 8 loci appears not to be a
consensus of all species. Hein and Dudler (1993) have shown that in the ovine species, yd T cells
express a broad repertoire of receptors. There is greater diversity in the V and C region gene
segments of both the y and 8 loci. There are 28 V8 genes belonging to 4 families and 10 Vy
genes belonging to 6 families. In addition the ovine y loci encodes 5 constant genes and the 8
loci one. Specific splicing of each of the Cy genes to distinct sets of rearranged Vy segments
increases the diversity of the ovine yd TCR in comparison to other species.
1.3.2 y8 T cell receptor development.
There are numerous nomenclatures describing the variable gene usage of the yd T cell subsets.
These are discussed by Raulet (1989). In this introduction, the V region nomenclature used will
be that followed by Heilig and Tonegawa (1986).
In the mouse, y8 T cells consist of multiple lineages of cells which differ from each other by
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parameters such as time of appearance in ontogeny, anatomical location, TCR repertoire and
thymus dependence (Haas et al., 1993). The first virgin T cells seen in the thymus are CD4
negative and CD8 negative cells expressing the TCR rearrangement Vy5VSl. This is followed by
a second wave of cells expressing the Vy6VSl TCR (Havran and Allison, 1988; Ikuta et al., 1992;
Ito et al., 1989). These two y8 T cell subsets are unusual in that their TCR show virtually no
diversity (Lafaille et al., 1989). The appearance from the thymus of Vy5 and Vy6 T cells slows
down and ends in late fetal life. Vy4, Vy7 and TCR a(3 rearrangements then appear in succession
and these rearrangements continue to be expressed in adult life (Ikuta et al., 1992; Elliott et al.,
1988; Korman et al., 1988; Takagaki et al., 1989). It was reported, in the mouse, that the
precursors of all y5 T cells exported from the thymus must express both HSA and Thy-1 (Zorbas
and Scollay, 1993). The mechanisms that control the sequential appearance and disappearance of
Vy regions are still unclear. In the adult, Vy5 expressing cells home to the epidermis (Asarnow et
al., 1988; Havran and Allison, 1990). Cells found in the skin express only Vy5V5l sequences
whereas Vy5 expressing cells in the intestinal epithelium have a broad receptor diversity
(Tonegawa et al., 1989). Presumably the monomorphic TCR expression in the skin and
epithelium arose through an evolutionary pressure and these cells will have only one specificity.
Vy6 expressing cells are found in the mucosal epithelia of the female reproductive tract and the
tongue (Itohara et al., 1990; Tonegawa et al., 1989). These cells again have no TCR diversity and
in human oral epithelium it has been shown that there is preferential expression of the VSl
sequence (Pepin et al., 1993). Cells expressing the Vy4 rearrangement are found in the blood,
spleen and lymph node of adults and have a high degree of TCR diversity.
The molecular mechanisms underlying the appearance of distinct y8 T cell subsets are obscure. It
was recently shown that an intracellular mechanism acting at the level of DNA rearrangement in
the thymus, rather than a cellular selection mechanism, plays a key role in the differential
generation of y8 T cell subsets (Itohara et al., 1993).
1.3.3 ap T cell receptor development.
The principle pathway for development of T cells that will express ap TCR complexes is again in
the thymus. Firstly, the TCR p chain is expressed in disulphide linkage with the development
protein gp33 and in association with CD3 (Groettrup et al., 1993). Cross-linking of this induces
calcium mobilisation (Groettrup et al., 1992; Groettrup and von Boehmer, 1993) and is
responsible for promoting the development of thymocytes. This occurs to avoid the
accumulation of thymocytes with either no, or a nonproductive TCR P chain rearrangement
(Mombaerts et al., 1992; Mallick et al., 1993). Following this, further TCR p chain
rearrangements are suppressed ensuring the expression of only one TCR P allele. The TCR P
chain may also enhance TCR a chain rearrangements. Once the signal has been delivered, TCR a
chain rearrangements are accelerated and gp33 expression is terminated. The next stage of
development is different in the human and mouse species. Human cells differentiate into CD4hi,
CD8-negative, CD3-negative (Kraft et al., 1993) while mice cells differentiate into CD8hi, CD4-
negative, CD3-negative (Guidos et al., 1989, 1989a). This leads to the expression of both co-
receptors and gives rise to double positive cells: CD8-positive, CD4-positive blast cells. These
cells express low levels of the ap TCR-CD3 complex and are the starting point for most of the
reported TCR based selection within the thymus. The blast cells either progress into a small cell
progeny and die off or follow a two-stage differentiation into CD4-positive (CD8-negative)
TCRhi or CD8-positive (CD4-negative) TCRhi virgin T cells (Guidos et al., 1990).
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1.4 T cell selection in the thymus.
Antigen recognition by the TCR molecule occurs in association with MHC class I or MHC class II
molecules. Antigen recognition and MHC presentation is discussed later (section 1.8). The TCR
is predicted to have a similar structure to immunoglobulin molecules and is orientated to interact
with peptide fragments and the MHC molecules which hold them (Hong et al., 1992; Kaye and
Hendrick, 1988; Malissen et al., 1988). The antigen binding sites of the TCR has three variable
domains termed complementarity determining regions (CDR). CDR1 and CDR2 are made up
from the variable regions of the genome and CDR3 is formed from the V(D)J segments
(Jorgensen et al., 1992). The CDR3 region is involved in the recognition of the peptide fragment
(Hong et al., 1992) whilst the CDR1 and CDR2 regions make contact with the a-helices of the
MHC molecules (Clavarie et al., 1989; Davis and Bjorkman, 1988; Bjorkman et al., 1987).
Because of the nature of antigen receptor formation there will be receptors which are specific for
either self-MHC a-helices which are in association with foreign antigenic peptides or self-MHC
a-helices which are in association with self peptides or no peptide at all. There has to be
therefore, some form of negative selection which prevents self-specific lymphocytes from
becoming auto-aggressive and also positive selection by internal ligands, so avoiding the
accumulation of redundant lymphocytes.
A major function of the thymus is the selection of cells that co-recognise peptides which are held
in association with self-MHC a-helices only. Cells that survive and are found in the periphery of
an individual have undergone positive and negative selection. Positive selection leaves behind
cells which recognise, but are not stimulated by sclf-MHC. Negative selection removes those cells
with receptors which strongly recognise either self-MHC alone or self-MHC plus self antigens.
Negative selection occurs predominantly by a clonal abortion process (Kappler et al., 1987). It is
not known whether positive selection or negative selection occurs first (Guidos et al., 1990;
Borgula et al., 1991).
Most reports in the literature describe positive and negative selection of a(3 T cells. It has
however been suggested that y5 T cells are subject to positive and negative selection in a manner
analogous to the a(3 T cell population (Matis et al., 1991; Wells et al., 1993). Some reports
contradict this and have demonstrated that y5 T cells can develop normally in the absence of
MHC class II molecules (Bigby et al., 1993). It has been proposed that heat shock proteins or
endogenous ligands, such as viral sequences, may play a role in the positive selection of y5 T cells
though the more restrictive rearrangements of the y5 TCR implied a less stringent selection
process (Lafaille et al., 1990; Sim and Augustin, 1990). It was also reported recently (Dent et al.,
1993) that self reactive y5T cells undergo programmed cell death following negative selection.
1.4.1 Positive selection.
Numerous models have described positive selection (Teh et al., 1988; Kisielow et al., 1988; Scott
et al., 1989) which was recently reviewed by Bevan (1994). The nature of the MHC ligands
inducing positive selection is unknown though the recognition of a peptide is thought to be
essential for positive selection. The thymus is thought to be able to generate virtually all the
peptides that could possibly fit into the groove of a given MHC. This may occur at sufficiently
low concentrations to allow for positive selection, without causing active responses leading to
negative selection (Kourilsky et al., 1989). An alternative view is that the peptides are needed
simply to stabilise the MHC molecules on the cell surface and that the ligands required for
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positive selection are generally different to those inducing T cell activation.
It is believed that T cells which express a TCR with intermediate avidity for either the MHC class I
or MHC class II peptide complexes are positively selected. Following positive selection via the
TCR, the selected cells further develop into functionally mature cells. T cells which bind MHC
class I peptide complexes make a second contact between the CD8 molecule and the MHC class I
molecules. T cells which bind MHC class II peptide complexes make a second contact between
the CD4 molecule and the MHC class II molecule. The second contact induces a decrease in the
cell surface expression of unengaged CD4 or CD8 molecules (Robey et al., 1991; Borgula et al.,
1991).
Associated with the positive selection via the TCR is a shut-down of the recombinase associated
genes, RAG1 and RAG2, which terminate the cells' TCR rearrangements. The TCR a-chain
product, in contrast to the TCR (i-chain, does not induce feedback regulation of further TCR a-
chain rearrangements and two different TCR a-chain transcripts have been observed in the same
cell at both the RNA and protein level (Casanova et al., 1991; Borgula et al., 1992).
1.4.2 Negative selection.
Negative selection is the process by which a TCR-antigen interaction results in the death of the T
cell expressing the given TCR molecule (reviewed by Nossal, 1994). If the avidity between the
MHC peptide complex on the thymic stroma and the TCR on the T-cell is sufficiently high, the
thymocyte will undergo apoptosis and is deleted from the lymphocyte repertoire of that
individual (Jenkinson et al., 1989; MacDonald and Lees, 1990; Ucker et al., 1992). The death
of a self-reactive lymphocyte is termed clonal deletion. The majority of clonal deletion of
thymocytes occurs when the thymocyte has a CD4-positive, CD8-positive phenotype (Spain and
Berg, 1992). T cells can also be silenced by persistent stimulation with an antigen without
undergoing apoptosis. This is termed clonal anergy (Nossal and Pike, 1980).
1.5 The immunobiology of y5 T cells.
1.5.1 Extrathymic origin of y8 T cells.
It is known that not all y8 T cells are generated in the thymus. Populations of murine y5 T cells
have been shown to be generated extrathymically in the gut (Guy-Grand et al., 1991, 1991a;
Rocha et al., 1991), the liver (Abo et al., 1991) and the lungs (Sim and Augustin, 1990: Sim and
Augustin, 1991; Augustin et al., 1989). Human di George syndrome patients (van Dongen et al.,
1990) and thymoectomised chickens (Bucy et al., 1991) have also been shown to generate
populations of y5 T cells. In contrast, thymoectomised lambs do not generate any populations of
y5 T cell populations (Hcin et al., 1990a).
1.5.1.1 Intraepithelial y8 T cells.
The populations of ilEL in all species examined comprise T cells bearing y5 and a(3 TCR. Most
ilEL expressing a y5 TCR are extrathymically derived and it has been shown that tolerance,
functional anergy and deletion occur in this environment (Barrett et al., 1993). y§ T cells are a
major population of ilEL in humans (Deusch et al., 1991), mice (Allison and Havran 1991;
Taguchi et al., 1991) and sheep (Gyorffy et al., 1992). y5 ilEL are found primarily in the small
intestine interspersed between the villous epithelial cells and are unique to all other y5 T cells in
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numerous ways. Firstly, murine y8 ilEL preferentially use Vy7 variable region and express
extensive junctional diversity. This is in contrast to all other y8 T cells localised at epithelial sites
within this species (Robijn et al., 1993; Bonneville et al., 1988; Asamow et al., 1989; Takagaki et
al., 1989a). Secondly, y8 ilEL express CD8 act homodimers (Bandcira et al., 1991; Boneville et
al., 1988). The functional significance of the lack of CD8p chain expression is unclear but
CD8a-chain expression is sufficient for signal transduction (Dembic et al., 1987). CD8 act
homodimers can also be expressed by activated y8 T cells from peripheral tissues (Cron et al.,
1989) and lectin stimulated thymocytes (MacDonald et al., 1988). Expression of the CD8 aa
homodimers may be indicative of an activated y8 T cell lineage within the gastrointestinal
microenvironment (Guy-Grand et al., 1991). Alternatively, expression of the CD8 aa
homodimers may imply that y8 ilEL have the potential to recognise foreign peptide presented by
MHC class I or MHC class I-like molecules such as TL or CD1 antigens. MHC class I, TL
antigens or CD1 antigens are all expressed by gut epithelial cells and are implied to have
functional roles as presentational elements in antigen presentation to y5 T cells (Taguchi et al.,
1991; Hershberg et al., 1990; Bleicher et al., 1990; Wu et al., 1991; Eghesady et al., 1992).
Thirdly, few murine y5 IEL express CD5 and only half of the cells express Thy-1 (Ledbetter et al.,
1980; Lefrancois, 1991).
It was recently shown that in microbe-deprived mice, the level of y5 ilEL remained constant whilst
the aP ilEL level decreased with a loss in cytolytic activity also observed (Kawaguchi et al., 1993).
It is therefore believed that there is no requirement for the intestinal flora for the presence of y8 T
cells.
1.5.2 y8 T cell function
There is, as yet, no clear delineation of the function of y8 T cells although y8 T cells have been
attributed a great number of functions. These functions however have all been identified with yS
T cells clones or with transgenic animals devoid of certain subsets of cells. This obviously
reduces the significance of any results found, due simply to the artificial circumstances and
environments under which the cells were treated and responses analysed.
From in vivo studies, y8 T cells are believed to play a large part in the immunosurveillance system
and in primary immune response to several infectious organisms. Increases in y8 T cell number
were observed in the peripheral blood during numerous bacterial and parasitic infections of both
humans and mice (Janis et al., 1989; Eichelberger et al., 1991; Carding et al., 1990; Ohga et al.,
1990; Alaibac et al.,1993; van der Heyde et al., 1993; Takada et al., 1993). During the course
of diseases such as leprosy (Modlin et al, 1989; Falini et al., 1989), Graves disease (Roura-Mir et
al., 1993), tonsillitis (Kawaguchi, 1993), HIV infected patients with AIDS (Autran et al., 1989; De
Paoli et al., 1991) and multiple sclerosis (Hvas et al., 1993) an increased number of tissue resident
and circulatory yS T cells were also observed. Additionally, y8 T cells have been isolated from the
synovial fluid of patients with rheumatoid arthritis (Holoshitz et al., 1989) and from the lungs of
patients with sarcoidosis (Balbi et al., 1990) which suggested a role for these cells in the
pathogenesis of autoimmune diseases.
In addition to increases in the y8 T cell population as a whole, individual sub-populations of y8 T
cells with single variable chains are known to respond to certain infections. A preferential
expansion of the V82 subset was observed following Brucella meltensis infection (Bertotto et al.,
1993) and similarly during the acute stage of Epstein-Barr Virus the number of circulating VS2
10
expressing y8 T cells was also greater. Little of the evidence however suggested that the expansion
in the circulation, or accumulation of y8 T cells in the infected tissues, was due to recognition of
microbial antigens. Responses were thought to be directed toward a host derived stimuli. In some
cases, no detectable in vitro response by y5 T cells from an infected individual, was observed to
antigens from the infectious agents, (Bertotto et al., 1993; Eichelberger et al., 1991).
1.53 Ligand recognition by y5 T cells.
A diverse array of antigens have been identified as ligands for y5 T cells in both the murine and
human species. This heterogeneous group of ligands includes classical and non-classical MHC
molecules (Matis et al., 1987, 1989; Bluestone et al., 1988; Bonneville et al., 1989a),
mycobacterial heat shock proteins (Born et al., 1990, 1990a; Russo et al., 1993), superantigens
such as staphylococcal enterotoxins (Rust et al., 1990) and self antigens including CD1 (Porcelli
et al., 1989), cell surface immunoglobulins (Wright et al., 1989) and autologous stress proteins
(Born et al., 1990; Ramanujam et al., 1990). None of these antigens however appear to be
representative targets for y5 T cells as a whole or their defined subsets. The exceptions, which are
described below, are the recognition of Mycobacterium tuberculosis antigen by human peripheral
blood y5 T cells, the recognition of heat shock proteins by murine peripheral blood y5 T cells and
the recognition of keratinocyte antigens by skin y5 T cells in the murine species.
In human peripheral blood 50-70% of y5 T cells express a Vy9/V52 heterodimeric structure
whereas Vy9/V52 y8 T cells represent only a minor population in cord blood (Parker et al., 1990;
Faure et al., 1990). The majority of human peripheral blood Vy9/VS2 y8 T cells respond to
Mycobacterium tuberculosis lysates and stimulation of human cord blood with Mycobacterium
tuberculosis lysates selectively expanded the Vy9/V82 y5 T cell population. Pfeffer and
colleagues (1990, 1992) reported that the moiety which stimulated the human Vy9/V82 y§T cell
population was a lectin-binding, protease resistant ligand of l-3kDa which exhibited the
hallmarks of a superantigen for y8 T cells.
Murine y8 T cells expressing Vyl/VS6 were shown to recognise both mycobacterial hsp 65 and
murine hsp 60 (Born et al., 1990, 1990a; Happ et al., 1989). The cross reactivity of Vyl/V86 yS
T cells with eukaryotic and prokaryotic heat shock proteins occurs because of the high degree of
conservation between heat shock proteins (Kaufmann, 1990). Furthermore, murine Vyl/VS6 y5T
cells hybridomas recognised a 16 amino acid peptide corresponding to residues 180-196 of
mycobacterial hsp 65 (O'Brien et al., 1989, 1991) and y5T cells responded to this peptide in
vivo. In the murine species, y5 T cells which recognise heat shock proteins are proposed to have a
developmental role (Ferrick and Gemmell-Hori, 1992) and a role in bacterial immunity and
autoimmunity (Reardon et al., 1992). In the human species, y8 T cells which recognise heat
shock proteins are proposed to have an autoaggressive role in muscle disease (Hohlfeld and
Engel, 1992)
Invariant, murine y8 T cells expressing Vy3/V8l reside in intimate contact with keratinocytes and
recognised self antigens on stressed neighbouring cells in a non-MHC restricted fashion (Havran
et al., 1991). The keratinocyte antigen recognised is a low molecular weight moiety which can be
acid eluted from stressed keratinocytes (Havran and Boismenu, 1994).
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1.5.4 Effector functions of y5 T cells.
1.5.4.1 Secretion of cytokines by y5 T cells.
The secretion of cytokines is an integral part of the function of ap helper T cells following
antigenic stimulation. It has been shown in humans and mice that y5 T cells, like a(3 T cells, can
be stimulated to secrete many lymphokines. As the antigen specificity and restriction elements of
y5 T cells are unknown, non-specific stimuli were used to stimulate the y5 T cells. In contrast,
many y5 T cell clones in cattle could not be stimulated to secrete the major cytokines IL-2, IL-4
and y-IFN (W.I. Morrison, personal communication). In the human and mouse species IL-2 is
secreted by y5 T cells following stimulation though the levels of IL-2 produced are considerably
lower than the levels of IL-2 produced by a(3 T cells (Bender and Kabelitz, 1990; Patel et al.,
1989; Warren et al., 1989). The cytokines IL-3, IL-4, IL-5, IFNy, TNF-a, TNF-P and GM-CSF
are also produced by y5 T cells in response to a variety artificial stimuli (Biassoni et al., 1991;
Patel et al., 1989; Krangel et al., 1990; Carding et al., 1990a; Carrel et al., 1991). Different
combinations of lymphokines were shown to be produced by different y8 T cell clones though it
is not clear if there are any analogies to the TH1 and TH2 subsets of the a[3 T cell lineage
(Bluestone et al., 1991; Krangel et al., 1990; Morita et al., 1991; Spits et al., 1989; Raziuddin et
al.,1992; Taguchi et al., 1991). In the absence of details of the physiological roles or antigenic
stimuli of y5 T cells, it is difficult to speculate on the function of the produced cytokines.
1.5.4.2 Cytotoxic y5 T cells.
y8 T cells have been shown to lyse target cells in a manner analogous to CD8-positive T cells, NK
cells and LAK cells in humans (Koide et al., 1989; Spits et al., 1989), mice (Goodman and
Lefrancois, 1988; Klein, 1986) and sheep (MacKay et al., 1988a). Those y8 T cells which
express a disulphide-linked form of the T cell receptor (Cyl) are more highly cytotoxic than
those expressing the non-disulphide linked form (Cy2) (Christmas 1989; Dastot et al., 1990). It
was also suggested that the cytotoxicity of human y5 T cells is associated with surface phenotype.
CD8-positive y5 T cell clones and CD4-negative, CD8-negative y8 T cell clones mediated
cytotoxic function whilst CD4-positive y5 T cell clones did not (Morita et al., 1991). The
expression of CD8 by some cytotoxic y5 T cell clones may suggest that these cells recognise cells
in a MHC class I restricted manner. This however, has not been shown although y8 T cell
mediated lysis via non-polymorphic class lb molecules has been reported (Porcelli et al., 1989).
In addition, y5 T cells are known to localise at epithelial sites where MHC class lb molecules are
known to be expressed (Vroom et al., 1991; Eghesady et al., 1992)
Indirect evidence of a cytotoxic function of y5 T cells was found in the murine species were
electron dense granules were located in the cytoplasm of murine y8 T cells (Koizumi et al., 1991).
It is known for CD8-positive cytotoxic T cells that perforin is stored in cytoplasmic electron dense
granules which are visible by electron microscopy (Kraehenbuehl and Tschopp, 1990). In
addition, both human and murine y5 T cells express mediators of cytotoxicity such as perforin
and serine esterases 1 and 2 (Nakata et al., 1990; Koizumi et al., 1991). In contrast, in the ovine
species, electron dense granules were not observed in y5T cells in the ovine species (Evans, 1993).
1.6 The immune response.
Immune activation of lymphocytes occurs in the periarteriolar lymphoid sheaths of the spleen
and the paracortex of the lymph node where antigen specific cells are selectively sequestrated.
12
The spleen is the locus of immune responses to most blood borne antigens whilst the different
lymph nodes and the Peyer's patches are the loci of the immune responses to antigen taken up
into the afferent lymph.
The number of T cells specific for the foreign peptides of a given pathogen is very low in an
unprimed individual. Dendritic cells appear to provide a mechanism which ensures that these few
specific T cells and antigen meet (Steinman, 1991). Dendritic cells express both MHC class I and
class II molecules and the turnover of these molecules is very low. In addition, MHC class lb
molecules and MHC class I-like molecules such as CD1, which have been shown to play a role in
antigen presentation, are expressed by dendritic cells (Steinman, 1991). Dendritic cells migrate to
lymph nodes, spleen and mucosal sites where they strongly adhere. Quiescent, recirculating T
cells "scan" the MHC surfaces of the dendritic cells and once an interaction of the correct avidity
occurs, the antigen specific T cells are activated, divide, and become effector cells.
In the lymph node, primary B cell follicles contain mostly resting B cells, while T cells are
predominantly found in the T cell domains of the paracortex (Gutman and Weissman, 1972).
When stimulated, CD4-positive T cells move from the paracortex of the lymph node to the
interface between it and the B cell dominated primary follicle (Gutman and Weissman, 1972;
Rouse et al., 1982). These activated CD4-positive T cells are thought to stimulate antigen specific,
follicular B cells. A few days after antigenic challenge, proliferating B cells can also be detected
in the periarteriolar lymphoid sheath of the spleen and are subsequently found in primary
lymphocyte follicles. In the lymph node, large germinal centres are prominent for about two
weeks and contain: i) follicular dendritic cells which effectively store and present antigen, ii)
activated T helper cells, iii) proliferating B cells and their non-dividing progeny. After several
days the expanded populations are released into the circulation and carry out effector functions.
1.7 Memory cells.
Following the clearance of antigen at the end of a primary response wide scale T cell elimination
is known to occur (Rocha and von Boehmer, 1991; Moskophidis et al., 1993) and most effector
B cells (plasma cells) die within 1-2 weeks (Ho et al., 1986). A proportion of antigen specific
cells however remain and become long-lived memory cells. Memory T cells are derived from
effector T cells (Moskophidis et al., 1993) and the resulting memory cells have identical TCR
affinities to the effector cells. Memory T cells (CD45Rhi, L-selectinhi, CD4410) have a distinct
surface phenotype compared to naive cells (CD45R10, L-selectin1(>, CD44h9 (Fowell et al., 1991;
Swain et al., 1991; Budd et al., 1987) though memory T cells have been reported to revert to a
naive phenotypic status (Bell and Sparshott, 1990). Memory T cells also express a number of
other markers lacking on naive cells (Shimizu et al., 1990; Mackay, 1993) and differ in their
pattern of cytokine release (Mossmann and Coffman, 1989). It is believed that maintenance of
immunological memory requires the persistence of antigen and the incomplete elimination of
viral infections. Dendritic cells and sequestered antigen are retained in the germinal centres of a
lymph node for months to years (Mandcl et al., 1980; Tew et al., 1990). It has also been seen in
some viral infections that viruses can avoid complete elimination (Ahmed, 1992; Oehen et al.,
1992; Gray, 1993).
The generation of memory B cells occurs by affinity maturation in the germinal centres and is
associated with somatic hypcrmutation and immunoglobulin class switching (MacLennan, 1994;
Berek et al., 1991; Rajewsky, 1992; Leanderson et al., 1992; Nossal, 1992). Memory and naive
B cells, unlike the equivalent T cells, are believed to originate from two different precursor cell
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sub-populations distinguished by different levels of HSA (a phosphoinositol-glycolipid linked
glycoprotein) (Linton et al., 1989; Yin and Vitetta, 1992). HSA-positive cells elicit strong
primary responses whereas HSA10 or HSA-negative cells function well as precursors of memory
cells. Memory B cells express higher levels of CD44 than naive B cells and they also differ in the
isotype of immunoglobulin expressed on the cell surface.
1.8 Antigen processing and presentation.
The majority of T cell clones do not recognise native antigen but instead recognise a peptide
derived from proteolytic cleavage of the native antigen (Unanue, 1984; Townsend and Bodmer,
1989). Two major intracellular routes of antigen processing and presentation have been
identified. One route generates peptides from endogenously synthesised proteins which are
presented in association with MHC class I molecules (Townsend and Bodmer, 1989; Morrison et
al., 1988). The second route generates peptides from exogenously acquired protein material
which are presented in association with MHC class II molecules (Unanue and Allen, 1987)
1.8.1 MHC molecules.
Immunologists first became aware of the MHC loci, which encode the molecules involved in
antigen presentation, as a result of intraspecies tissue grafting experiments (Counce et al., 1956).
MHC class I molecules have one integral membrane subunit, a 45kDa heavy chain, non-
covalently associated with the 12kDa molecule (32 microglobulin which is encoded outside the
MHC (Bjorkman and Parham, 1990). MHC class I molecules are expressed on all nucleated cells
of the body although expression varies and is typically highest on hematopoietic cells. MHC
class II molecules are heterodimers of two transmembrane proteins, an a subunit of 33kDa and an
(3 subunit of 29kDa. MHC class II molecules are constitutively expressed on B cells,
macrophages, monocytes, dendritic cells and endothelium. Under the influence of the cytokine
y-interferon, however, MHC class II expression can be induced on diverse cell types.
The X-ray crystallographic structure of MHC class I molecules (Bjorkman et al., 1987; Madden
et al., 1992) and MHC class II molecules (Brown et al., 1993) have been determined. MHC class I
and MHC class II molecules have a peptide groove consisting of a floor of eight P strands of
amino acids which support walls of a helices. It has been proposed, due to sequence homology,
that the MHC molecule peptide-binding regions may have evolved from the peptide-binding
domain of hsp70 chaperones (Flajnik et al., 1991; Rippmann et al., 1991). For both classes of
MHC molecules, the diverse peptide binding capacity arises from hydrogen bonds formed
between conserved residues of the MHC molecule and backbone or terminal groups of the
associated peptides.
1.8.2 MHC class I antigen processing and presentation.
MHC class I molecules generally present peptides which are generated by degradation of
cytosolic protein. Townsend and colleagues (1985) showed that CD8-positive cytotoxic T cells
required MHC class I molecules and cytoplasmic or nuclear viral proteins for their activity. In
addition, cytoplasmic and nuclear proteins were seen to be the principle source of peptides eluted
from purified MHC class I molecules (Hunt et al., 1992a). The processing of endogenously
derived proteins to the peptides associated with MHC class I molecules occurs in the cytosol
(Morrison et al., 1986; Moore et al., 1988; Townsend et al., 1985, 1986). This process involves a
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multicatalytic, ATP-dependant protease assembly called the 26S proteasome (reviewed by
Goldberg and Rock, 1992). The first step in the hydrolysis of most endogenous protein involves
the covalent conjugation of the protein to ubiquitin (Rechsteiner, 1987; Hough et al., 1987;
Finley and Chau, 1991). This is the rate limiting step and requires ATP. Once associated with
ubiquitin, the polypeptide undergoes rapid hydrolysis by the ATP-dependant 26S proteasome.
An essential component of the 26S protease assembly is the 20S proteasome called CF-3 (Tanaka
et al., 1988). Complexes referred to as low molecular mass proteins (LMP), which are similar in
composition and size to the 20S proteosome, have been mapped to the MHC locus (Monaco and
McDevitt, 1982; Brown et al., 1991; Martinez and Monaco, 1991). It is suggested that LMP are
specialised types of 20S proteasomes (Goldberg and Rock, 1992).
Monaco (1992), identified genes encoding TAP-1 and TAP-2 proteins (TAP=transport associated
with antigen processing) which are responsible for the ATP-dependent transport of short MHC
class I binding peptides from the cytoplasm to the endoplasmic reticulum and then onto MHC
molecules (Shepherd et al., 1993; Neefjes et al., 1993). It was shown that the peptide was a
prerequisite for stable expression of the MHC class I heavy chain and (^-microglobulin complex
and that empty MHC class I heavy chains are not transported out of the E.R. hence reducing the
likelihood of exogenous peptide acquisition and presentation. The retention of empty MHC class
I heavy chains is due to the binding of calnexin (p88, Ip90) (Degen et al., 1992). Calnexin is
dissociated when (32-microglobulin and peptide have become associated with the heavy chain to
form a stable MHC molecule. To date, no physical association has been found between the
proteasomes or LMP and the TAP proteins.
MHC class I molecules bind antigenic peptides, using topographically clustered residues at the
very ends of their binding grooves in association with the free NH2 and COOH groups of the
associated peptide (Matsumura et al., 1992; Madden et al., 1992). The interaction of the N-
terminal and C-terminal amino acids with the MHC class I molecules are critical and prevent
peptides of the incorrect length from forming a stable MHC molecule. This feature of the MHC
class I-pcptide interactions results in a strong bias for short peptides in the range of 8-10 residues
(Falk et al., 1991).
1.8.3 MHC class II antigen processing and presentation.
MHC class II molecules assemble in the endoplasmic reticulum in association with a
nonpolymorphic, non MHC encoded type II integral membrane protein called the invariant chain
(Cresswell et al., 1990). The invariant chain possesses a short internal segment called the class II
associated invariant chain peptide region (Riberdy et al., 1992) which either occludes or closes the
MHC class II peptide binding site. The invariant chain is required for the active assembly of
MHC class II a and P chains and enables MHC class II molecules to avoid any unproductive
interaction with protein peptides in the endoplasmic reticulum. (Roche and Crosswell, 1990;
Teyton et al., 1990).
MHC class II molecules generally present peptides which are generated from exogenous antigen.
Exogenous antigen is endocytosed in numerous ways into MHC class II expressing antigen
presenting cells (Allen et al., 1987; Puri and Factorvich, 1988). By nonspecific adsorption or
fluid phase pinocytosis into macrophages; by specific Fc-receptor mediated uptake of antigen-
antibody in an immune complex into dendritic cells (Bujdoso et al., 1990; Harkiss et al., 1990)
15
or via high affinity immunoglobulin antigen receptors on B cells (Sallusto and Lanzavecchia,
1994).
Exogenous antigen, once endocytosed, undergoes proteolytic degradation by acid proteases or
cathepsins in endocytic vacuoles of the late endosomal/lysosomal pathway (Allen et al., 1987). A
novel endocytic compartment distinct from endosomes and lysosomes has recently been
discovered (Amigorena et al., 1994; Tulp et al., 1994; West et al., 1994). This compartment for
peptide loading of MHC class II molecules is biochemically distinct from conventional
endosomes and lysosomes and represents a new stage in the endocytic-lysosomal pathway. The
acidic nature of the vacuoles are believed to assist in the efficiency of peptide binding by the
MHC class II molecules (Neefjes and Ploegh, 1992). Once peptide is acquired, the MHC class II
molecule-peptide complex is long lived on the surface of the cell (Germain and Hendrix, 1991;
Davidson et al., 1991). The cytoplasmic tail of the invariant chain has been shown to play an
important role at this time in the recruitment of new MHC class II molecules to the endocytic
vacuoles (Lotteau et al., 1990) and has also been shown to play a key role in the overall efficiency
of MHC class II peptide capture and binding (Viville et al., 1993; Bikoff et al., 1993).
The peptide binding sites of MHC class II molecules are open such that peptides can extend out
(Brown et al., 1993) and consequently, MHC class II-associated peptides are typically 12-24
residues in length (Rudensky et al., 1991; Chicz et al., 1992; Hunt et al., 1992b). The binding
of the peptides by MHC class II molecules involves polymorphic residues in the MHC molecule
and specific side chains of the peptide. The MHC class II groove is lined with structural pockets
in which the side chains of some of the specific amino acids of peptides line up (Falk et al., 1991;
Hammer et al., 1993). These amino acids are termed anchor residues and two or three are
required on a peptide for optimal binding to the MHC class II molecules. The requirement of
anchor residues has helped in describing simple motifs which can help to predict the part of a
protein which might be effectively presented by a given MHC class II molecule.
1.8.4 Putative presentational elements for y8 T cells.
The specificity, if any, of y5 T cells for antigen in association with antigen presenting molecules is
one of the most fundamental questions in y5 T cell immunobiology which remains unanswered.
The function of this population of T cells will be more accurately assessed once the ligand these
cells recognise has been identified.
Murine and human yS T cells have been shown to mount strong proliferative responses to killed
mycobacteria in the presence of antigen presenting cells. The major stimulatory components of
mycobacteria were found in the small molecular weight fraction (2-10kDa) of extracts and were
resistant to proteolytic enzymes (Pfeffer et al., 1990, 1992). The chemical nature of this material
remains to be elucidated. It is also unknown if the ligand that was recognised was of
mycobacterial origin or was an endogenous ligand induced on antigen presenting cells.
y8 T cells do not have a bias for classical MHC class I or class II proteins. Few murine or human
y5 T cell clones have been found which recognise antigen in association with MHC class I or
MHC class II molecules (Haas et al., 1993). In addition, it has been reported that the specific
recognition of MHC molecules by some y5 T cell clones was due to fortuitous cross reactivity of
the y5 TCR with a constant region on the side chain of the MHC molecule (Schild et al., 1994).
Furthermore, increases in y5 T cell number in mice experimentally infected with malaria was
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shown not to be due to any classical or non-classical MHC class I presentation. The same level of
increase in the yS T cell population was observed in (32-microglobulin deficient mice (van der
Heyde et al., 1993). In addition, yS T cells do not appear to play any part in graft rejection, their
effects potentially being one of suppression of a(3 T cell responses (Haas et al., 1993).
Non-classical MHC-like proteins are thought to play a part in the immunopresentation of antigen
to yS T cells (Strominger, 1989). In the mouse, TL region encoded proteins are expressed on
epithelial cells in the intestine. The T3b product is expressed on columnar epithelial cells found
in close proximity to y8 T cells (Wu et al., 1991). In addition, peptide was found associated with
the T3b product (Imani and Soloski, 1991; Vidovic et al., 1989). It was therefore proposed that
various murine y8 T cell subsets may recognise antigens presented by different tissue specific TL
region encoded proteins (Stominger et al., 1989). The class I gene (T22b) (van Kaer et al., 1991)
and the class I gene (27b) (Ito et al., 1990) both encoded within the TL region presented ligands
to y8 T cells.
The human MHC class I family includes at least 15 loci other than the classical transplantation
antigens (Malissen et al., 1982). Some of these genes encode MHC class I like proteins which
may be the human equivalents of the murine TL proteins. Recognition of ligands presented by
any of these proteins has not however been reported. Two human y8 T cell clones were found to
recognise CDlc which is encoded by one gene of a cluster of five closely related MHC class I-like
genes on chromosome 1 (Porcelli et al., 1989; Faure et al., 1990a; Calabi and Milstein 1986).
1.9 Lymphocyte activation.
The adaptive immune response can be split into three distinct stages. Firstly naive lymphocytes
become activated following recognition of foreign antigens via their antigen receptor molecules.
Secondly, antigen specific cells proliferate and differentiate to become effector cells and thirdly
the infectious agent of the immune response is removed.
Activated T lymphocytes undergo replication and produce a single clone of cells which are
specific for the antigenic peptide first encountered. All a(3 T lymphocytes undergo this process
having recognised peptide antigen The nature of the response is thought to be determined by the
nature of the signals received during encounter with antigen and antigen presenting cells. The
activation of CD4-positive T cells may be the most important as they control the activation of B
cells, macrophages and sometimes CD8-positive T cells. It is widely accepted that T cells require
two distinct signals to proliferate and subsequently differentiate into armed effector cells
(Schwartz, 1992). The first signal comes from the interaction of the TCR with its complementary
MHC molecule presenting the required peptide. The second, or co-stimulatory signal, does not
induce T cells responses by itself, but is required when the TCR and MHC molecules are engaged.
Lack of a co-stimulatory signal induces cell death (Webb et al., 1990) or anergy (Jenkins et al.,
1988). Naive CD4-positive T cells respond most efficiently when the signals required for their
activation are expressed on the same cell (Liu and Janeway, 1992; Galvin et al., 1992).
Immune activation of B lymphocytes involves the cells leaving the G0 stage of the cell cycle and
replicating to create a number of different clones of progressively more differentiated
immunological effector cells. Once activated, B cells become effector cells and differentiate into
B cell blasts. These cells initially express the p heavy chain but in time receive cytokine signals
from T cells that induces them to undergo immunoglobulin class switching (Kraal et al., 1982;
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Butcher et al., 1982). Immunoglobulins produced by the B cell blast progeny have somatic
mutations in their variable region. B cell blasts in the germinal centre which produce higher
affinity antibodies will continue to proliferate and differentiate, whilst those which produce lower
affinities are diminished following the mutations and die by programmed cell death. The
continued expression of the gene bcl-2, is associated with survival of B cell blasts, whereas failure
of continued expression is associated with programmed cell death of germinal centre B cell blasts
(Vaux et al., 1988 McDonnell et al 1989).
1.9.1 Co-stimulatory molecules for T cell activation.
For naive T cells to proliferate, the MHC and peptide antigen for which they are specific, must be
expressed on a cell which also expresses the protein B7/BB1. B7/BB1 is a ligand for both CD28
which is expressed on naive CD4-positive T cells (Linsley et al., 1991a; Koulova et al., 1991) and
for CTLA-4 which is expressed on antigen-experienced T cells (Lindsey et al., 1991b; Brunet et
al., 1987). CTLA-4 is related to CD28 but binds B7/BB1 with a higher affinity. CTLA-4 was
used in vitro and in vivo as a soluble, functionally active, fusion protein and inhibited numerous
CD4-positive T cell responses to antigen, inducing unresponsiveness or anergy (Ledbetter et al.,
1992; Liu et al., 1992b; Linsley et al., 1992; Tan et al., 1993). These results showed that the
ligand for B7/BB1 is critical for the co-stimulation of naive CD4-positive T cells The importance
of B7 was demonstrated by transfecting nonimmunogenic, transplantable tumour cells with the B7
gene (Townsend and Allison, 1993; Chen et al., 1992; Baskar et al., 1993). These tumour cells
were immunogenic when transplanted into mice and moreover, mice which were cleared of the
tumour cells had active immunity against identical non-transfected tumour cells. It was also
shown that CD28 and CTLA-4 recognises ligands other than B7 (Liu et al., 1993; Hathcock et al.,
1993; Freeman et al., 1993b; Lenschow et al., 1993) and a second ligand, B7.2, has been cloned
(Freeman et al., 1993a).
HSA can also costimulate growth of naive CD4-positive T cells (Liu et al., 1992a). Soluble
CTLA-4 fusion protein and anti-HSA antibodies independently blocked naive CD4-positive T cell
responses by 90%. When used together, these reagents completely inhibited the responses. The
receptor for HSA is not known. In addition, it has been shown that molecules which costimulate
the growth of CD4-positive T cells also appear to costimulate the growth of CD8-positive T cells
(Townsend and Allison, 1993; Chen et al., 1992; Baskar et al., 1993).
1.9.2 Co-stimulatory molecules for B cell activation.
B cell responses are regulated by the CD40 ligand (gp39) (Noelle et al., 1992; Hallenbaugh et
al., 1992) which is usually expressed by helper T cells (Allen et al., 1993; Aruffo et al., 1993).
CD40 is constitutively expressed on B cells and the CD40 ligand is rapidly induced on helper T
cells when they encounter antigen (Armitage et al., 1992; Macchia et al., 1993). The interaction
of CD40 and ligand activates the B cell which can then respond to soluble cytokines produced by
the T cell (Banchereau and Rousset, 1991). The CD40-gp39 interaction is also important for the
process of Ig switching (Paul and Seder, 1994).
1.9.3 Co-stimulatory molecule expression on APC.
Dendritic cells and B cells present antigen to CD4-positive T cells. These cell types constitutively
express MHC class II molecules in the peripheral lymphoid organs. Dendritic cells found in
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tissues are not however constitutively co-stimulatory. Following migration via the afferent
lymphatics to lymphoid tissue, these cells differentiate and acquire a co-stimulatory activity
(Janeway and Bottomly, 1994). Co-stimulatory dendritic cells are highly efficient activators of
naive CD4-positive T cells (Knight and Stagg, 1993) and express the co-stimulatory molecules
which bind CD28 and CTLA-4 (Liu et al., 1992b; Larsen et al., 1992). Dendritic cells also
express high levels of ICAM-1 and are very effective at forming clusters with T cells (Knight and
Stagg, 1993).
B cells are believed to present the peptides formed from soluble protein antigens (Ron et al.,
1981) to memory CD4-positive T cells (Fuchs and Matzinger, 1992; Ronchese and Hausmann,
1993). Resting B cells do not express the ligands for CTLA-4 in contrast to activated B cells (Liu
et al., 1992b; Hathcock et al., 1993). It was recently shown that expression of CTLA-4 ligands
on B cells was induced in a feedback mechanism following binding of the CD40 ligand on CD4-
positive T cells by B cells (Ranheim and Kipps, 1993).
1.9.4 Signal transduction by lymphocyte antigen receptors.
T cells and B cells have structurally different receptors for antigen and as a consequence
recognise fundamentally distinct forms of antigen, yet the signal transduction events that result
from the interaction of their receptors with antigen are similar. In addition to the antigen specific
receptors, other molecules contribute to cell activation by either: i) functioning as co-receptor
molecules which directly contribute to the formation of the complex between the antigen receptor
and the antigen/MHC complex. The known co-receptors on T cells are CD4 and CD8 which bind
to MHC class II and class I molecules respectively (Janeway, 1992). The co-receptor on B cells is
a complex of three proteins: CD19, complement receptor 2 (CR2) which binds CD23 (Carter and
Fearon, 1992) and TAPA-1. ii) increasing the avidity of the interaction between the two cells (e.g.
adhesion molecules such as LFA-1). or iii) inducing separate signal transduction events that
influence the cellular response (e.g. CD28, CD40).
1.9.4.1 Involvement of protein-tyrosine kinases (PTK) in T cell activation.
The TCR is associated non-covalently with the CD38, CD3e, and CD3y chains and a C, chain which
is either self-associated as a homodimer or associated as a heterodimer with either a r\ chain or a
FceRfy chain (Clevers et al., 1988). The TCR does not have intrinsic PTK activity and is not
expressed on the cell membrane independently of the signal transducing subunits (Weiss, 1991).
The cytoplasmic domains of the receptor associated chains are considerably larger than the
cytoplasmic domains of the TCR and are responsible for coupling the receptor subunits to the
intracellular signalling machinery and thereby activating cytoplasmic PTK. The signal
transduction functions of the TCR-associated chains were revealed by recent studies with mutant
cell lines (Wegner et al., 1992) and chimeric receptors (Irving and Weiss, 1991; Letoumeur and
Klausner, 1992; Romeo and Seed, 1991). A common cytoplasmic domain motif was found on
the TCR associated chains which couples these proteins to intracellular PTK (Weiss, 1993). The
consensus sequence is referred to as the antigen recognition activation motif, (ARAM) (Weiss and
Littman, 1994) and is sufficient to couple chimeric receptors to early and late signalling events
(Irving et al., 1993; Romeo et al., 1992). Multiple copies of ARAM sequences are found within a
single receptor and may provide a means of signal amplification.
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1.9.4.2 Association of CD4 and CD8 with PTK.
Most encounters of lymphocytes with antigen are thought to involve low affinity interactions of
the antigenic receptors. In addition, it has been estimated that as little as a few hundred relevant
peptide/MHC complexes are present on an antigen presenting cell (Harding and Unanue, 1990).
T lymphocytes use co-receptor molecules that act synergistically with the antigen receptor to
induce signal transduction events. It has been shown that binding of the CD4 co-receptor to the
same antigen presenting MHC augments signalling via the TCR receptor by up to 100-fold
(Dianzini et al., 1992; Miceli et al., 1991). Mechanisms underlying signal amplification have
been thoroughly scrutinised in a(3 T lymphocytes, whose integral membrane proteins, CD4 and
CD8 serve the essential co-receptor function. Firstly, the extracellular domains of CD4 and CD8
molecules bind to membrane-proximal regions of MHC molecules (Cammarota et al., 1992;
Konig et al., 1992). These interactions permit simultaneous binding of both TCR and CD4 or
CD8 to the same MHC molecule. Secondly, both CD4 and CD8 bind to the protein tyrosine
kinase Ick through their cytoplasmic domains (Veillette et al., 1991). The mechanism of
synergistic activation is believed to be due to interplay between molecules associated with the
cytoplasmic tails of the TCR and associated proteins (Diazani et al., 1992).
Two classes of cytoplasmic PTK have been implicated in signalling by the TCR, namely the src
and sykfLAP-10 families. Members of the src family have a unique N-terminal domain with a
myristylated glycine at position 2 which is responsible for membrane association and a C-terminal
tyrosine phosphorylation site which is the site of negative control of the catalytic activity. Three
members of the src family are generally expressed in most T cells, lck,fyn and yes. The clearest
documented role for these molecules is that for Ick which interacts with the cytoplasmic domains
of the co-receptors CD4 and CD8 (Rudd, 1990; Veillette et al., 1991). Ick works in two distinct
ways in co-receptor-assisted T cell activation. Enzymatically active Ick localises to the TCR
complex where it acts early in the pathway phosphorylating tyrosines in ARAM sequences of
CD3 and £ chains (Weiss and Littman, 1994). Furthermore, Ick co-ordinates interaction of the
TCR and co-receptors with a single MHC molecule (Saizawa et al., 1987; Collins et al., 1992; Xu
and Littman, 1993). CD8 avidity for MHC class I is also increased following TCR stimulation
(O'Rourke et al., 1990) although a requirement for Ick has not been shown. Genetic and
biochemical studies have also shown fyn to have an important role in signal transduction. The
activity offyn increases 2- to 4-fold following TCR stimulation (Tsygankov et al., 1992) and fyn
PTK activity was detected in TCR immunoprecipitates (Sarosi et al., 1992). In addition, fyn
activity was found directly associated with the C, chain (Gauen et al., 1992).
The association between syk or ZAP-70 and ARAM containing receptors is well defined. Syk and
ZAP-70 are not myristylated and hence are not constitutively localised at the plasma membrane.
This family of proteins lack a src-homology 3 (SH3) domain and the C-terminal negative
regulatory tyrosine phosphorylation site which is found in src family members. ZAP-70 is a
70kDa PTK expressed exclusively in T cells and NK cells (Chan et al., 1992) whereas syk is a
72kDa PTK expressed preferentially in B cells, myeloid cells and thymocytes (Taniguchi et al.,
1991). ZAP-70 is not associated with the TCR in the resting state, but following stimulation, is
rapidly recruited to the £ and CD3 chains (Chan et al., 1991) only associating with tyrosine
phosphorylated forms of £. It is suggested that the TCR interacts with two PTK sequentially. The
first, a src family member, phosphorylates ARAM sequences which results in the recruitment of
ZAP-70 to the membrane complex (Chan et al., 1992).
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1.9.4.3 Protein-tyrosine phosphatases (PTPase).
Protein-tyrosine phosphorylation following activation of T cells or cross-linking of cell surface
proteins occurs by stimulating the functions of PTK. Protein-tyrosine phosphorylation however
can also be enhanced by inhibiting PTPase such as CD45. CD45 is an abundant plasma
membrane protein that is differentially expressed on all cells of the hematopoietic lineage except
erythroid cells (Trowbridge, 1991). On T cells, the various isoforms of CD45 distinguish
different subsets (Bottomly et al., 1989; Byrne et al., 1988). Genetic studies have demonstrated
that CD45 is required for TCR signal transduction, including induction of PTK activity (Justement
et al., 1991; Pingel and Thomas, 1989). Targets for the CD45 PTPase activity in T cells are the
negative regulatory sites of tyrosine phosphorylation in Ick and fyn (Cooper et al., 1986). In
CD45-deficient cells, Ick and fyn are hyperphosphorylated at this negative regulatory site (Hurley
et al., 1993; Ostergaard et al., 1989; Sieh et al., 1993) whereas in normal cells, CD45 de-
phosphorylates this site activating the PTK function (Mustelin et al., 1989). The function(s) of
the different extracellular domains of CD45 isoforms have not yet been established though recent
studies with chimeric CD45 molecules have indicated that the extracellular and transmembrane
domains are not required for CD45 function (Desai et al., 1993; Hovis et al., 1993; Volarevic et
al., 1993).
1.9.5 Intracellular signal transduction.
Stimulation of the lymphocyte receptors induces tyrosine phosphorylation of many cytoplasmic
and membrane proteins. It is not known which of these proteins are direct substrates of the PTK
and the identity of many of these proteins and the functional significance of most of the tyrosine
phosphorylations are not known. The most well characterised events following the stimulation of
the TCR are the activation of PLC, calcineurin (a calcium/calmodulin-dependant serine
phosphatase) and ras, all of which are implicated in events leading to the transcriptional activation
of the IL-2 gene (Waldman, 1989).
Stimulation of the TCR induces the activation of PLCyl via tyrosine phosphorylation (Imboden
and Stobo, 1985; Secrist et al., 1991; Weiss, 1991). The activated PLCyl hydrolyses
phosphatidylinositol (PI) 4,5-bisphosphate into the second messengers inositol 1,4,5-trisphosphate
(IP3) and diacylglycerol (DAG) (Izquicrdo and Cantrell, 1992). The second messengers, IP3 and
DAG are responsible for the observed TCR induced increase in cytoplasmic free calcium ([Ca2+ij)
and activation of protein kinase C respectively (Weiss and Imboden, 1987). The increase in
[Ca2+]j is rapid and sustained and influences calcium/calmodulin dependent events. Work with the
immunosuppressive drugs cyclosporin A (CsA) and FK506 has helped elucidate some of the
downstream effects of [Ca2+]j. These drugs bind to cytoplasmic proteins known as
immunophilins (Schreiber and Crabtree, 1992) and these complexes in turn bind calcineurin with
a high affinity, thus inhibiting the phosphatase activity (Liu et al., 1991). It was shown that the
phosphatase activity of calcineurin contributes to the activation of transcription factors which are
involved in IL-2 transcription (Clipstone and Crabtree, 1992).
Ras is a 21kDa GTP-binding protein with GTPase activity which is rapidly activated following
stimulation of the TCR (Downward et al., 1992). The activation of ras correlates with the
transcriptional activation of the IL-2 gene (Rayter et al., 1992; Woodrow et al., 1993) and
activation of the ras pathway is not sensitive to CsA treatment.
It has been shown that CD4-positive T cells stimulated by peptide antigen respond differently to
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the same cells when stimulated with a superantigen (Liu et al., 1991). It was also suggested that
different peptides presented by the same cells may elicit distinct outcomes in the responding T
cell (DeMagistris et al., 1992; Jameson et al., 1993; Racioppi et al., 1993; Sloan-Lancaster et al.,
1993). In addition, some anti-TCR monoclonal antibodies stimulated cells with only 100
molecules bound per cell while other anti-TCR monoclonal antibodies required >10,000
molecules to be bound per cell (Rojo and Janeway, 1988). These results implied that different
signals can be delivered to the nucleus of a cell from the same cell surface receptor and it was
therefore suggested that the TCR interprets signals through conformational changes induced in
the receptor by the binding of the ligand (Janeway and Bottomly, 1994).
1.9.6 Signal transduction by cytokine receptors.
It was originally proposed that each cytokine exerted a specific effect on its own target cell. This,
however, is not the case as most cytokines exhibit a wide range of biological effects on various
tissues and cells often in a redundant manner. Molecular analysis of cytokine receptors has
explained much of this redundancy. Cytokine receptors fall into a family characterised by an
extracellular 200 amino acid region of structural homology. This comprises a multichain
complex which contains a receptor specific for its ligand and a signal transducing element (Bazan,
1992; Miyajima et al., 1992; Taga and Koshimoto, 1992). IL-6, leukemia inhibitory factor and
IL-11 receptors use the same signal transducer (gpl30) and so these cytokines have the same
function on various different tissues (Taga et al., 1989, 1992; Ip et al., 1992; Yin et al., 1992).
IL-3, IL-5 and GM-CSF receptors similarly all interact with the same signal transducing element
(Miyajima et al., 1992). Likewise, the IL-2, IL-4 and IL-7 receptor systems share the IL-Ry chain
thereby possibly explaining the similar growth promoting functions of these cytokines.
A general first step in the signalling process of immune and hematopoietic cytokines is ligand
induced dimerization of the receptor components. The cytoplasmic regions of the cytokine
receptors interact to initiate a signal transduction cascade (Kishimoto et al., 1994). There are no
obvious enzymatic motifs (Murakami et al., 1991; Fukunaga et al., 1991) in the cytoplasmic
region of the cytokine receptors but a conserved membrane proximal region and dimerization
may allow a stable interaction with a signalling molecule. The tyrosine kinase JAK2 has been
shown to directly associate with lymphokine receptors and become activated in response to
numerous cytokines (Witthuhn et al., 1993; Silvennoinen et al., 1993; Argetsinger et al., 1993).
In addition, the tyrosine kinases fes, which interacts with the IL-3R and GM-CSFR (Hanazono et
al., 1993), and Ick, lyn and fyn which participate in IL-2 signalling pathways in different cells
(Hatakeyama et al., 1992; Torigoe et al., 1992; Kobayashi et al., 1993) have been reported to
interact with cytokine receptors.
The binding of IL-2 to the high affinity receptor IL-2R results in signal transduction mediated by
the 75kDa protein (IL-2Rp) and internalisation of the receptor complex. The IL-2R(3 chain is
used in two distinct signalling pathways. One region of the IL-2RP chain induces cytoplasmic
protein tyrosine kinase activation, leading to induction of c-jun and c-fos (Shibuya et al., 1992).
A second region of the IL-2Rp chain uses a kinase-independant pathway and induces
proliferative responses. This signal leads to the induction of the transcription factor c-myc which
causes the cell to enter into the S-phase of the cell cycle and enter cell division (Shibuya et al.,
1992). Studies on the transcriptional activation of acute phase proteins have also provided
evidence of two distinct signalling pathways mediating the effects of IL-6 (Akira and Kishimoto,
1992; Kishimoto et al., 1992, 1994). In addition, the receptor common to IL-3, GM-CSF and
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IL-5 can deliver different signals from distinct regions of the molecule following stimulation
(Sato et al., 1993).
1.10 Lymphocyte homing patterns.
Lymphocytes, which drain to the peripheral lymph nodes from the skin, muscle, gut-associated
lymphoid tissues such as Peyer's patches and many other sites, differ in the types of antigens they
will have encountered. Separate lineages of lymphocytes, including memory cells have been
shown to exhibit specific patterns of recirculation to the skin, gut and lung (Mackay, 1992, 1992a,
1992b; Picker and Butcher, 1992). This occurs due to differences in the expression of adhesion
molecules on the lymphocytes extravasating different tissues (Mackay et al., 1992a) and because
of these recirculation patterns, lymphocytes are more likely to return to the tissue were they first
encountered antigen (Mackay, 1992).
Three families of adhesion molecules have been identified which are involved in the homing of
lymphocytes; namely selectins, integrins and chemoattractants. Selcctins mediate the attachment
and tethering of flowing leucocytes to the vasculature (Lawrence and Springer, 1991; Ley et al.,
1991; von Adrian et al., 1991; Lasky, 1992; Mayadas et al., 1993) and are a prerequisite for
chemoattractant and integrin mediated cellular adhesion (Arfors et al., 1987; Lawrence and
Springer, 1991) Integrins recognise O-linked sialylated carbohydrate residues on serine and
threonine rich mucin-like proteins (Rosen, 1993) and integrins are important in leucocyte
extravasation (Anderson and Springer, 1987; Larson and Springer, 1990).
1.11 The ruminant immune system.
A general overview of the vertebrate immune system has been discussed with reference to the
human and murine species. Ruminants are phylogenetically distinct to mice and man therefore
differences in the ruminant immune systems may reflect different ways in which ruminants
respond to foreign antigen.
1.11.1 The cellular immune system.
Three distinct subpopulations of ovine T cells have been identified by their expression of either
WC1 (T19), CD4 or CD8 (MacKay et al., 1986). The WC1 protein is expressed on y5 TCR
positive lymphocytes and is exclusively expressed in ruminants (MacKay et al., 1989). In the
murine and human species, CD4-positive and CD8-positive T cells express the a[3 TCR
(Samuelson et al., 1985; Danska, 1989). To date, no monoclonal antibody specific for the ovine
a(3 TCR has been produced. Since mminant y5 T cells generally do not express CD4 or CD8, it is
assumed that mminant T cells expressing CD4 or CD8 are similar to murine and human T cells
expressing CD4 or CD8, and express an a(3 TCR.
The proportion of the various T cell subsets changes markedly during the lifespan of the sheep.
Fetal blood has a predominance of CD4-positive and CD8-positive T cells over y8 T cells whereas
during the neonatal period y5 T cells become the predominant subset. In young sheep >50% of
PBL express the y5 TCR. This may imply that young sheep have a greater dependence on y5 T
cells rather than a[3 T cells. This is in contrast to humans and rodents where the major T cell
subsets express the cup TCR. During the post-natal period the yS T cell percentage within the
lymphocyte population declines and CD4-positive and CD8-positive T cells once again
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predominate (MacKay et al., 1986, 1989; Evans, 1993).
The large antigenic load to which neonates are exposed after birth may lead to activation and
preferential clonal, or oligoclonal, selection of y8 over a(3 T cells (Hein and MacKay, 1991; Hein
and Dudler, 1993). The expressed repertoire of yS T cells in humans and mice is very small, with
T cells expressing distinct Vy and V5 pairings which populate distinct sites such as skin and gut
tissue. In contrast, it has been shown that the repertoire of expressed Vy and V5 genes in the
peripheral blood of sheep is large compared to the human and mouse species (Hein and Dudler,
1993). In young sheep, the predominance of y8T cells may be accompanied by a greater
diversity in the expressed yS T cell repertoire.
It has been shown that the protein WC1, originally referred to as T19, is expressed exclusively on
y8 T cells in both the ovine species (MacKay et al., 1989) and the bovine species (Clevers et al.,
1990). The WC1 protein is not expressed on CD4-positive or CD8-positive T cells, or B cells.
During the course of this thesis, a cDNA encoding the bovine WC1 protein was cloned (Wijngaard
et al., 1992, 1994; Metzelaar, et al., 1992). It has also been shown in sheep, unlike human and
mice, that y8 T cells do not express CD2 (MacKay, 1988; Evans, 1993). This implies that yS T
cells in the ovine species have a decreased dependence on CD2 perhaps for cellular adhesion and
activation during an immune response and may rely on other cellular antigens to mediate these
effects. In the ruminant species, y8 T cells are prevalent at epithelial sites such as the intestine and
skin (Hein and MacKay, 1991) which suggest that they may be involved in immune surveillance
of epithelial sites as has been suggested for other species (Janeway et al., 1988).
One reported function of y8 T cells in humans, mice and sheep is cytotoxicity (MacKay et al.,
1988). In sheep however, it has been shown by electron microscopy that y8 T cells (Evans, 1993)
do not contain electron dense granules. It has been shown in CD8-positive cells of other species
that these electron dense granules contain perforin (Kraehenbuehl and Tschopp, 1990). These
observations suggest that cytotoxicity may not be the sole function of sheep yS T cells.
1.11.2 Gut associated lymphoid tissue (GALT).
The GALT consists of the organised lymphoid tissues such as Peyer's patches, mesenteric lymph
nodes, and LPL and ilEL (Mowat, 1987). In the sheep, there is a rapid expansion of CD4-
positive, CD8-positive and y8 T cells in the lamina propria following exposure to antigens
immediately after birth (Gorrell et al., 1988). In the adult sheep, the relative proportions and
phenotypes of LPL is similar to that of peripheral blood. In contrast to LPL, IEL are
predominantly CD8-positive or ySTCR positive cells (Gorrell et al., 1988; Press et al., 1991:
Gyorffy et al., 1992). In contrast to peripheral blood populations, a large proportion of IEL
express MHC class II molecules and lack the CD5 pan T cell marker (Gyorffy et al., 1992).
Furthermore, y8 IEL have an immature phenotype (WC1-negative and MHC class I-negative)
characteristic of y8 T cells developing in the thymus (MacKay et al., 1986).
1.11.3 Humoral immune system.
The major source of ovine B cells is the ileal Peyer's patch, unlike in murine and human system
where these cells are derived mainly from bone marrow (Landsverk et al., 1991). In the ovine
species, unlike other species, the placenta is impermeable to maternal immunoglobulins and no
transfer of these molecules occurs to the fetus (Brambell, 1970; Carlson and Owen, 1987).
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1.12 Aims of the thesis.
Research in the sheep has advanced dramatically in recent years with the development of a panel
of monoclonal antibodies specific for sheep cell surface proteins. The 1st International Workshop
on Ruminant Leucocyte Differentiation Molecules had recently identified monoclonal antibodies
which recognise the ovine and bovine homologues of murine and human proteins. These
monoclonal antibodies had been clustered according to the CD numbers assigned to murine and
human proteins. Numerous monoclonal antibodies were submitted to the workshops which could
not be assigned CD numbers because there was no human or murine homologue. The
monoclonal antibodies were placed in workshop clusters and analysed. One such cluster was
WC1.
The first aim of this thesis was to analyse the WC1 protein in the ovine species. This would be
done by use of a number of different anti-WCl monoclonal antibodies from the 2nd
International Workshop on Ruminant Leucocyte Differentiation Molecules. It was intended to
analyse the expression of WC1 on ovine leucocytes and, in addition, to establish the WC1 epitope
expression on ovine peripheral blood yS T cells. It had recently been reported in the bovine
species (Davis et al., 1990), that some y5 T cells expressed epitopes of the WC1 protein on
mutually exclusive populations of cells. It was of interest to determine if the same sub-
populations of PBL existed in the ovine species. A further aim in the analysis of the WC1 protein
was to clone and sequence cDNA encoding this molecule, this is outlined in the appendix.
In the ovine species, y8 T cells do not express the molecules CD2, CD4 or CD8. These molecules
have been shown to be associated with the activation of T cells (Janeway and Bottomly, 1994). In
addition, y8 T cells have long been viewed as the first line of defence against invading pathogens
(Haas et al., 1993). If this is the case, yS T cells may respond at a faster rate and in a different
manner to a(3 T cells. Accordingly, the second major aim of this thesis was to investigate the
activation and proliferative response of peripheral blood y8 T cells following in vitro culture with
the T cell mitogen ConA, or following culture with antigens to which individual animals have
been primed. The responses of yS T cells, either in an unfractionated population of PBL or
purified, were measured. These responses were compared to the response of a(3 T cells in
identical conditions.
The results reported in this thesis attempted to address each of the aims set out above. Novel data
on the expression of different WC1 epitopes in the ovine species is reported. In addition, novel
data on the kinetics of activation of yS T cells and responses to antigen of y8 T cells are also
reported. These data show clearly that yS T cells respond in a different manner compared to a(3 T
cells. These findings have important implications in understanding the mechanism(s) of




2 MATERIALS AND METHODS
2.1 Animals.
2.1.1 Animals of different age and antigenic burden.
Finnish Landrace sheep of various ages were housed at the Moredun Research Institute,
Edinburgh. Blood samples were obtained, by staff at Moredun Research Institute, by
venipuncture and collected in Lithium Heparin vacutainers. In addition, lambs kept in
gnotobiotic and specific pathogen free (SPF) conditions were also housed at the Moredun
Research Institute, Edinburgh. Blood was obtained from age matched gnotobiotic, SPF and
normal animals (3-4weeks) and collected in Lithium Heparin vacutainers.
2.1.2 Experimental animals.
All procedures involving experimental animals were carried out in accordance with the regulations
laid down in The Animals (Scientific Procedures) Act, 1986. Male and female Finnish Landrace
cross Dorset and Grey Faced cross Suffolk sheep were obtained from the Moredun Research
Institute, Edinburgh. Animals were immunised with 1 mg ovalbumin (Sigma; Grade V, Cat. No.
A5503) and 1 mg heat-killed M. tuberculosis (PPD, batch 295, Central Veterinary Laboratory,
V£ybridge.) emulsified (1:1) in complete Freund's adjuvant (Sigma; Cat. No. F5881) containing
H37RA M. tuberculosis (ATCC 21577) injected over two sites intramuscularly. A second
immunisation with the same antigens in incomplete Freund's adjuvant (Sigma; Cat. NO.F5506)
was given four weeks later.
2.2 Media.
2.2.1 Medium for lymphocyte culture.
Lymphocyte cultures were maintained in RPMI 1640 (Gibco Biocult.; Cat. no. 074-01800)
supplemented with 2 mM L-glutamine (Sigma; Cat. No. G2159), 100 U/ml benzylpenicillin and
100 U/ml streptomycin, 0.05 mM (3-mercaptoethanol (Sigma; Cat. No. M6250) and 5mM Hepes
(Sigma; Cat. No. H7523). Culture medium consisted of RPMI 1640 with supplements and 10%
fetal calf serum (FCS) (Flow Laboratories, Hertfordshire). Wash medium consisted of RPMI with
supplements and 1% FCS.
2.2.2 Medium for bacterial culture.
The basic growth medium for£. coli strains was Luria-Bertani (LB) medium (1% tryptone, 0.5%
yeast extract, 1% NaCl (Sigma; Cat. No. S7653) made to pH 7.4 with 5N NaOH (Sigma; Cat.
No.S5881)). The selective medium was LB containing 150 pg/ml of ampicillin (LBAmp).
2.2.3 Medium for COS-1 cell culture.
COS-1 cells were maintained in Glasgow's Minimal Essential Medium (G-MEM) (Gibco Biocult;
Cat. No. 042-02541) supplemented with 2 mM L-glutamine, 100 U/ml benzylpenicillin and 100
U/ml streptomycin, 0.05 mM P-mercaptoethanol and 5mM Hepes. Culture medium consisted of
G-MEM with supplements and 10% FCS, wash medium consisted of G-MEM with supplements
and 1% FCS.
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2.3 Tissue culture plasticware.
All tissue culture plasticware used for cell culture was supplied by Gibco Biocult, Uxbridge unless
otherwise stated.
2.4 Isolation and purification of mononuclear cells.
2.4.1 Peripheral blood mononuclear cells (PBMC).
Ovine peripheral blood was obtained by venipuncture and collected into preservative-free heparin.
The final concentration of heparin was 10 units per ml of blood. White blood cells were buffy
coated by centrifugation of heparinized whole blood at 1300xg for 15 minutes at 20°C. Buffy
coat cells were harvested into sterile PBS with 1% FCS (PBSF) and centrifuged over Lymphoprep
(Nyegaard, Oslo, Norway) at 850 xg for 20 minutes at 20°C, with no brake applied at the end of
the centrifugation. PBMC were isolated from the Lymphoprep-PBS interface and washed twice
with ice cold PBSF. Cells were harvested during each wash procedure by centrifugation at 250 xg
for 4 minutes at 4°C. Throughout this thesis, cells were washed and harvested by centrifugation at
250 xg for 4 minutes at 4°C unless otherwise stated.
2.4.2 Mononuclear cells from lymph nodes, spleen or thymus.
Tissues were removed aseptically from animals by standard surgical techniques and were
immersed in ice-cold PBSF. Cells were obtained by teasing the tissues apart using forceps and a
scalpel blade. The resultant cell suspension was depleted of large debris via sedimentation by
gravity for 15 minutes. The supernatant was collected carefully and washed twice with ice-cold
PBSF. Mononuclear cells were then purified over Lymphoprep as described in section 2.4.1.
2.4.3 Intraepithelial and lamina propria mononuclear cells from ileal mucosa.
Sections of ileum were isolated by standard surgical techniques and opened by longitudinal
section. The tissue was cut into 2-4 cm2 portions and washed twice in Hanks' balanced salt
solution (HBSS) (Gibco Biocult; Cat. No. 041-04020). Sections were incubated in calcium and
magnesium free HBSS (fHBSS) (Gibco Biocult; Cat. No. 041-04170) supplemented with 1 mM
EDTA (Sigma; Cat No. E6758) and 5% FCS for 30mins at 37°C with vigorous agitation. The
supernatant, containing intraepithelial cells was carefully removed. Intraepithelial mononuclear
cells were then isolated over Lymphoprep as described in section 2.4.1. The sections of tissue
were then treated to obtain lamina propria cells. The first incubation was repeated for one hour at
37°C and the cell suspension in the supernatant discarded. The sections were then incubated in
fresh fHBSS containing 1 mM EDTA, 5% FCS and 50 U/ml collagenase Type XI (Sigma; Cat. No.
C7657). Tissues were incubated for 90 minutes to digest collagen. The resulting cell suspension
was removed and filtered over nylon wool. Mononuclear cells were subsequently purified by
density gradient centrifugation over Lymphoprep as described in section 2.4.1.
2.4.4 Afferent and Efferent mononuclear cells.
Pseudo-afferent and efferent lymphatic cannulations were performed by Dr. John Hopkins
(Department of Veterinary Pathology, University of Edinburgh) as previously described (Hall
1967). Pseudo-afferent cannulations required the excision of lymph node at least eight weeks
prior to the cannulation, during which time the afferent vessels re-anastamose with the efferent
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duct. Cannulated sheep were kept in standard pattern metabolism cages and fed hay and water
ad libitum. Lymph was collected into sterile 250 ml plastic bottles, containing 2.5xl03 units of
heparin and 2.5x104 units each of penicillin and streptomycin. Lymph was collected during the
same 2 hour period on each day. Lymphocytes were washed twice with ice cold PBSF and
subsequently used in assays.
2.4.5 Enrichment of y8 T cells by positive selection using MACS.
Purified lymphocytes were resuspended in PBSF at 4xl07 cells per ml. These were incubated with
the biotinylated anti-WCl monoclonal antibody, CC15 for 20mins at 4°C and then washed with
PBS supplemented with 5mM EDTA. Cells were further incubated with avidin microbeads
(Miltenyl Biotec, Eurogenetics UK Ltd.; Cat. No. 481-01) and SA-PE for 15mins on ice and then
washed with PBSF. The labelled lymphocyte pellet was resuspended in PBSF and loaded onto a
MACS separator (Becton Dickinson, Oxford). This consists of a ferromatrix column located
within a strong magnetic field, which was precoolcd by washing with ice-cold PBSF. The column,
with loaded cells, was then washed with 3-4 column volumes of PBSF in the presence of the
magnetic field. Cells retained on the column were then washed back to the top of the column by
a series of back flushes with PBSF in the absence of the magnetic field, followed by subsequent
washing with 3-4 column volumes of PBSF in the presence of the magnetic field. Positively
retained cells were subsequently recovered by removal of the magnetic field and elution of the
column with PBSF. These cells were analysed by FACS to determine their percentage purity. The
purification procedure was repeated until cells were >96% pure.
2.5 Monoclonal antibodies and immunofluorescence staining.
The monoclonal antibodies used in this thesis are shown in Table 1 (Chapter 3). Their
specificities, isotype and reference publications are listed.
2.5.1 Titration of working dilution of monoclonal antibodies.
Ascitic fluid and culture supernatant from the monoclonal antibody cell lines were collected.
Ascitic fluid was diluted lin 50 into PFA and then doubling dilutions were made in PFA to a final
dilution of 1 in 3200. A doubling dilution of culture supernatant was made into PFA to a final
dilution of 1 in 128. 50pl of these dilutions of antibody preparations were then incubated with
lxlO6 PBL, from the species to which the monoclonal antibody was raised, for 20 minutes on ice.
Unbound antibody was removed by washing the cell once with ice-cold PFA. The cells were then
incubated with 50pi of FITC conjugated F(ab)2 fragment of rabbit anti-mouse immunoglobulin
(Dakopatts, Denmark; Cat. No. F313) at the manufacturers recommended working dilution in
PFA, for 15 minutes on ice. Cells were then washed twice and analysed by flow cytometry. The
optimal working dilution of the monoclonal antibody preparation was determined by the analysis
of the histograms of fluorescence intensity versus cell number. The greatest dilution which gave
the highest intensity of staining was used routinely throughout this thesis as the working dilution
of the monoclonal antibody.
2.5.2 Immunolabelling of cell surface antigens.
The cell surface markers of lymphocytes were stained. Lymphocytes, isolated from any of the
tissues or body fluids described above were first washed twice with ice-cold PFA (PBS
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supplemented with 1%FCS and 0.1% Sodium Azide (Sigma; Cat. No. S8032) and treated as
described below.
2.5.2.1 Single colour immunofluorescence.
For single colour immunofluorescence analysis, lxlO6 cells were incubated with 50 pi of the
primary monoclonal antibody at the appropriate dilution in PFA for 20 minutes on ice. Unbound
antibody was removed by washing once with ice-cold PFA. The cells were then incubated with
50pl of FITC conjugated F(ab>2 fragment of rabbit anti-mouse immunoglobulin (Dakopatts,
Denmark; Cat. No. F313) at the appropriate dilution in PFA for 15 minutes on ice. Subsequently,
cells were washed twice with PFA prior to analysis by flow cytometry.
2.5.2.2 Two colour immunofluorescence.
Two colour immunofluorescence analysis requires that the reactivity of each monoclonal antibody
is detected by a different fluorochrome. For this type of analysis, lxlO6 cells were treated in one
of the following three ways:
1) Cells were incubated with 50pl of each of the two primary monoclonal antibodies, of
different isotypes, at the appropriate dilutions in PFA for 20 minutes on ice. Unbound antibody
was removed by washing once with ice-cold PFA. The reactivity of one of the monoclonal
antibody used was detected by incubation for 15 minutes on ice with an isotype specific F1TC-
conjugated secondary antibody. The FITC-conjugated secondary antibodies used were either
sheep anti-mouse IgGl-FITC conjugate (The Binding Site, Birmingham; Cat. No. PF273), sheep
anti-mouse IgG2a-FITC conjugate (The Binding Site, Birmingham; Cat. No. PF274) or sheep
anti-mouse IgM-FITC conjugate (The Binding Site, Birmingham; Cat. No. PF278). The reactivity
of the second monoclonal antibody, of different isotype, was developed by incubating the cells
with an isotype specific biotin-conjugated secondary antibody for 15 minutes on ice followed by
incubation with phycoerythrin conjugated to streptavidin (Pharmacia; Cat. No. STAR4) for 5
minutes on ice. The biotinylated secondary conjugates used were either sheep anti-mouse IgGl-
biotin (The Binding Site, Birmingham; Cat. No. PB273), sheep anti-mouse IgG2a-biotin (The
Binding Site, Birmingham; Cat. No. PB274) or sheep anti-mouse IgM-biotin (The Binding Site,
Birmingham; Cat. No. PB278). The secondary reagents selected were dependent on the isotype
of the primary monoclonal antibody and used at appropriate dilutions in PFA. Subsequently, cells
were washed with PFA and analysed.
2) The method used routinely throughout this thesis was to biotinylate one of the primary
monoclonal antibodies (as described in Section 2.5.3). This allowed for quicker experimentation.
It was necessary that the two monoclonal antibodies used were of different isotypes. The
reactivity of the non-biotinylated monoclonal antibody was developed as in method 1. The
reactivity of the biotinylated monoclonal antibody was detected by incubation with phycoerythrin
conjugated to streptavidin for 5 minutes on ice. Cells were then washed with PFA and analysed.
3) A method which allowed for comparison of reactivity of monoclonal antibodies of the
same isotype by two colour immunofluorescence involved sequential staining. One of the
monoclonal antibodies was biotinylated. Cells were incubated with the non-biotinylated
monoclonal antibody for 20 minutes on ice. Unbound antibody was removed by washing once
with ice-cold PFA. Reactivity of this monoclonal antibody was detected by incubating the cells
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with 50pl of FITC conjugated F(ab)2 fragment of rabbit anti-mouse immunoglobulin for 15
minutes on ice. The cells were washed with PFA and then incubated with 1% normal mouse serum
(NMS) (Sigma; Cat.No. M5905), diluted in PFA, for 15mins on ice to block any remaining
reactivity of the secondary anti-mouse immunoglobulin. Cells were once again washed in PFA
and incubated with an appropriate dilution of the biotinylated monoclonal antibody. The
reactivity of the biotinylated monoclonal antibody was detected, following washing in PFA, by
incubation with phycoerythrin conjugated to streptavidin for 5 minutes on ice. Finally cells were
washed with PFA and analysed.
2.5.3 Immunofluorescence analysis.
All immunofluorescence analysis described in this thesis was carried out using a Becton Dickinson
FACScan system, Mountain View, California, USA. After immunolabelling, fluorescence
measurements were made on populations of cells defined by setting electronic gates on forward
scatter (FSC) and side scatter (SSC) measurements. Dead cells were excluded on the basis of low
forward light scatter 104 "live gated' cells were analysed per sample. The fluorescence profile of
a gated population of cells was displayed as a histogram of fluorescence intensity versus relative
cell number. Background fluorescence was determined following reactivity of cells with NMS or
NMS-biotin.
2.5.4 Biotinylation of monoclonal antibodies.
Ascitic fluid of the monoclonal antibodies CC15, SBU-T4, SBU-T8 was supplied by Esme Mills
(Hybridoma Unit, Department of Veterinary Pathology, University of Edinburgh). Ascitic fluid of
the monoclonal antibodies BAQ4A, CACTB1A was a kind gift from Dr. W. C. Davis (Washington
State University). IgG was purified from ascitic fluid by precipitation of high molecular weight
proteins. 25pl of 1M acetic acid (BDH; Cat. No. 10001) was added per 500|ol of ascitic fluid and
mixed. To this 100% caprylic acid (Sigma; Cat. No. C2875) was added dropwise (37.5pl of
caprylic (octanoic) acid per millilitre of original ascitic fluid with vigorous shaking and incubated
at room temperature for 30 minutes. Precipitated proteins were removed by microfuging for 30
seconds. The supernatant was retained and dialysed extensively into PBS over 72 hours. A lmg
ml-i solution of biotin-o-succinimide ester (Sigma; Cat. No. HI759) was prepared in DMSO
(Sigma; Cat. No. D2650) and 0.1M NaHC03 pH 8.3 (BDH; Cat. No. 10247). The protein
concentration of the dialysed immunoglobulin was determined and 75|il of the biotin solution
added per lmg of immunoglobulin. This suspension was mixed immediately and incubated with
mixing for 4 hours at room temperature. The biotinylated immunoglobulin was then dialysed
extensively against PBS and the immunoglobulin concentration determined by
spectrophotometry. FACS analysis was used to determine that the monoclonal antibody had
retained activity and that the biotinylation procedure was effective.
2.6 In vitro proliferation assays.
2.6.1 Irradiation of antigen presenting cells (APC).
PBMC prepared from ovine peripheral blood as described above were resuspended in culture
medium at a concentration of 2x10 cells ml1 and irradiated using a cobalt-caesium source
(Kings Buildings, University of Edinburgh) The level of irradiation which prevented subsequent
proliferation of PBMC when cultured with Con A (Sigma Cat. No. C2631) was determined and
found to be 3000 rads (data not shown). This amount of radiation was used for treatment of
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antigen presenting cells in subsequent proliferation assays.
2.6.2 Proliferative response of unfractionated cells.
Ovine mononuclear cells were purified as described in Section 2.4 and resuspended in culture
medium. The proliferative response of unfractionated PBMC was measured as follows. 1x10s
cells in IOOjjI were added per well to 96-well, round-bottom micro-culture plates (Nunculon,
Denmark). Various concentrations of antigens (Mycobacterium paratuberculosis (M.tb.) and
Ovalbumin (Ova)) were then added to the wells to make a final volume of 200jil. Each
concentration of antigen was tested in triplicate. Positive and negative controls were established in
the presence of Con A or culture media respectively. Cells were incubated at 37°C in a humidified
atmosphere of 5% 00^95% air for 3-5 days and pulsed with lpCi 3H-thymidine, specific activity
2Ci/mMole, (Amersham Cat. No. TRK310) over the last 5 hours. Cells were collected onto glass
filter paper using a Tomtek automated harvester and 3H-thymidine incorporation was assessed by
liquid scintillation counting. The data is expressed as the geometric mean for the triplicate
cultures with standard deviation included. No irradiated antigen presenting cells were added to
the culture.
2.6.3 Proliferative response of purified y8 T cells.
Sheep y8 T cells were purified from peripheral blood of young lambs by positive selection using
the anti-WCl monoclonal antibody CC15 and magnetic activated cell sorting (MACS) as
described in detail in Section 2.4.5. The positively selected cells were >96% y5 T cells as judged
by immunofluorescence staining. y5 T cells purified from antigen-primed or non-primed sheep
were resuspended in medium and 1x10s cells in 50pl were added per well to 96-well, flat-bottom
micro-culture plates (Nunculon, Denmark). 1x10s autologous irradiated PBMC in 50pl were also
added to each well to act as antigen presenting cells. Various concentrations of recall antigens
(M.tb and Ova) were added to make a final volume of 200pl. Each concentration of antigen was
tested in triplicate. Positive and negative controls were established with either Con A and culture
media respectively. The proliferation assays were incubated at 37°C in a humidified atmosphere
of 5% C02/95% air for 3-5 days and subsequently pulsed with lpCi 3H-thymidine and harvested
as previously described in Section 2.6.2.1. Unfractionated and y8T cell depleted populations
were cultured in an identical manner to monitor the role of y8 T cells or other PBMC in
generating proliferative responses.
2.6.4 Concanavalin A activation of unfractionated PBL and purified y5 T cells.
PBL and y8 T cells prepared from ovine peripheral blood, were resuspended in culture medium at
a concentration of 2X106 cells per ml. Cell were then cultured in the presence or absence of Con
A at a final concentration of Spgml1. At various time intervals, viable lymphocytes were
harvested by density centrifugation over Lymphoprep as previously described and then washed
into PFA. Both single colour and two colour immunofluorescence analysis were performed on
harvested viable cells.
2.6.5 Antigen-induced activation of unfractionated PBL and purified y8 T cells.
PBL and yS T cells prepared from ovine peripheral blood, were resuspended in culture medium at
a concentration of 2xl06 cells per ml. Cells were cultured in the presence or absence of optimum
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concentrations of antigens. At various time intervals, viable cells were harvested by density
centrifugation over Lymphoprep as previously described and then washed in PFA. Both single
colour and two colour immunofluorescence analysis was then performed on harvested viable cells
to determine the expression of activation markers on the cell surface.
2.6.6 Mixed lymphocyte cultures of unfractionated PBL and purified y5 T cells.
Sheep y5 T cells, as responders, were purified from peripheral blood of young lambs by positive
selection using the anti-WCl monoclonal antibody CC15 and magnetic activated cell sorting
(MACS) as described in detail in Section 2.6.2. The positively selected cells were >96% y5 T cells
as judged by immunofluorescence staining. lxlO5 purified y5 T cells cells in lOOpl were added
to 96-well, round-bottom micro-culture plates (Nunculon, Denmark). For stimulator cells,
peripheral blood was obtained from two sheep of a non-matched breed, PBL were purified and
then irradiated. Various numbers of irradiated PBL were added to wells containing responding
cells. Dilutions of stimulator cells were made from lxlO6 cells to ~4xl03 cells per well. Each
dilution of stimulator cells was assayed in triplicate. An autologous population of irradiated PBL
was added to a set of wells to determine the allo-specificity of any responses. Cultures were made
to a final volume of 200jxl. Positive and negative controls were established with either Con A or
culture media. The proliferation assays were incubated at 37°C in a humidified atmosphere of 5%
C02/95% air for 3-5 days and subsequently pulsed with lpCi 3H-thymidine and harvested as
previously described. Unfractionated and y5 T cell depleted populations of PBL were treated in
an identical manner in order to determine the role of y5 T cells or other PBL in generating
proliferative responses.
2.7 Affinity purification.
2.7.1 Affinity purification of immunoglobulin.
Saturated supernatant made from the monoclonal antibody producing cell line ST197 was
prepared by Esme Mills (Hybridoma Unit, Department of Veterinary Pathology, University of
Edinburgh). Immunoglobulin from this supernatant was purified by affinity chromatography on
a GammaBind-PLUS affinity column (BDH; Cat. No. GBA 030005). The column was washed
with 10 volumes of the fresh culture medium and supernatant then applied to the column at a flow
rate of 10ml hr-i. The material was passed through the column once. The column was then
washed extensively with washing buffer (0.01M sodium phosphate pH 7.0, 0.15M sodium
chloride and 0.01M EDTA). [0.01M sodium phosphate was prepared by mixing 0.01M sodium
dihydrogen orthophosphate (BDH; Cat. No. 10249) with 0.01M di-sodium hydrogen
orthophosphate (BDH; Cat. No. 30716) until the correct pH was obtained]. Once no protein was
detectable in the flow through from the column, as judged by spectrophotometry at 280nm on a
Pharmacia LKB Ultraspec, bound material was eluted with 0.05M Acetic acid adjusted to pH 3.0
with ammonium hydroxide (Sigma; Cat. No. A6899). 2ml fractions were collected into 0.9ml
1.0M Tris HC1 (Sigma; Cat. No. T6791) pH 9.0 to neutralise the acid (450pl per ml of eluate).
Protein containing fractions were identified by spectrophotometry at 280nm. Peak fractions were
pooled and dialysed extensively against a sodium bicarbonate buffer pH 8.3 containing 0.5M
NaCl. The column was washed with five volumes of cleaning buffer (1.0M acetic acid) and re-
equilibrated with washing buffer to pH 7.0 prior to subsequent re-use.
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2.7.2 Preparation of affinity columns for the purification of ovine WC1.
Affinity purified immunoglobulin (ST197) was coupled to cyanogen bromide (CNBr) activated
Sepharose 4B (Sigma; Cat. No. C9142) according to the protocol described in the Pharmacia
guide to affinity chromatography (Pharmacia literature, 1983). Briefly, the required amount of
CNBr-activated Sepharose 4B was washed and swollen on a scintered glass filter with ImM HC1
(BDH; Cat. No. 10125). The beads were finally washed into coupling buffer (0.1M sodium
bicarbonate buffer pH 8.3 containing 0.5M NaCl). Immunoglobulin previously dialysed into the
coupling buffer was added to the sepharose and left overnight at 4°C. To block remaining active
groups the gel was washed with 1.0M ethanolamine pH 8.0 (Sigma; Cat. No. E9508) and mixed
for 16 hrs at 4°C. Excess non-adsorbed protein was removed by washing with coupling buffer
followed by a 0.1M acetate buffer pH 4.0 containing 0.5M sodium chloride and finally coupling
buffer. Immediately before use the column was pre-eluted with eluting buffer (15mM
triethanolamine (Sigma; Cat. No. T1502), 0.5M NaCl and 0.5% sodium deoxycholate (Sigma;
Cat. No. D5670) at pH 11.3) and re-equilibrated with neutralising buffer (0.2M phosphate buffer
pH 8.5). In order to remove any non-specific material from the lysates applied (Section 2.7.3),
pre-columns were made as described above for the ST 197 column. The pre-column was coupled
to normal mouse sera immunoglobulin and the pre-pre-column contained no immunoglobulin.
2.7.3 Preparation of spleen lysates.
Spleens were obtained from freshly killed animals at the abbatoir and put on ice. Splenocytes
were removed from the spleen by dissection of the enclosing connective tissue capsule with a
scalpel and forceps. The material remaining was homogenised with ice-cold Hanks Balanced Salt
Solution (HBSS) for 1 minute. Large particulate material was left to settle out for lOmins then the
supernatant was removed. Peripheral blood lymphocytes or lymphocytes isolated from lymphatic
vessels were washed three times with HBSS. The cell suspension of splenocytes or lymphocytes
was pelleted by centrifugation at 630g for 15 minutes at 4°C. The supernatant was discarded and
the cells resuspended for 30 minutes in ice cold TNT buffer (20mM Tris HC1, 140mM NaCl,
0.5% Triton XI00 (Sigma; Cat. No. X-100)) containing a final concentration of 0.2mM PMSF
(Sigma; Cat. No. P7626). Cellular debris was removed by centrifugation at 630g for 20 minutes
at 4°C, followed by centrifugation at 12000g for 2 hours at 4°C. The spleen lysate was filtered
through Millipore prefilters of 0.6pm pore size (Millipore, Ireland; Cat. No. AP 1504700)
immediately before addition to the column.
2.7.4 Affinity purification of ovine WC1.
Spleen lysates prepared as described in Section 2.7.3 were applied to the affinity columns at 4°C
at a flow rate of 10ml per hour. The material was passed through the column three times. The
columns were then washed extensively with washing buffer consisting of 15mM triethanolamine
and 0.5% sodium deoxycholate at pH 8.0 until no protein was detectable, by spectrophotometry
at 280nm, in the flow through. The bound material was eluted with eluting buffer (15mM
triethanolamine, 0.5M NaCl and 0.5% sodium deoxycholate at pH 11.3). 2ml fractions were
collected into 0.5M Triethanolamine (TEA) pH 7.9 to neutralise the alkalinity of the eluted
material (300pl per ml of eluate). Protein containing fractions were identified by
spectrophotometry at 280nm and peak fractions were pooled. The column was re-equilibrated
with 5 volumes of neutralising buffer (0.01 M sodium phosphate pH 8.5) and then finally washed
with 10 volumes of washing buffer.
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2.8 Immunohistology of tissues.
Tissues were removed by standard surgical techniques and were snap-frozen in dry ice/isopentane
(BDH; Cat. No. 29452). Cryostat sections of tissue cut at 5pm thickness were air-dried onto glass
slides and fixed for 10 minutes in acetone at 4°C. Expression of the various ovine lymphocyte
surface antigens was detected by staining with monoclonal antibodies listed in Chapter 3 using a
commercially available streptavidin-biotin immunoperoxidase staining kit (EURO/DPC, Witney,
UK; Strept A-B Universal Kit) according to the manufacturers instructions. Positive staining was
visualised by conventional microscopy.
2.9 Protein immunochemistry.
2.9.1 Immunoprecipitation.
2.9.1.1 Iodination of lymphocytes.
Peripheral blood lymphocytes were purified as described and finally washed three times with PBA
(PBS supplemented with 0.1% azide). Lymphocytes were radiolabelled with lmCi of 125I
(Amersham, U.K.). Briefly, lOOpl of lmg/ml iodogen in dichloromethane was dried onto a
microfuge tube with a stream of gaseous nitrogen. 2xl07 cells were resuspended in 200pl of PBS
then added to the microfuge tube with dried iodogen. lmCi of 12SI was added immediately to the
same microfuge tube and the reaction was incubated at room temperature for 2-4 hours, shaking
every 15-20mins. Following iodination, the cells were washed twice with PBA.
2.9.1.2 Preparation of lymphocyte lysates.
Labelled or unlabelled lymphocytes were pelleted by centrifugation at 630g for 15 minutes at
4°C. The supernatant was discarded and the cells resuspended for 30 minutes in ice cold TNT
buffer (20mM Tris HC1, 140mM NaCl, 0.5% Triton X100 (Sigma; Cat. No. X-100)) containing a
final concentration of 0.2mM PMSF (Sigma; Cat. No. P7626). Cellular debris was removed by
centrifugation at 630g for 20 minutes at 4°C, followed by centrifugation at 12000g for 2 hours at
4°C.
2.9.1.3 Coupling of monoclonal antibodies to protein A-sepharose beads.
5ml of protein A-sepharose (Sigma; Cat. No. P3391) was washed twice with PBA. lOOpl of
protein A-sepharose was incubated with 10|il of rabbit anti-mouse Ig (Serotech Cat. No. SERT
100) overnight at 4°C. The protein A-sepharose coupled to rabbit anti-mouse Ig was washed twice
with PBA and was then incubated overnight at 4°C with an 100pl aliquot of cold lymphocyte
lysate to block any non-specific sites of reactivity. The protein-A sepharose beads were washed
free of cold lysate and were then incubated overnight at 4°C with lOpl ascitic fluid of the required
monoclonal antibody. The following day the protcin-A sepharose beads coupled to rabbit anti-
mouse Ig and monoclonal antibody were finally washed twice with PBA.
2.9.1.4 Immunoprecipitation of antigen.
100pl of radiolabelled lysate was incubated with lOOpl protein A-sepharose coupled to rabbit
anti-mouse Ig overnight at 4°C. This was to remove any non-specific antigen which was
radiolabelled. The following day the protein A-sepharose coupled to rabbit anti-mouse Ig was
removed by centrifugation. lOOpl of the pre-cleared radiolabelled lysate was added to lOOpl of
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protein A-sepharose coupled to the monoclonal antibody of choice. This was incubated
overnight at 4°C. The lysate was then removed and the protein A-sepharose/antigen complex was
washed. The complex was washed twice in wash buffer I (0.5% sodium deoxycholate, 150mM
lithium chloride (Sigma; Cat. No. L0505), 0.1M tris.Cl pH 8.0) then washed once in wash buffer
two (0.5% sodium deoxycholate, 0.5M sodium chloride, 0.1M tris.Cl pH 8.0). The series of
washes was repeated twice. The protein A-sepharose/antigen complex was resuspended in
reducing sample buffer and boiled for 3 minutes. 25pl of the sample was run on a 5-15% SDS-
PAGE and the gel then dried. The dried gel was put on X-ray film (Kodak Products, UK) at -
70°C for 1-3 weeks and the X-ray film was developed.
2.9.2 Protein quantitation.
Purified protein concentrations were estimated with the Bio-Rad dye-binding assay (Bio-Rad
Laboratories; Cat. No. 500-0006) according to the manufacturers instructions. Known
concentrations of bovine serum albumin (Sigma; Cat. No. A2153) were used as standards.
2.9.3 ELISA.
10Op] of capture monoclonal antibody, ST197, (100pg/ml) was coated onto 96-well flat-bottomed
plates (Nunculon, Denmark) overnight at 4°C. The capture monoclonal antibody was removed
and retained for further use. The plates were washed x3 with wash buffer (PBS, 0.1% Tween 20
(Sigma; Cat. No. P1379) then incubated with 1% BSA in PBS to block any non-specific reactivity.
lOOpl aliquots of eluted WC1 antigen were added to the wells in triplicate at various
concentrations and incubated overnight at 4°C or at 37°C for 30 minutes. Excess antigen was
removed and the wells were washed x3 in wash buffer. Biotin conjugated developing monoclonal
antibody (CC15) was added to the wells at a previously determined working dilution and the
plates were incubated for 30 minutes at 37°C. The wells were washed x3 in wash buffer.
Streptavidin conjugated to alkaline phosphatase (Boehringer Mannheim Chemica, Germany; Cat.
No. 1089 161) was added at a dilution of 1:1000 to the wells and the plates incubated for 30
minutes at 37°C. The plates were washed x3 with wash buffer and once with ELISA substrate
buffer (0.05M glycine, 0.03M NaOH, 0.25 mM each of ZnCl2 (Sigma; Cat. No. Z3500) and
MgCl2(Sigma; Cat. No. Ml028)). The assay was then developed by adding the phosphatase
substrate, p-nitrophenyl phosphate (Sigma; Cat. No. 043-H6157) at 0.1M in substrate buffer for
10-30 minutes at 37°C. ELISA plates were read at a wavelength of 405nm, on a Dynatech
MR3000 micro ELISA plate reader. Controls were set up using an irrelevant biotinylated
monoclonal antibody to develop the captured WC1 antigen and also with no WC1 antigen present.
2.9.4 SDS-PAGE.
2.9.4.1 Preparation of samples for SDS-PAGE.
Lymphocytes were isolated from either peripheral blood or cannulated lymphatic vessels as
previously described (Section 2.4) and washed three times in ice cold PBS. Lymphocytes were
then harvested by centrifugation at 250g for 4 minutes at 4°C and resuspended at a concentration
of 1x10s cells per ml in lysis buffer (2% Nonidet P-40 (Sigma Cat. No. N6507) in PBS
containing 0.2mM PMSF). The suspension was incubated for 30 minutes on ice. Cellular debris
was removed by centrifugation in a microfuge for 10 minutes and the supernatant collected and
diluted 1:1 with sample loading buffer (10% (v/v) P-mercaptoethanol; 10% (w/v) SDS (Sigma;
Cat. No. L5750); 125 mM Tris.Cl, pH 6.7; 20% (v/v) glycerol (Sigma; Cat. No. G7893); 0.1%
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(w/v) bromophenol blue (Sigma; Cat. No. B6896)). The samples were heated in a boiling water
bath for 4 minutes prior to use.
2.9.4.2 Running SDS-PAGE.
Protein separation was by discontinuous polyacrylamide gel electrophoresis using a Tris-glycine
buffer containing SDS (384 mM glycine; 0.1% SDS; 50 mM Tris.Cl,
pH 8). Gels were either non-gradient or 5-15% linear gradient acrylamide gels. The stock
acrylamide solution was 30% acrylamide (Bio-Rad Laboratories; Cat. No. 161-0100):0.7%
bisacrylamide (Bio-Rad Laboratories; Cat. No. 161-0200)) in 375 mM Tris.Cl (pH 8.6), 0.1%
SDS buffer. Stacking gels were made of 3% acrylamide:0.07% bisacrylamide in 125 mM Tris.Cl
(pH6.7), 0.1% SDS buffer. Separating gels were either non-gradient 10% acrylamide:0.23%
bisacrylamide or gradient 5-15% acrylamide:0.1-0.35% bisacrylamide in 375mM Tris.Cl
(pH8.7), 0.1% SDS buffer. Gel solutions were made and then cast by the addition of 50pl of 10%
ammonium persulphate (Bio-Rad Laboratories; Cat. No. 161-0700) and 5pl TEMED (Bio-Rad
Laboratories; Cat. No. 161-0800). Protein samples were loaded and electrophoresed through
vertical slab gels using Bio-Rad Mini-protean II gel equipment. Gels were run at 200V for 30-45
minutes along with Pharmacia Electrophoresis Calibration Kit markers (molecular weight range
14.4 - 94.0kDa). P-galactosidase (118kDa) (Sigma; Cat. No. G8511) and Myosin (205kDa)
(Sigma; Cat. No. M3889) were used as comparable high molecular weight markers.
2.9.4.3 Staining of SDS-PAGE.
Coomassie Brilliant Blue G (BBG) (Sigma; Cat. No. B8522) was dissolved in methanol (BDH; Cat.
No. 10158) to a final concentration of 0.25%. A solution of 20% methanol-BBG and 5% acetic
acid was filtered through Whatman No. 1 filter paper and used to stain gels for 15 minutes at
room temperature. Gels were then destained with several changes of 20% methanol, 5% acetic
acid. Gels to be silver stained were first fixed in 50% methanol, 10% acetic acid for 15 minutes
with constant agitation. This was then replaced by 5% methanol, 7% acetic acid for 30 minutes
and finally replaced by 10% glutaraldehyde (BDH; Cat. No. 28682) for 30 minutes. Fixed gels
were rinsed well in several changes of Milli-Q water. The gels were then stained with 0.1% silver
nitrate (BDH; Cat. No. 10233) for 15 minutes and rinsed in water. The stain was developed in a
3% Na2C03/ 0.02% formaldehyde (Sigma; Cat. No. F1268) solution. When required solid citric
acid (Sigma; Cat. No. C0759) was added to stop the reaction. Developed gels were washed in
several changes of distilled water, fixed in 10% 'Ilfofix' (Ilford Ltd., Mobberley, Cheshire) for 1
minute and washed well in water.
Coomassie and silver stained gels, when developed, were transferred to 3MM paper and dried at
80°C under vacuum on a Bio-Rad Laboratories Gel Drier (Model 583).
2.9.5 Western Blot analysis.
After SDS-PAGE, proteins were transferred to nitrocellulose membranes (Hybond-C, 0.45fi,
Amersham) using a semi-dry electroblotter (Ancos, Denmark) (Khyse-Andersen, 1984). Transfer
was performed in 25 mM Tris.Cl, 20% methanol for 45 minutes at a constant current of 120 mA.
After blotting, the nitrocellulose membranes were "blocked" using 5% non-fat dried milk
(Sainsburys, Savacentre, Edinburgh) in PBS before overnight incubation in primary antibody,
diluted in PBS /1% non-fat dried milk. Blots were washed in several changes of blot washing
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buffer (lx PBS; 1% non-fat dried milk; 0.1% Tween 20) for 30 minutes at room temperature.
Bound primary antibody was detected by incubating for 60 minutes at room temperature with
either an anti-mouse (Sigma; Cat. No. B-7264) or anti-sheep (The Binding Site Ltd., Birmingham;
Cat. No. PB360) immunoglobulin biotin conjugate (1:1000) followed by alkaline phosphatase
conjugated to streptavidin (1:1000). Excess reagent was removed by washing in several changes
of buffer over 30 minutes at room temperature. The immunoblots were developed with 0.28
mg/ml nitro blue tetrazolium (Sigma; Cat. No. N5514) and 70pg/ml 5-bromo-4-chloro-3-indolyl
phosphate (Sigma; Cat. No. B6149) in 0.1M Tris.Cl (pH 9.5) as described by Pluzek and Ramlau
(1988). Development of blots was halted by washing in water.
2.10 Statistical analysis of data.
Data obtained in this thesis was statistically analysed to determine the significance of any observed
differences. Following consultation with Dr. Ian Wilson, University of Reading, data was analysed
by one of two methods depending on the experimentation used. Regression analysis was used to
determine the significance of observations made over time, were time is a covariate. When
regression analysis could not be used, two sample t-tests were used to determine the significance
of the difference between two sets of data. The statistical analysis was carried out using the
Minitab 10 for Windows™ statistical package (Minitab Inc., 1994). The significance of




Escherichia coli.{E.Coli.) strain JM101 (supE, thi, A(lac-proAB), [F, traD 36, proAB, lacli Z
AM15]) (Yanisch-Perron et al„ 1985) was used for bacterial transformations.
2.11.2 Preparation of competent E. coli.
E. coli, competent for transformation by plasmid DNA were prepared by a modification of the
method of Hanahan (1983). 200 pi of a fresh overnight culture of E. coli was diluted 1:100 into
psi broth (2% tryptone, 0.5% yeast extract, 20mM magnesium sulphate, lOmM sodium chloride,
5mM potassium chloride). Cells were grown with vigorous shaking (230 rpm) at 37°C, until the
OD at 550nm reached 0.3. 5 ml of the culture was diluted 1:20 in psi broth and grown until OD
550nm reached 0.48. The culture was chilled briefly on ice, and then centrifuged at 2000xg for
5 minutes at 4°C. The cell pellet was resuspended in 33 ml ice-cold transforming buffer I (35mM
sodium acetate, lOOmM calcium chloride, lOOmM rubidium chloride (Sigma; Cat. No. R2252),
50mM manganese chloride (Sigma; Cat. No. M3634), 15% glycerol, made to pH 5.9 with acetic
acid) and held on ice for 10-15 minutes. This was then centrifuged at 2000xg for 5 minutes at
4°C. The pellet was resuspended in 4 ml of Transforming Buffer II (lOmM morpholinopropane
sulfonic acid (Sigma; Cat. No. M5162), lOmM rubidium chloride, 75mM calcium chloride, 15%
glycerol; made to pH 6.7 with potassium hydroxide) and kept on ice for a further 20 minutes.
200pl aliquots were then snap-frozen in liquid nitrogen and stored at -70°C until required.
2.11.3 Transformation of E. coli with recombinant plasmid DNA.
For bacterial transformation a 100pl aliquot of competent E. coli was thawed on ice. To this, 100-
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200ng of DNA was added. The suspension was chilled on ice for 30 minutes prior to heat-
shocking at 42°C for 60-90 seconds. Cells were cooled briefly and then each aliquot was made to
lml with LB broth (containing no antibiotics) and incubated, with shaking, at 37°C for 1 hour.
Cells were pelleted at 500xg for 10 seconds and resuspended in 200pl of LB. Initial selection was
achieved by plating out cell suspension on plates of LBAmp agar. Antibiotic resistant colonies
were picked and investigated for the presence of plasmid DNA containing the required DNA
insert by restriction endonuclease analysis.
2.12 Molecular biological techniques.
The manipulation of DNA, including phenolxhloroform extraction of nucleic acids and their
subsequent precipitation by ethanol and sodium acetate, were based on the methods of Sambrook
et al., 1989.
2.12.1 Miniprep of plasmid DNA.
Transformants were grown to saturation in LBAmp broth and 10 ml of this culture was used for
the preparation of plasmid DNA isolated by the alkaline/SDS lysis method of Ish-Horowicz and
Burke (1981). The bacteria were pelleted and resuspended in 200pl TNE buffer (25 mM Tris.Cl,
pH 8.0; 50 mM NaCl; 1.5 mM EDTA, pH 8.0; 0.8% glucose). The cells were then lysed by
adding 400pl sodium dodecyl sulphate (SDS) buffer (0.2N sodium hydroxide, 1% SDS) and
incubating for 5 minutes on ice. 300pl of ice-cold 3M sodium acetate (pH 4.7 with acetic acid)
was then added to precipitate denatured chromosomal DNA, SDS and protein. After a 5 minute
incubation on ice, the material was removed by centrifugation. Plasmid DNA was recovered from
the supernatant by precipitation with the addition of 0.6 volumes isopropanol (BDH; Cat. No.
10224). Precipitated plasmid DNA was pelleted by centrifugation, resuspended in SDW and
phenokchloroform extracted. DNA was then re-precipitated by the addition of ethanol and 0.3M
sodium acetate followed by centrifugation. The final DNA pellet was resuspended in 20pl of
SDW containing a final concentration of 50pg/ml RNAse A (Boehringer Mannheim Chemica,
Germany; Cat. No. 109 169). 2-5pl of each sample DNA from a miniprep was analysed by
restriction endonuclease digestion followed by agarose gel electrophoresis.
2.12.2 Restriction endonuclease digestion of plasmid DNA.
Samples of plasmid DNA were digested with relevant restriction endonucleases. The digestions
were carried out as recommended by the manufacturer. Briefly, a sample of the DNA preparation
was incubated for 2-3 hours at 37°C in a final volume of 20-50gl with 1-2.5 Units of the
restriction enzyme per pg of purified DNA. Following the incubation, the DNA was visualised by
horizontal agarose gel electrophoresis.
2.12.3 DNA agarose gel electrophoresis.
DNA was analysed by horizontal gel electrophoresis using 1.5% agarose (Sigma; Cat. No. A9918)
gel in TAE buffer (40mM Tris-acetate; ImM EDTA, pH 8.0). The agarose was dissolved by
heating and allowed to cool to 50°C prior to the addition of ethidium bromide (Sigma; Cat. No.
E8751) at a final concentration of O.lpg/ml. DNA was mixed with loading buffer (5% glycerol,
12.5 mM EDTA (pH 7.9), 0.25% bromophenol blue) and loaded into wells. Gels were run at 5-
10 V/cm for 30-60 minutes submersed in TAE and the DNA was visualised on an ultra-violet
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(UV) transilluminator. DNA standards were run on every gel for comparison.
2.12.4 Large scale purification of plasmid DNA.
Large scale preparations of plasmid DNA were based on the alkaline lysis methods of Birnboim
and Doly (1979) and Ish-Horowicz and Burke (1981). Transformed E. coli were grown, with
shaking at 37°C, overnight in 500mls LBAmp broth. Bacteria were pelleted by centrifugation at
7500xg for 10 minutes and the supernatant removed. Cells were resuspended in 36mls of GTE
buffer (50mM glucose; 25mM Tris.Cl, pH 8.0; lOmM EDTA) and 4 mis of freshly made
lysozyme (Sigma; Cat. No. L6876) (40mg/ml in GTE) was added. The suspension was mixed
thoroughly and incubated at room temperature for 30 minutes. 80mls of freshly prepared
alkaline SDS (0.2M NaOH, 1% SDS) was then added and mixed gently. The suspension was
incubated on ice for 10 minutes. To this mixture, 60mls of ice-cold 3M potassium acetate (pH
4.7 with acetic acid) was added and incubated on ice for 60 minutes with occasional agitation to
break up the precipitate. The suspension was centrifuged (15000xg for 10 minutes) to pellet
chromosomal DNA, SDS and protein. The supernatant was transferred to a fresh centrifuge bottle
and 0.6 volumes of ice-cold isopropanol added. Nucleic acids were recovered by centrifugation
(9500xg for 10 minutes) and the pellet resuspended in 30mls TE (lOmM Tris.Cl, pH 8; ImM
EDTA). 30g of solid cesium chloride (Sigma; Cat. No. C3309) were dissolved in this suspension
and ethidium bromide was added to a final concentration of 800pg/ml. A cesium chloride
gradient was formed by centrifugation at 40000rpm for 18 hours at 20°C in a Beckman Vti 50
rotor (Beckman L8-60M ultracentrifuge). DNA intercalated with ethidium bromide was
visualised under UV and collected with a syringe and needle. The ethidium bromide was removed
by extraction 6 times with isoamyl alcohol (BDH; Cat. No. 27214). The suspension was finally
made up to lOmls with TE buffer. The DNA was then precipitated with 2.5 volumes of 70%
ethanol and 0.3M sodium acetate for one hour at 4°C and centrifuged at 9500xg. The DNA
pellet was resuspended in TE and precipitated twice in 1 volume 3M ammonium acetate and 2
volumes 95% ethanol. The final pellet of DNA was washed with 70% ethanol, resuspended in
SDW and stored at -70°C. The concentration of DNA was measured by spectrophotometry.
2.12.5 Quantitation of DNA.
A suitable dilution of purified DNA in SDW was prepared and the optical density at 260nm and
280nm was measured. Pure DNA gives an approximate OD260/OD28o ratio of 1.8-2.0. An
OD260 of 1-00 corresponds to approximately 50|ig/ml of double-stranded DNA. The
concentration of purified DNA was also further verified by visualisation on ethidium bromide
agarose gel electrophoresis against standards of known DNA concentration.
2.13 Monkey kidney cell line (COS-1 cells) manipulation.
2.13.1 Growth conditions.
COS-1 cells were kindly supplied by Dr. Neil Barclay (University of Oxford). Cells were grown to
90% confluence in tissue culture flasks and then harvested by incubation with 0.01%
Trypsin/0.01% Versene (Media Supply) for 10 minutes at 37°C. Flasks were gently tapped and
resuspended cells were aspirated and washed free of trypsin/versene by centrifugation. The cells
were then innoculated into fresh tissue culture flasks at a dilution of 1 in 4 and incubated at 37°C,
5% CO2 until required.
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2.13.2 TVansfection.
COS-1 cells were passaged when only 80-90% confluent. This was done at least twice, to obtain
cells in a log phase of growth. Cells passaged for the second time were innoculated into 25cm2
flasks at a concentration of 3x10s cells per ml and incubated overnight. The cells were
transfected after -18 hours of culture using DEAE-Dextran (Sigma; Cat. No. D9885). The
medium from the cells was aspirated and the cells washed twice with prewarmed G-MEM. DNA
(200ng per flask) and DEAE-dextran (250pg/ml final concentration) were made up in G-MEM.
A volume of 1ml was added to each of the flasks and the cells incubated for 5 hours at 37°C, 5%
C02. Following the 5 hour incubation, the DNA/DEAE-dextran mix was removed and the cells
washed twice with prewarmed Hepes-buffered G-MEM. Cells were then DMSO shocked for
90secs with 1ml of 10% DMSO in PBS. The DMSO solution was then removed, the cells were
washed with prewarmed Hepes-buffered G-MEM and then incubated for the required lengths of
time at 37°C, 5% CO2.
2.13.3 Harvest of transfected COS-1 cells and measure of plasmid DNA expression.
Transfected, mock transfected and non-transfected COS-1 cells were harvested at various time
points by incubating with 0.5mM EDTA in PBS for 15 minutes at 37°C. The flasks were tapped
gently and the resuspended cells washed into PFA. The cells were aliquoted and
immunofluorescently labelled as described in Section 2.5.1.1. Following labelling, the cells were
fixed in 2% paraformaldehyde (Sigma; Cat. No. P6148) in PBS for 15 minutes. The cells were
then analysed on a FACScan.
2.13.4 Positive selection of transfected cells.
Transfected cells were harvested with 0.5mM EDTA in calcium and magnesium free PBS and then
washed twice with PFA. All recovered cells were then incubated for 15mins at 4°C with a working
dilution of an appropriate monoclonal antibody. The positive control transfection and recovery
system used rat CD2. The anti-CD2 monoclonal antibody 0X34 was kindly supplied by Dr. Neil
Barclay, University of Oxford. The cells were washed with PBS/0.5mM EDTA and then incubated
with Dynabeads M-450 sheep anti-mouse IgG (Dynal Prod. No. 110.01) according to the
manufacturers instructions. Cells were harvested by placing the suspension, in a plastic universal,
in a strong magnetic field and aspirating the supernatant. The magnetically labelled positive cells
were held in place at the side of the tube. This was repeated twice to ensure sufficient enrichment
of cells expressing WC1 or CD2 on the cell surface.
2.13.5 Recovery of plasmid DNA from positively expressing transfected cells.
Recovery of the plasmid DNA contained in the recovered cells was by Hirt precipitation (Hirt,
1967). Briefly, cells were recovered as outlined above and pelleted. The pellet was then lysed in
400|il of 0.6% SDS, lOmM EDTA followed by addition of lOOpl of 5M NaCl. This was
incubated on ice for 15min and the cell debris then pelleted. The supernatant, containing any
plasmid DNA was retained and phenol:chloroform extracted twice. Plasmid DNA was then re-
precipitated by the addition of ethanol and 0.3M sodium acetate followed by centrifugation. This
plasmid DNA was then transformed into recipient competent bacteria E. Coli (MC1061/p3). The
p3 plasmid contains amber mutated ampicillin and tetracycline drug resistance elements (Seed
and Aruffo, 1987) which are only expressed in the presence of a Sup F element such as that
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present on CDM8 plasmids. Therefore cells containing the plasmid CDM8 are resistant to the
drugs ampicillin and tetracycline. The transformed bacteria were grown on an agar plate
containing 12.5(Xg/ml ampicillin and 7.5(Xg/ml tetracycline. Transformants may contain DNA
recovered by Hirt precipitation from the positively selected COS cells. Plasmid DNA from




Monoclonal antibodies to WC1 proteins
INTRODUCTION:
Sheep, like other species, have two distinct populations of mature PBL, namely B cells and T cells.
These cells are divided into distinct subsets according to function and cell surface phenotype.
Three sub-populations of T lymphocytes exist in the sheep and each population expresses one of
the following proteins: WC1 (T19); CD4 or CD8 (MacKay et al„ 1986, 1988). The WC1 protein
was first identified on ovine PBL by the monoclonal antibodies 19-19 (MacKay et al., 1986) and
ST197 (McClure et al., 1989) and was referred to as T19. In this thesis all references made to the
T19 molecule, or antibody cluster, will use the term WC1. This complies with the international
nomenclature defined in the 1st International Workshop on Ruminant Leucocyte Differentiation
Molecules (Morrison, 1991) (hereinafter referred to as the 1st Workshop).
It has been established both in the human (Brenner et al., 1986) and murine (Bluestone et al.,
1988) species that the majority of lymphocytes expressing the molecules CD4 or CD8 co-express
the ap T cell receptor (TCR) for antigen. It is assumed that a similar situation exists in the sheep.
However, at the present time, there is no monoclonal antibody specific for the ovine a|3 TCR to
confirm this is the case. In the sheep, cells which express WC1 co-express the y and 5 TCR genes
(MacKay et al., 1986).
In 1991, fourteen monoclonal antibodies specific for WC1 were submitted to the 1st Workshop.
Twelve of the monoclonal antibodies were raised against cattle lymphocytes and two of the
monoclonal antibodies were raised against sheep lymphocytes (Morrison and Davis, 1991). The
monoclonal antibodies were clustered because they reacted with the same populations of cells and
recognised the same proteins. As no human homologue of the WC1 proteins has been identified,
a CD number could not be assigned. A temporary Workshop Cluster (WC1) was formed. The
results from the workshop showed the reactivity of the fourteen monoclonal antibodies in the
WC1 cluster with PBL from both the ovine and bovine species.
In cattle, all the WC1 monoclonal antibodies identified populations of y8 T cells. In particular the
monoclonal antibody CC15 reacted with all y8T cells (Sopp et al., 1991) whereas other WC1
monoclonal antibodies reacted with different numbers of y5 T cells. All the monoclonal
antibodies immunoprecipitated two high molecular weight proteins of 215kDa and 300kDa,
which were non-covalently linked. In addition, immunohistological analysis revealed that the
different monoclonal antibodies recognised cells with the same tissue distribution. In the ovine
species only twelve of the fourteen WC1 clustered monoclonal antibodies reacted with PBL. This
indicated that some WC1 epitopes are not conserved between the ovine and bovine species. The
monoclonal antibody CC15 reacted with the greatest number of lymphocytes, and all y5 TCR
positive cells. All the other WC1 monoclonal antibodies reacted with sub-populations of y8 T
cells. All of the monoclonal antibodies immunoprecipitated a protein of 215kDa. Other higher
and lower molecular weight proteins of 144kDa and 300kDa were also immunoprecipitated by
some of the monoclonal antibodies (Hein et al., 1991).
Further monoclonal antibodies to WC1 have since been generated and these were submitted to the
2nd International Workshop on Ruminant Leucocyte Differentiation Molecules (hereinafter
referred to as the 2nd Workshop). The Department of Veterinary Pathology at the University of
Edinburgh was one of the participants in the 2nd Workshop. In this chapter the results generated
in this thesis and submitted to the final proceedings of the 2nd Workshop are discussed (Lund et
al., 1993). All of the WC1 monoclonal antibodies investigated here were raised against cattle
lymphocytes. The reactivity of the WC1 monoclonal antibodies with ovine PBL was assessed.
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The proteins recognised by each of the WC1 monoclonal antibodies were also identified. In
addition, the distribution of cells in the major immune compartments reactive with each of the
different WC1 monoclonal antibodies was determined.
In this chapter, and elsewhere in this thesis, data is presented from the analysis of
immunofluorescently labelled lymphocytes from ovine peripheral blood and other ovine
lymphocyte compartments. The results were obtained on a FACScan. The immunofluorescence
profile of a population of stained cells is displayed as a histogram of fluorescence intensity versus
cell number. The intensity of fluorescence is a consequence of two variables: (i) the level of
expression of target molecule on the cell surface and (ii) the affinity of the monoclonal antibody
for its epitope.
This chapter will introduce the methodology of the FACScan analysis undertaken in this thesis
and will describe the calculations used in determining specific staining by the monoclonal
antibodies used both in single colour and two-colour immunofluorescence analysis.
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RESULTS:
3.1 Immunofluorescence analysis of ovine PBL.
The lymphocyte population to be analysed by FACScan was identified by a forward scatter (size)
versus side scatter (granularity) profile. Figure 3.1 shows the forward scatter versus side scatter
profile of ovine PBMC on the FACScan. The different sub-populations of cells can be defined by
electronic gates. This allows for the subsequent analysis of individual populations of cells,
excluding all other cells in the sample. The various sub-populations of cells within PBMC were
gated as follows: PI-lymphocytes and monocytes; P2-granulocytes; P3-lymphoblasts; P4-all
leucocytes; P5-gate Pl+gate P3. Gates PI, P4 and P5 were routinely used throughout this thesis.
Gate PI was used for the analysis of the lymphocyte population found in peripheral blood,
thymus, spleen, mesenteric lymph node, prescapular lymph node, intestinal epithelium, intestinal
lamina propria, afferent lymph and efferent lymph. Gate P4 was used for the analysis of whole
blood PBMC and gate P5 was used for the analysis of activation of lymphocyte subsets.
3.1.1 Single-colour immunofluorescence.
Single colour FACScan analysis with control monoclonal antibodies of different mouse antibody
isotypes was compared to that of NMS and b-NMS (data not shown). No significant differences
were observed in the staining profiles with these control reagents. As a consequence NMS and b-
NMS were used routinely to determine the non-specific staining of populations of cells. The
staining profile for NMS is shown in figure 3.2. In addition, figure 3.2 shows examples of
positive cell surface fluorescence using the monoclonal antibodies SBU-1 (anti-ovine MHC class
I) and SBU-T4 (anti-ovine CD4). The percentage of cells stained specifically by the test
monoclonal antibody is calculated by subtracting the percentage of stained cells with NMS (non¬
specific staining) from the percentage of cells stained with the test monoclonal antibody (positive
staining). The percentage of cells stained with a reagent is determined on those cells with
fluorescence intensity greater than that seen with NMS (i.e. to the right of the marker shown on
each histogram).
3.1.2 Two-colour immunofluorescence.
Two colour immunofluorescence required the use of different fluorochromes. The reactivity of
one monoclonal antibody was detected by incubation with FITC-conjugated anti-isotype specific
immunoglobulin reagents and measured in the FL1 channel (green fluorescence). The reactivity
of a second monoclonal antibody was measured in the FL2 channel (red fluorescence). FL2 was
detected with streptavidin-phycoerythrin (SA-PE) which followed staining with either biotinylated
monoclonal antibodies or monoclonal antibodies followed by biotin-conjugated anti-isotype
specific immunoglobulin reagents. Two control reagents, NMS or b-NMS, were first used to
determine non-specific staining (Fig 3.3A). The specific monoclonal antibodies were then
examined against the control sera to enable compensations to be set to account for any residual
fluorescence in the overlap of emittance spectrums of FITC and SA-PE fluorescence (Fig 3.3B &
3.3C). Figure 3.3D shows PBL stained with the monoclonal antibody 86D (anti-y5 TCR) detected
by FITC-conjugated anti-IgGl secondary reagent and biotinylated monoclonal antibody CC15
(anti-WCl) detected with SA-PE. The number of WC1 positive cells expressing the y5 TCR was
calculated as described in the legend of figure 3.3. This method of calculation was adopted for
the analysis of all two colour immunofluorescence staining reported in this thesis.
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FIGURE 3.1: Scatter profile of ovine PBMC.
Forward Scatter ►
Figure 3.2: Single colour immunofluorescence.
PBL were purified from 6 month old sheep (n=6) and stained with NMS, anti-MHC class I or
anti-CD4 monoclonal antibodies then anti-mouse FITC. The figures show the single colour
immunofluorescence histogram for each of the monoclonal antibodies tested on PBL from one
animal. The percentage of positive cells was determined as being that value to the right of the
vertical marker shown. The marker was set with reference to the staining of NMS (always
<3%). This experiment was repeated eight times and the same trends were seen with PBL from
each animal and on each occasion tested.
FIGURE3.2:Singlecolourimmunofluorescence. SBU-1 Greenfluo esc nce
Figure 3.3: Two-colour immunofluorescence analysis of monoclonal
antibodies CC15 versus 86D.
PBL were purified from 6 month old sheep (n=8) and stained with either NMS or anti-y8,
followed by b-NMS or biotinylated anti-WCl, then streptavidin-phycoerythrin. The figures
show the two colour immunofluorescence profiles for each of the combinations of monoclonal
antibodies used. Figure 3.3A shows NMS (x-axis) versus b-NMS (y-axis) on which the non¬
specific staining values were set. Figure 3.3B shows NMS (x-axis) versus biotinylated anti-
WCl (y-axis) and figure 3.3C shows anti-y8 (x-axis) versus b-NMS (y-axis). Figures 3.3B
and 3.3C allowed the compensations for FL1 and FL2 fluorescence to be set. Figure 3.3D
shows biotinylated anti-WCl (y-axis) versus anti-yS (x-axis). Using the other figures of non¬
specific staining the calculation of the percentage of CC15-positive cells expressing 86D was as
follows:
Quadrant 1 (Figure A) + Quadrant 2 (Figure A) = Non-specific staining
Quadrant 1 (Figure D) + Quadrant 2 (Figure D) = Monoclonal antibody staining
Specific staining = Monoclonal antibody staining - Non-specific staining
Percentage of CC15-positive cells expressing 86D:
Quadrant 2 (Figure D) - Quadrant 2 (Figure A)
X 100
Specific staining
For determination of the number of 86D-positive cells expressing CC15 the values for quadrant
1 in figure A and figure B are replaced by the values for quadrant 4 in figure A and figure B.
Figure 3.3: Two-colour immunofluorescence analysis of
monoclonal antibodies CC15 versus 86D.
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3.2 Monoclonal antibodies to ovine lymphocyte molecules.
The monoclonal antibodies which were used in this thesis are listed in table 3.1 along with their
isotype and specificity. The majority of the monoclonal antibodies were sheep specific, derived
from fusions performed following immunisation of mice with ovine lymphocytes. Some
monoclonal antibodies were generated to lymphocyte antigens of the bovine species and found to
cross react with ovine lymphocytes, indicating the conservation of some epitopes across species.
3.2.1 Single colour immunofluorescence analysis of ovine PBL.
Reference immunofluorescence profiles of some of the monoclonal antibodies used in this thesis
are shown in figure 3.4. Representative staining patterns were obtained by staining of PBL from a
6 month old lamb. The profiles shown in figure 3.4 match those previously reported in the
literature (see references, table 3.1).
3.2.2 CD4-positive T cells; CD8-positive T cell; B cells.
CD4 and CD8 co-receptor molecules are each defined in the ovine species by two monoclonal
antibodies. The anti-CD4 monoclonal antibodies ST4 (IgGl) (MacKay et al., 1988) and SBU-T4
(IgG2a) (Maddox et al., 1985), both reacted with populations of ovine PBL of similar size (data
not shown). The anti-CD8 monoclonal antibodies ST8 (IgM) (MacKay et al., 1988) and SBU-T8
(IgG2a) (Maddox et al.,1985), both reacted with populations of ovine PBL of similar size (data
not shown). Figure 3.5 shows that in two-colour immunofluorescence assays, the pairs of
different subset specific reagents stained the same populations of cells. This allowed an
interchange of the subset-specific reagents when different isotypes were required. Figure 3.5A
shows the two-colour FACScan analysis of cells stained by the monoclonal antibodies ST4 (IgGl)
and SBU-T4 (IgG2a). It was seen that both ST4 (IgGl) and SBU-T4 (IgG2a) recognised epitopes
on the same populations of lymphocytes. These monoclonal antibodies were used
interchangeably in subsequent two-colour immunofluorescence assays. Figure 3.5B shows the
two-colour FACScan analysis of cells stained by the monoclonal antibodies ST8 (IgM) and SBU-
T8 (IgG2a). It was seen that both ST8 (IgM) and SBU-T8 (IgG2a) recognise epitopes on the
same populations of lymphocytes. However, some of the cells which were stained by the
monoclonal antibody ST8 at a low intensity did not react with the monoclonal antibody SBU-T8.
These monoclonal antibodies were used interchangeably in subsequent two-colour
immunofluorescence assays.
The anti-ovine B cell monoclonal antibodies VPM8 (IgGl) (McConnell, unpublished data) and
DIJ2.104 (IgM) (Hein, unpublished data) both reacted with similar sized populations of ovine
PBL (data not shown). Two-colour FACScan analysis of cells stained by the monoclonal
antibodies VPM8 (IgGl) and DU2.104 (IgM) showed that they recognised epitopes on the same
populations of lymphocytes (data not shown). These monoclonal antibodies were used
interchangeably in subsequent two-colour immunofluorescence assays.
3.2.3 y5 TCR positive T cells.
The monoclonal antibody 86D reacts with the ovine yS TCR molecule (MacKay et al., 1989). The
y5 T cell population in ruminants also express an unique set of cell surface glycoproteins called
WC1. The WC1 molecules are detected by a number of monoclonal antibodies of which the
monoclonal antibodies CC15 recognises all known WC1 molecules. Figure 3.3 shows the two
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Table 3.1: Monoclonal antibodies used for the immunofluorescence
analysis of ovine cell surface antigens.
The monoclonal antibodies used routinely in this thesis are listed along with their isotype,
specificity and reference.
TABLE 3.1: Monoclonal antibodies used for the immunofluorescence
analysis of ovine cell surface antigens.








































anti-ovine MHC class II (a-chain) IgG2b
anti-ovine MHC class II ((3-chain) IgGl




MacKay et al., 1989
Maddox et al., 1985
Clevers et al., 1990
MacKay et al., 1988
Maddox etal., 1985
MacKay et al., 1988
Maddox et al., 1985
McConnell, unpublished
Hein, unpublished
Naessans et al., 1992
Hopkins et al., 1986
Hopkins et al., 1993
Hopkins et al., 1993
MacKay et al., 1990
Gogolin-Ewens et al., 1985
unpublished
 
FIGURE 3.4: Reactivity of some of the monoclonal













Figure 3.5: Two-colour immunofluorescence analysis of monoclonal
antibodies to CD4-positive and CD8-positive T cells.
PBL were isolated from 6 month old lambs (n=4) and 106 cells were stained with ST4 or ST8
then anti-IgGl FITC, and biotinylated SBU-T4 or biotinylated SBU-T8 then SA-PE. These
cells were analysed by FACScan and the two-colour immunofluorescence profiles shown. The
figure shows the positive staining of cells from one animal when compared to the non-specific
staining of NMS versus and b-NMS (always <3%). This experiment was repeated four times
and the same trends were seen with PBL from each animal and on each occasion tested.
FIGURE3.5:Two-colourimmunofluorescenceanalysisfmonoclo altibodiestCD4 p sitiv8cells ST4
ST8
colour immunofluorescence staining profiles of ovine PBL with CC15 and 86D. 98% of CC15
positive cells expressed the y8 TCR and 98% of y5 T cells expressed WC1.
3.3 WCl-cIustered monoclonal antibodies.
Table 3.2 lists the monoclonal antibodies in the WC1 cluster which were submitted to the 2nd
Workshop. Also listed is the workshop number, the isotype and the donating laboratory of each
of the monoclonal antibodies. The monoclonal antibodies were clustered following initial
FACScan analysis. A detailed analysis of these WC1 monoclonal antibodies is described in this
chapter.
3.3.1 WC1 monoclonal antibodies react with ovine PBL.
Most of the WC1 clustered monoclonal antibodies submitted to the 2nd workshop were raised
against bovine lymphocytes (Morrison and Davis, 1991). The reactivity of these monoclonal
antibodies with ovine PBL was determined. Table 3.3 shows the percentage of PBL from 6 weeks
old lambs and 18 months old adult sheep which reacted with each of the WC1 monoclonal
antibodies. The percentage of positively stained calf PBL were included as a positive control, and
to allow a comparison between the ovine and bovine species.
All of the WC1 clustered monoclonal antibodies tested, apart from BAQ72A, reacted with PBL
isolated from lambs and adult sheep. Smaller percentages of adult PBL reacted with the WC1
monoclonal antibodies compared to PBL from young animals. The 2nd workshop WC1
monoclonal antibody standard, CC15, showed greatest reactivity of all the WC1 monoclonal
antibodies and stained 22% of lamb PBL and 8% of adult PBL.
Figure 3.6 shows the single colour FACScan profiles of PBL from 6 month old lambs and 6
month old calves when stained with WC1 monoclonal antibodies. The monoclonal antibody
CC15 stained lamb and calf PBL with the same high intensity. This epitope is conserved across
species. BAQ89A and CACTB7A (not shown), like BAG25A (shown), reacted with 9-11% of
lamb PBL. The patterns of reactivity of BAQ89A, CACTB7A and BAG25A on both ovine and
bovine PBL were the same. The monoclonal antibodies CC101 and CC115 (not shown), like
CC117 (shown), reacted with 7-9% of lamb PBL and showed similar profiles of staining. The
intensity of staining however, was not the same across species. Ovine PBL did not express the
epitopes recognised by the monoclonal antibodies CC101, CC115 and CC117 with the same high
intensity as was seen in the bovine species. The monoclonal antibodies CACTB15B and
CACTB1A reacted with <6% of lamb PBL and showed different immunofluorescence profiles
with PBL from the ovine species when compared to those from the bovine species. The size of the
populations of PBL stained by the monoclonal antibodies CACTB1A and CACTB15B is smaller
in the ovine species than in the bovine species. PBL from lambs were stained with both a high
intensity and low intensity by the monoclonal antibodies CACTB1A and CACTB15B. PBL from
the bovine species however were stained with an high intensity only.
3.3.2 WC1 monoclonal antibodies react with CC15-positive ovine PBL.
Of all the WC1 monoclonal antibodies tested, CC15 reacted with the greatest number of ovine
PBL. This monoclonal antibody was submitted to the 2nd Workshop as a control for reactivity of
other WC1 monoclonal antibodies. The reactivity of CC15 with ovine PBL was compared to that
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Table 3.2: Workshop monoclonal antibodies analysed.
The WC1 specific monoclonal antibodies which were submitted to the 2nd International
Workshop on Ruminant Leucocyte Differentiation Molecules and used in this thesis are listed


























































Table 3.3: Reactivity of WC1 monoclonal antibodies with ovine PBL.
PBL were isolated from 6 week old lambs (n=6), 18 month old adult sheep (n=3) and as a
control a 6 month old calf (n=l). 106 cells were stained with all of the anti-WCl monoclonal
antibodies listed then anti-IgG FITC and analysed by FACScan. The percentages listed are
positive cells with respect to NMS used as a negative control. The results shown are the mean
values obtained and the standard deviation of the means are shown in the brackets.
TABLE3.3:ReactivityofWC1monoclonalantibodieswithv nPB . AntibodyLambPBLdult (6weeksold)18month CC1521.6(6.9)8.0(1.9) CC1017.5(2.0)4.5(1.8) CC1178.9(3.2)2.9(1.2) CC1157.3(2.7)1.7(0.9) CACTB1A5.5(1.7)0.9(0.8) CACTB15B3.7(1.7)4.9(2.7) BAQ72A0.0(0. )1.6(1.3) BAQ89A8.7(3.6)3.1(1.6) CACTB7A9.2(4.4)2.9(1.5) BAG25A10.9(6.8)3.4(1.4)
CalfPBL
(6monthsold) 25 17 19 17 13 12 9 11 11 15
Figure 3.6: Reactivity of WC1 monoclonal antibodies.
PBL were isolated from 6 week old lambs (n=6) and a 6 month old calf (n=l) then stained with
all of the anti-WCl monoclonal antibodies listed then anti-IgG FITC and analysed by
FACScan. Single colour immunofluorescence profiles of the monoclonal antibodies CC15,
BAG25A, CC117, CACTB1A and CACTB15B on PBL from one animal are shown. This
experiment was repeated three times and the same trends were seen with PBL from each animal
and on each occasion tested.





of all cross-reactive WC1 monoclonal antibodies by two colour immunofluorescence. Table 3.4
shows two sets of data: i) the percentage of CC15-positive PBL which reacted with the other WC1
monoclonal antibodies, ii) the percentage of PBL reactive with the WC1 monoclonal antibodies
which also reacted with CC15. The results were obtained with PBL from 6 month old lambs. All
of the workshop monoclonal antibodies reacted with sub-populations of CC15-positive PBL. The
monoclonal antibodies CC101, CC115, CC117, BAQ89A, CACTB7A and BAG25A reacted with
52-67% of the CC15 positive populations. The monoclonal antibody CACTB15B stained only
25% of CC15-positive PBL and the monoclonal antibody CACTB1A stained only 49% of CC15-
positive PBL. All of the PBL which reacted with the monoclonal antibodies CC101, CC115 and
CC117 also reacted with CC15. In addition, 90-96% of PBL which reacted with the monoclonal
antibodies BAQ89A, CACTB7A and BAG25A also reacted with CC15. Representative two-colour
immunofluorescence profiles for CC15 versus the monoclonal antibodies CC117, like CC101 and
CC117, and BAG25A, like CACTB7A and BAQ89A, are shown in figure 3.7. The profiles
demonstrate that all the PBL which reacted with the monoclonal antibodies CC117 and BAG25A
are found in the upper right quadrant and therefore express the epitope recognised by the
monoclonal antibody CC15. Figure 3.7 also demonstrates that PBL stained at high intensity with
CACTB1A or CACTB15B all reacted with CC15, but of the PBL which stained with a low intensity
only a proportion reacted with CC15.
3.4 Characterisation of proteins immunoprecipitated from ovine PBL by WC1
monoclonal antibodies.
It was shown in both the bovine species, and the ovine species, that all WC1 monoclonal antibodies
submitted to the 1st Workshop reacted with proteins of molecular weight 215kDa. In sheep, some
of these monoclonal antibodies also reacted with proteins of 144 and 300kDa. Figure 3.8 shows
the proteins immunoprecipitated by the WC1 monoclonal antibodies submitted to the 2nd
W)rkshop. The monoclonal antibodies B7A1 and BAQ4A were submitted to the 1st Workshop
and the proteins immunoprecipitated by these monoclonal antibodies were included for a
comparison with previous data. All of the monoclonal antibodies, except CC101, reacted with
proteins of molecular weights of 140 and 220kDa. The monoclonal antibody CC101
immunoprecipitated the 220kDa form of the protein only. In addition all the monoclonal
antibodies, except CACTB1A and CACTB15B, immunoprecipitated a protein of molecular weight
300kDa. The monoclonal antibodies CC15 and BAQ4A routinely immunoprecipitated the
highest level of protein whilst the monoclonal antibodies B7A1, BAG25A and BAQ89A
immunoprecipitated intermediate levels of the protein and CC101, CACTB7A, CACTB15B and
CACTB1A immunoprecipitated low levels of the protein. No protein bands were
immunoprecipitated in the presence of NMS.
3.5 Affinity purification of WC1 proteins from ovine PBL.
The reactivity of WC1 monoclonal antibodies with the purified WC1 protein was
determined. The WC1 proteins were purified on an affinity column comprising WC1
antibody ST197. This section details the preparation of the WC1 affinity column, the
of WC1 proteins and the detection of purified WC1 proteins.
3.5.1 Preparation of anti-WCl column.






immunofluorescence analysis of reactive WC1
antibodies.
PBL were isolated from 6 month old lambs (n=6) and stained with each of the anti-WCl
monoclonal antibodies listed then anti-isotype FITC, and biotinylated anti-WCl monoclonal
antibody CC15 then SA-PE. The percentage of positive cells was calculated with reference to
the staining of biotinylated NMS versus NMS. The results shown are the mean values obtained
and the standard deviations from the means are shown in the brackets.
TABLE3.4:wo-colourimmunoflourescenceanalysisfre ctiveWC1mon cl nalntibod s. MonoclonalA tibody CC101 CC117 CC115 CACTB1A CACTB15B BAQ89A CACTB7A BAG25APercentageofCC15-positiv populationreactingwith WC1antibody. 63.1(4 3) 66.7(2 6) 52.4(5 0) 48.7(14.5) 25.0(6 4) 52.3(5 4) 52.5(8 6) 58.4(6 1)
Percentageof WCl-positivecells expressingCC15. 100.0( . ) 100.0( . ) 100.0( . ) 65.9(10.6) 80.1(8 8) 94.0(9 1) 90.0(10.8) 96.1(2.4)
Figure 3.7: Two-colour immunofluorescence analysis of WC1
monoclonal antibodies.
PBL were isolated from 6 month old lambs (n=6) and stained with the anti-WCl monoclonal
antibodies CC117, BAG25A, CACTB1A and CACTB15B then anti-isotype FITC, and
biotinylated anti-WCl monoclonal antibody CC15 then SA-PE. The quadrants of the two-
colour immunofluorescence profiles shown were determined by the staining of NMS versus b-
NMS. This experiment was repeated three times and the same trends were seen with PBL from
each animal and on each occasion tested.
FIGURE3.7:Two-colourimmunofluorescenceanalysisfWC1mon clonala tib dies.
Figure 3.8: Immunoprecipitation of WC1 protein.
An 125I-labelled ovine PBL lysate was prepared and pre-cleared of non-specific material by
incubation with agarose beads coupled to anti-Ig. Agarose beads coupled to anti-Ig were pre-
adsorbed with cold lysate to prevent non-specific radiolabelled antigen binding. The listed anti-
WC1 monoclonal antibodies were then coupled to the pre-adsorbed anti-Ig beads. Anti-WCl
coupled beads were then incubated with the 125I-labelled lysate and the WC1 antigens
immunoprecipitated. The proteins immunoprecipitated were then run on a 5-15% SDS-PAGE
gel. The relative mobility of the molecular weight markers are shown at the left of the figure.
Each of the anti-WCl monoclonal antibodies used is listed along the top of the figure.
Figure 3.8: Immunoprecipitation of WC1 protein
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gamma-bind, protein G sepharose column. Approximately 10 litres of supernatent yielded
37.5mg of ST197 monoclonal antibody. Figure 3.9 shows a Coomassie stained SDS-PAGE of
ST 197 monoclonal antibody culture supematent prior to, and following, purification. No
antibody proteins were visible in the culture supernatent whilst the heavy chain (55kDa) and light
chain (28kDa) of the monoclonal antibody were stained in the purified sample. The reactivity of
purified ST197 with PBL from the ovine species was determined by FACScan analysis. At a
dilution of 1/2000 the monoclonal antibody reacted with PBL (data not shown). Purified ST197
monoclonal antibody was coupled to CNBr activated agarose according to the manufacturers
instructions. The amount of protein in solution prior to, and after, coupling to CNBr was
measured and the coupling efficiency of the monoclonal antibody ST197 to the agarose
calculated to be 95%. Antibodies from NMS were purified in an identical manner on the gamma
bind column and then coupled to agarose. The coupling efficiency of NMS antibodies was 87%.
The NMS column was used as a pre-column to remove any non-specific proteins. In addition, a
pre-pre-column of swollen agarose only was prepared.
3.5.2 Detection of purified WC1 protein.
WC1 protein isolated on the ST197 affinity column was purified from spleen lysates as described
in section 2.7. The purified material was analysed by two methods; SDS-PAGE and ELISA.
3.5.2.1 SDS-PAGE of purified WC1 protein.
Purified WC1 protein was eluted from the affinity column and a 15pl aliquot of each fraction
analysed on a 5-15% polyacrylamide gel. The proteins present on the gel were detected by silver-
stain. Faint bands were detected at 220kDa and 300kDa in fractions 4 through to fraction 12 as
shown in figure 3.10. In addition, high molecular weight proteins were also visible in fractions
24-27. A number of other non-specific protein bands of lower molecular weights were observed
in all fractions.
3.5.2.2 ELISA of purified WC1 protein.
The specificity of the WC1 ELISA which was developed is shown in figure 3.11. Monoclonal
antibody ST197 was used to capture the WC1 proteins in the solution. Captured WC1 protein was
subsequently detected with a biotinylated secondary monoclonal antibody, CC15. The optical
density readings shown indicated the presence of the WC1 antigen. No signal could be detected
in an identical assay developed with a non-specific secondary monoclonal antibody (anti-CD8).
These results demonstrated that the ELISA developed was specific for WC1 antigen. Using this
ELISA, the presence of WC1 in fractions of material eluted from the affinity columns was
determined. Figure 3.12 shows the optical density readings in the capture ELISA of an 50pl
aliquot of each of the fractions of material eluted from the affinity columns. The WC1 antigen
was detected in fractions 6-13 of the WC1 affinity column. This correlated with the silver stain of
an SDS-PAGE of each of the fractions shown in figure 3.10.
3.6 WC1 monoclonal antibodies react with purified WC1 proteins of a similar
molecular weight.
The results in section 3.4 and 3.5 suggested that the workshop monoclonal antibodies grouped in
the WC1 cluster recognised epitopes on proteins of the same molecular weight. This was
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Figure 3.9: Purification of ST197 monoclonal antibody.
The monoclonal antibody cell line ST 197 was grown to saturation. From the culture
supematent, monoclonal antibody was purified by affinity chromatography. The protein
content of the samples before and after purification was assessed by conventional Coomassie
staining of SDS-PAGE. Column 1 shows the protein content of the saturated ST197
supematent before affinity purification; column 2 shows the molecular weight markers and
columns 3, 4, 5 and 6 show the protein content of 1, 3, 5 and lOpl of the purified monoclonal
antibody respectively.
Figure 3.9: Purification of ST197 monoclonal antibody
Figure 3.10: Silver stain of purified WC1 protein.
WC1 was purified from spleen lysates by affinity chromatography. 25pl of each eluted fraction
from the affinity column was ran on a 5-15% SDS-PAGE. The gel was developed by silver
staining. The mobility of the molecular weight markers is shown to the left of the figure. The
fraction numbers in ascending order following elution from the column are shown above the
respective lanes on the gels. The arrows to the right of the figure indicate the position of faint
bands of molecular weights approximating to 220kDa and 300kDa seen in fraction 4 through to
fraction 12 inclusive.
Figure 3.10: Silver stain of purified WC1 protein
Fraction number
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Figure 3.11: WC1 ELISA.
Flat-bottomed 96-well plates were coated with the anti-WCl monoclonal antibody ST197 and
blocked with 1% BSA. 50pl of various dilutions of the purified WC1 protein were added to
individual wells. The wells were washed, and any captured WC1 protein detected with the
biotinylated WC1 monoclonal antibody CC15. Biotinylated anti-CD8 monoclonal antibody
was used as a negative control. Streptavidin-alkaline phoshatase was added to each of the wells
and the ELISA developed by addition of the alkaline phosphate colour substrate. Optical
density (OD) readings were taken at 405nm. The OD's of the WC1 positive reactions: (—






Figure 3.12: Affinity purification of WC1.
Flat-bottomed 96-well plates were coated with the anti-WCl monoclonal antibody ST197 then
blocked. 50|d of each fraction eluted from the WC1 affinity column ( o ), the pre-
column (.. ) and the pre-pre-column ( ) was added to individual wells. The
wells were washed, and any captured WC1 protein detected with the biotinylated WC1
monoclonal antibody CC15. Streptavidin alkaline phosphatase was added to each well and the
ELISA reaction developed by addition of the alkaline phosphatase colour substrate. Optical
density (OD) readings were taken at 405nm. The OD values for the first 25 fractions eluted




confirmed by Western Blot of purified WC1 proteins. Purified WC1 proteins were separated by
SDS-PAGE under both reducing and non-reducing conditions, transferred to a nitrocellulose
membrane, and the reactivity of each of the WC1 monoclonal antibodies with the WC1 protein
assessed. Figure 3.13A shows that under non-reducing conditions the monoclonal antibody
CC15 recognised proteins of molecular weight 140kDa, 220kDa and 300kDa. The monoclonal
antibodies ST197, BAG25A, CACTB1A, CACTB7A and BAQ89A recognised protein bands of
similar molecular weight but with less intensity than those seen with the monoclonal antibody
CC15. The monoclonal antibody BAQ4A reacted with proteins of molecular weight 140kDa,
220kDa and 300kDa and did so with greater intensity than seen with the monoclonal antibody
CC15. In contrast, the monoclonal antibodies CC101 and B7A1 reacted a protein with an
apparent molecular weight of 144kDa, and along with all the other monoclonal antibodies, except
CC15, recognised proteins of lower molecular weights. WC1 proteins with molecular weights
lower than 144kDa have not previously been reported and those identified here are thought to be
degradation products which occurred as a result of the treatment of the purified material. The
epitope recognised by the monoclonal antibody CC15 is possibly conformation dependent, and
its loss occurs through degradation of the WC1 molecule. Figure 3.13B shows the results
obtained under reducing conditions. None of the monoclonal antibodies reacted with any
proteins. This implies reactivity by the monoclonal antibodies with WC1 protein is dependent
upon disulphide bonding. This may be a consequence of the high number of cysteine residues
found in the protein sequence (see figure 3.20).
3.7 Subsets of WC1 positive T cells have no apparent recirculatory patterns.
Sheep PBL have a number of sub-populations of WC1 positive y5 T cells as defined by the
expression of different WC1 epitopes described in this chapter. The percentage of lymphocytes
expressing the different WC1 epitopes was determined in a number of different tissues and body
fluids from the sheep. If any specific recirculatory or homing patterns occurred for a subset of
WC1 positive cells these would be expected to predominate over the other WC1 cells in a
particular tissue. Table 3.5 shows the percentage of lymphocytes in various tissues and lymphoid
compartments which expressed each of the WC1 epitopes. Lymphocytes were isolated from the
tissues of 6 month old animals and from the lymph fluid of 9 month old animals. The expression
of the different WC1 epitopes on lymphocytes found in the peripheral blood of 6 month old
animals were included as a reference. There were no distinct recirculatory patterns of any of the
WC1 positive subsets in any of the tissues examined. Of all the different compartments examined,
the highest numbers of lymphocytes which expressed each of the WC1 epitopes were found in the
afferent lymph. Few lymphocytes isolated from both mesenteric and prescapular lymph nodes
expressed any of the WC1 epitopes. 18% of the lymphocyte population isolated from the
intestinal epithelium expressed the ySTCR however <5% of the lymphocyte population were
positive for any of the WC1 epitopes.
3.7.1 Histological identification of cells expressing WC1 epitopes.
In the previous section, lymphocytes isolated from different tissues and body fluids were analysed
to determine if there was any specific recirculation of lymphocytes which expressed the different
WC1 epitopes. However, the procedures employed for purifying lymphocytes from the different
tissues did not allow for an examination of the T cell specific areas of the different immune
compartments. The tissue distribution of lymphocytes expressing the different WC1 epitopes was
therefore determined in the spleen, thymus and lymph node. In all of the tissues examined, the
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Figure 3.13: Western blot of purified WC1 protein.
Purified WC1 was ran on a 5-15% SDS-polyacrylamide gel under either reducing (with 5% P-
mercaptoethanol) or non-reducing conditions. The material was then transferred from the SDS-
PAGE onto a nitrocellulose membrane. Strips of nitrocellulose were then incubated with each
of the WC1 monoclonal antibodies and the reactivity of the WC1 monoclonal antibodies was
developed with biotinylated anti-IgG and streptavidin-alkaline phosphatase. The relative
mobility of the molecular weight markers are shown at the left of the figure and the WC1
monoclonal antibodies used are listed along the top of the figure.


















































Table 3.5: Tissue distribution of WC1 populations
Lymphocytes were isolated from the listed tissues and peripheral blood of six month old
animals (n=5) and the lymphocyte compartments of nine month old animals (n=5). 106
lymphocytes from each tissue were stained with each of the monoclonal antibodies listed and
then anti-Ig FITC. The percentage of positive cells was calculated with respect to the staining
of NMS as a negative control (<3% positive). The results shown are the mean values obtained


























































































reactivity of the monoclonal antibodies CC115 and CC117 was similar to the reactivity of the
monoclonal antibody CCIOI. In addition, the monoclonal antibodies CACTB7A and BAQ89A
had similar patterns of reactivity as did the monoclonal antibodies CACTB1A and CACTB15B.
The monoclonal antibody BAG25A stained non-specifically all tissue sections.
Figure 3.14 shows the immunoperoxidase staining of lymphocytes with the monoclonal
antibodies CC15 (WC1) and 86D (y5 TCR) in the spleen of a nine month old animal. Stained
cells can be seen in the marginal zones, outwith and encircling the periarteriolar sheath and B cell
follicular area. This is indicative of cells in transit through the spleen and is consistent with
previously reported data (MacKay et al., 1986). Figure 3.15 shows the staining of lymphocytes in
the spleen by monoclonal antibodies to the different WC1 epitopes. The number of lymphocytes
stained by each of the workshop monoclonal antibodies appeared to be less than that observed
with the control monoclonal antibody CC15 (figure 3.14). In addition, the intensity of staining
by CC101(A) and CACTBIA(C) appeared to be less than that observed with the control
monoclonal antibody CC15 (figure 3.14).
Figure 3.16 shows the distribution of cells in the thymus reactive with the monoclonal antibodies
CC15 and 86D. It appeared that there were less WC1-positive cells present than y5 TCR-positive
cells. An increase in WC1 expression has been shown to occur late in thymic development
(MacKay et al., 1989). Positive cells were most predominant in the medulla with fewer cells seen
in the cortex. Figure 3.17 shows the distribution of cells reactive with the WC1 workshop
monoclonal antibodies. The distribution of cells reactive with the WC1 workshop monoclonal
antibodies was the same as the distribution of cells reactive with the control monoclonal antibody
CC15 (figure 3.16). The intensity of staining of the 2nd workshop monoclonal antibodies and
the number of cells which reacted with the 2nd workshop monoclonal antibodies may have been
less than that observed with the control monoclonal antibody CC15 (figure 3.16).
Immunohistological staining of the lymph node by the monoclonal antibodies CC15 and 86D is
shown in figure 3.18. Positively stained cells are concentrated in the peripheral areas of the
cortex adjacent to the subscapular and cortical sinuses and lining the trabeculae. The pattern of
reactivity is similar to that observed in the spleen and is indicative of trafficking cells. The
staining in the lymph node of the monoclonal antibodies CC101(A), CACTB7A(B) and
CACTBIA(C) is shown in figure 3.19. The staining of the WC1 monoclonal antibodies
CC101(A) and CACTBIA(C) appeared to be less intense than that of the control monoclonal
antibody CC15 (figure 3.18). In addition, all of the workshop monoclonal antibodies appeared to
stain fewer cells compared to the control monoclonal antibody CC15 (figure 3.18).
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Figure 3.14: Immunohistological staining of the spleen.
Cryostat sections of the spleen from a 6 month old sheep were stained with the monoclonal
antibodies CC15 (A) and 86D (B) and visualised with alkaline phosphatase. Sections were
viewed by conventional microscopy and photographs were taken at x40 magnification.
Positive cells are concentrated in the marginal zones. There are no positive cells in the
periarteriolar region or in the B cell follicle.
FIGURE 3.14: Immunohistological staining of the Spleen.
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Figure 3.15: Immunohistological staining of the spleen.
Cryostat sections of the spleen from a 6 month old sheep were stained with the monoclonal
antibodies CC101 (A), CACTB7A (B) and CACTB1A (C) and visualised with alkaline
phosphatase. Sections were viewed by conventional microscopy and photographs were taken
at x40 magnification. Positive cells are concentrated in the marginal zones. There are no
positive cells in the periarteriolar region or in the B cell follicle.
FIGURE 3.15: Immunohistological staining of the Spleen.
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Figure 3.16: Immunohistological staining of the thymus.
Cryostat sections of the thymus from a 6 month old sheep were stained with the monoclonal
antibodies CC15 (A) and 86D (B) and visualised with alkaline phosphatase. Sections were
viewed by conventional microscopy and photographs were taken at x40 magnification.
Positive cells are concentrated in the medulla with fewer positive cells scattered in the cortex.
FIGURE 3.16: Immunohistological staining of the Thymus.
(A) CC15
(B) 86D
Figure 3.17: Immunohistological staining of the thymus.
Cryostat sections of the thymus from a 6 month old sheep were stained with the monoclonal
antibodies CC101 (A), CACTB7A (B) and CACTB1A (C) and visualised with alkaline
phosphatase. Sections were viewed by conventional microscopy and photographs were taken
at x40 magnification. Positive cells are concentrated in the medulla with fewer positive cells
scattered in the cortex.




Figure 3.18: Immunohistological staining of the lymph node.
Cryostat sections of the lymph node from a 6 month old sheep were stained with the
monoclonal antibodies CC15 (A) and 86D (B) and visualised with alkaline phosphatase.
Sections were viewed by conventional microscopy and photographs were taken at x40
magnification. Positive cells are concentrated in the peripheral areas of the cortex adjacent to
the subscapular sinuses and the cortical sinuses and lining the trabeculae.
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Figure 3.19: Immunohistologica! staining of the lymph node.
Cryostat sections of the lymph node from a 6 month old sheep were stained with the
monoclonal antibodies CC101 (A), CACTB7A (B) and CACTB1A and visualised with alkaline
phosphatase. Sections were viewed by conventional microscopy and photographs were taken
at x40 magnification. Positive cells are concentrated in the peripheral areas of the cortex
adjacent to the subscapular sinuses and the cortical sinuses and lining the trabeculae.






This chapter introduces the use of fluorescence activated cell scanning (FACScan) to distinguish
sub-populations of peripheral blood mononuclear cells, in particular sub-populations of
lymphocytes. The expression of a number of different cell surface molecules was investigated
throughout the course of this thesis. This chapter has explained the methodology used to
calculate the level specific expression of these antigens on lymphocytes. Reference staining
profiles of some of the monoclonal antibodies have been shown. FACScan analysis of ovine PBL
showed that the epitope recognised by the WC1 monoclonal antibody CC15 was expressed on
virtually all y8 T cells. The monoclonal antibody CC15 is an IgG2a isotype. This monoclonal
antibody, or the monoclonal antibody 86D (anti-yS TCR), could therefore be used for the
identification of the y8 T cell population. It was also shown that the monoclonal antibodies ST4
and SBU-T4 both recognised epitopes on an identical population of lymphocytes. Therefore,
these monoclonal antibodies were used interchangeably. The isotype of SBU-T4 is also IgG2a
and the isotype of ST4 is IgGl. Similarly, monoclonal antibodies ST8 and SBU-T8 also
recognised similar populations of cells though SBU-T8 did not react with cells expressing the ST8
epitope at low levels. SBU-T8 is an IgG2a isotype antibody and ST8 and IgM isotype antibody.
The monoclonal antibodies CC15, SBU-T4 and SBU-T8 define the three known T cell
populations in the ovine species; y8, CD4 and CD8 respectively. Because CC15, SBU-T4 and
SBU-T8 are of the same isotype, these monoclonal antibodies allowed for direct comparisons of
changes in phenotype of the different T cell subsets when stained against monoclonal antibodies
of different isotypes. The monoclonal antibodies VPM8 and DU2.104 recognise sheep B cells.
DU2.104 is reported however to be a more specific marker (W. R. Hein, unpublished; P.Bird,
personal communication). This is thought due to the reactivity of the anti-light chain monoclonal
antibody, VPM8, with Fc receptors on some ovine cells. DU2.104 was shown to react only with
surface immunoglobulin-positive cells in efferent and afferent lymph, and also peripheral blood
(P. Bird, personal communication). DU2.104 is of an IgM isotype and was therefore chosen as a
B cell marker in assays requiring monoclonal antibodies other than the IgGl isotype.
A panel of monoclonal antibodies that recognise epitopes on the WC1 proteins on the cell surface
of ruminant y8 T lymphocytes were investigated. These monoclonal antibodies were raised
against bovine lymphocytes and their reactivity with ovine lymphocytes was determined here. It
was shown that, although the bovine and ovine species are closely related, not all the WC1 epitopes
expressed in the bovine species were expressed in the ovine species.
The WC1 epitopes recognised by the cross-reactive monoclonal antibodies were expressed on y8T
cells. All the WC1 monoclonal antibodies reacted with sub-populations of cells stained with the
monoclonal antibody CC15. CC15 is believed to recognise an epitope expressed on all WC1
proteins (Clcvers et al., 1988; Sopp et al., 1991). The WC1 monoclonal antibodies recognised
proteins of molecular weights 144kDa, 215kDa and 300kDa. It was confirmed by Western Blot of
purified WC1 protein that all the WC1 monoclonal antibodies recognised proteins of the same
molecular weight. The monoclonal antibody CC15 immunoprecipitated proteins of molecular
weight 144kDa, 215kDa and 300kDa, and recognised all three in a Western Blot. In contrast,
some WC1 monoclonal antibodies only reacted with the two lower molecular weight proteins. In
addition, the intensity of protein bands seen with the other WC1 monoclonal antibodies was less
than that seen with the monoclonal antibody CC15. This correlated with the FACScan analysis of
peripheral blood lymphocytes in that the monoclonal antibody CC15 stained the greatest number
of lymphocytes and with the highest intensity::; indicated that either (i) the WC1 monoclonal
antibodies had a weaker affinity for the protein thanidid the monoclonal antibody CC15; or (ii)
the epitopes recognised by the WC1 monoclonal antibodies are expressed at different levels on the
surface of yd T cells. Complex WC1 gene families have been found in cattle, sheep, goats, pigs
and horses (Wijngaard et al„ 1992, 1994; Metzelaar et al., 1992). The WC1 proteins could be
synthesised from the gene pool and different epitopes expressed on different products. The
epitope recognised by the monoclonal antibody CC15 may be part of the protein backbone and is
expressed on all WC1 molecules.
The function(s) of WC1 is unknown, yd T cells do not express the co-receptor molecules CD2,
CD4 or CD8. It has been proposed that WC1 may fulfil the role of an accessory molecule on the
surface of these cells (MacKay et al., 1986; Evans, 1993). Recently, three different bovine WC1
gene constructs have been cloned and sequenced (Wijngaard et al., 1992, 1994: Metzelaar et al.,
1992) allowing a putative structure for the WC1 protein to be predicted. Figure 3.20 shows the
predicted amino acid sequence of the WC1.1 gene. 91 amino acids (-6.3%) in the extracellular
domain of WC1 are cysteine residues. Disulphide bonds can be formed between cysteine residues
which cause the protein to fold and so increase the degree of secondary structure. In addition, 61
amino acids (4.2%) in the extracellular domain of WC1 are proline residues. The amino acid
proline has one fixed and one flexible peptide bond with adjacent amino acids. This also
increases the degree of secondary structure in a protein. It appears that the extracellular domain
of WC1 proteins will have extensive secondary structure caused in part by the large number of
cysteine and proline residues. This secondary structure could account for the observation that the
WC1 monoclonal antibodies did not recognise WC1 protein in a Western Blot when run under
reducing conditions.
The WC1 extracellular domain is a single polypeptide chain consisting of 11 non-identical repeats
of a 110 amino acid consensus sequence of a cysteine rich region as detailed in figure 3.21
(Wijngaard et al., 1992, 1994). These cysteine rich regions have also been found in a number of
other glycoprotein structures including CD5 (Jones et al., 1986; Huang et al., 1987) and CD6
(Aruffo et al., 1991) and the macrophage scavenger receptor cysteine rich (SRCR) domain which
may play a role in macrophage-associated immune responses and inflammation (Freeman et al.,
1990). The proteins CD5 and CD6 are known to be involved in T cell activation (Geppert et al.,
1990). The presence of these domains on the WC1 proteins suggests that the WC1 protein may
interact with a corresponding ligand system. CD5 interacts with its ligand CD72 via the SRCR
domains (van de Velde et al., 1991) therefore by analogy, WC1 may interact with a membrane
bound ligand via its own SRCR domains. It has been proposed therefore, that WC1 may function
by controlling tissue-specific homing of y5 T cells (Wijngaard et al., 1994).
It should be noted that no evidence was found in this thesis for a distinct recirculation of any of
the WC1 positive populations so far defined in the staining of the major T cell compartments.
The greatest number of lymphocytes which expressed the different WC1 epitopes was found in
the afferent lymph whilst few lymphocytes in the lymph node expressed any of the WC1 epitopes.
However, in both lymphocyte compartments no WC1 sub-population prevailed. In the intestinal
epithelium, few of the yd T cell population expressed any of the WC1 epitopes. This lack of
expression of WC1 has been suggested by others (MacKay et al., 1986; McClure et al., 1989) and
there are at least three possibilities to explain this observation: (i) a homing of WC1-negative yd T
cells to the intestinal epithelium; (ii) a loss of the WC1 protein upon localisation of the yd T cell
population to the intestinal epithelium; (iii) no monoclonal antibody exists which recognises an
epitope on this tissue specific population of yd T cells.
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Figure 3.20: Predicted amino acid sequence of bovine WC1.
The full amino acid sequence of bovine WC1 is shown in single letter format. The sequence of
the pWCl.l cDNA clone is available in the EMBL database under accession number X63723
(Wijngaard et al., 1994). The structurally important amino acids cysteine (C) and proline (P)
are underlined and the transmembrane domain is shown in bold italics. The numbers on the left






























3.20: Predicted amino acid sequence of bovine WC1
MAL GRHLSLRGLC VLLLGTMVGG QALELRLKDG VHRCEGRVEV
KHQGEWGTVD GYRWTLKDAS WCRQLGCGA AIGFPGGAYF GPGLGPIWLL
YTSCEGTEST VSDCEHSNIK DYRNDGYNHG RDAGWCSGF VRLAGGDGPC
SGRVEVHSGE AWI£VSDGNF TLATAQIICA ELGCGKAVSV LGHELFRESS
AQVWAEEFRC EGEEPELWVC PRVPCPGGTC HHSGSAQWC SAYSEVRLMT
NGSSQCEGQV EMNISGQWRA LgASHWSLAN ANVIgRQLGg GVAIST£GG£
HLVEEGDQIL TARFHCSGAE SFLWSCPVTA LGGPDCSHGN TASVICSGNQ
IQVLgQCNDS VSQPTGSAAS EDS7i£YgSDS RQLRLVDGGG PCAGRVEILD
QGSWGTICDD GWDLDDARW CRQLGCGEAL NATGSAHFGA GSGPIWLDNL
NCTGKESHVW RCPSRGWGQH N£RHKQDAGV ICSEFLALRM VSEDQQCAGW
LEVFYNGTWG SVCRNPMEDI TVSTICRQLG CGDSGTLNSS VALREGFRPQ
WVDRIQCRKT DTSLWQ££SD PWNYNSCSPK EEAYIWCADS RQIRLVDGGG
RCSGRVEILD QGSWGTICDD RWDLDDARW CKQLGCGEAL DATVSSFFGT
GSG£IWLDEV NCRGEESQVW RC£SWGWRQH NgNHQEDAGV IgSGFVRLAG
GDGPCSGRVE VHSGEAWTPV SDGNFTL£TA QVICAELGCG KAVSVLGHMP
FRESDGQVWA EEFRCDGGE£ ELWSC£RVPC £GGT£LHSGA AQWgSVYTE
VQLMKNGTSQ CEGQVEMKIS GRWRALCASH WSLANANWC RQLGCGVAIS
T£RGPHLVEG GDQISTAQFH gSGAESFLWS CPVTALGGPD CSHGNTASVI
CSGNHTQVLP QCNDFLSQPA GSAASEESSP YCSDSRQLRL VDGGGPCGGR
VEILDQGSWG TI£DDDWDLD DARWCRQLG £GEALNATGS AHFGAGSG£I
WLDDLNCTGK ESHVWRCPSR GWGRHDCRHK EDAGVICSEF LALRMVSEDQ
QgAGWLEVFY NGTWGSVCRS £MEDITVSVI £RQLG£GDSG SLNTSVGLR
GSR£RWVDLI QCRKMDTSLW QCPSGPWKYS SCSPKEEAYI SCEGRRPKSC
£TAAACTDRE KLRLRGGDSE gSGRVEVWHN GSWGTV£DDS WSLMAEWC
QQLGCGQALE AVRS71AFGPG NGSIWLDEVQ CGGRESSLWD CVAE£WGQSD
CKHEEDAGVR gSGVRTTLPT TTAGTRTTSN SLPGJFSLPG VLCLILGSLL
FLVLVILVTQ LLRWRAERRA LSSYEDALAE AVYEELDYLL TQKEGLGSPD
QMTDV£DENY DDAEEV£VPG T£S£SQGNEE EV££EKEDGV RSSQTGSFLN
FSREAAN£GE GEESFWLLQG KKGDAGYDDV ELSALGTSPV TFS
Figure 3.21: Predicted amino acid sequences of SRCR region repeats in
the extracellular domain of bovine WC1.
The amino acid sequences of the eleven SRCR regions are listed in the single letter code. The
sequence of the pWCl.l cDNA clone is available in the EMBL database under accession
number X63723 (Wijngaard et al., 1994). All cysteine (C) residues are underlined. The
numbers at the right and left of each row represent the amino acid number of the first and last
letters in each row respectively.


































All WC1 monoclonal antibodies reacted with cells in the same regions of the lymph node, spleen
and thymus. The control monoclonal antibody CC15 appeared to react with the greatest number
of cells and with the highest intensity of all the WC1 clustered monoclonal antibodies. This
correlated with the FACScan analysis of both PBL and of lymphocytes isolated from tissues. In
the thymus, all the different WC1 epitopes were expressed predominantly on medullary
thymocytes with few reactive cells seen in the cortex. These results confirmed those previously
reported by others (MacKay et al., 1986). It is suggested that WC1 is expressed only on mature
thymocytes in the medulla, which unlike thymocytes in the cortex, also express MHC Class I
(MacKay et al., 1986).
The distribution of WC1 positive cells in the lymph node was indicative of cells in transit and
verified the preliminary studies of others (MacKay et al., 1986; Evans et al., 1994). It is known
that afferent lymph dendritic cells in the ovine species take up and present antigen (Bujdoso et al.,
1989, 1990). In the human and murine species, dendritic cells express all the molecules which are
known to present foreign antigen to T cells (Steinman, 1991). In addition, the majority of y8T
cells in the afferent lymph are activated (Evans et al., 1994). In contrast, yS T cells isolated from
lymph nodes did not express CD25 (data not shown). It has previously been hypothesised that y8
T cells may recognise antigen in association with dendritic cells (Bujdoso et al., 1989, 1990;
Evans, 1993). The interaction between y8 T cells and dendritic cells may take place in either the
tissue or afferent lymph and subsequently activated y8 T cells may localise in the lymph node, in
sites of transit. y8 T cells having localised at sites within the lymph node consequently lose their
activated phenotype. Alternatively, the majority of y8 T cells isolated from the lymph node may
be derived from the peripheral blood.
This chapter has characterised a panel of monoclonal antibodies specific for WC1. These
monoclonal antibodies were submitted to the 2nd International Workshop on Ruminant Leucocyte
Differentiation Molecules. The results reported in Chapter 5 detail work done in collaboration
with W.C.Davis, at WSU on a selected panel of WC1 monoclonal antibodies. These monoclonal
antibodies identified epitopes of the WC1 protein which were expressed on mutually exclusive
sub-populations of yS T cells in the bovine species. The expression of these WC1 epitopes and the





The only known y5 T cell-specific cell surface marker so far described is found in ruminants
(MacKay et al., 1989; Clevers et al., 1990). This was previously referred to as T19 but has recently
been termed WC1 (Howard et al., 1991). Numerous monoclonal antibodies specific for WC1
protein(s) were analysed at the 1st International Workshop on Leucocyte Differentiation Molecules
Workshop (Hein et al., 1991; Sopp et al., 1991). Subsequent to the publication of findings from the
1st Workshop, W.C.Davis of Washington State University (WSU) defined populations of
lymphocytes in cattle which expressed different WC1 epitopes (Davis et al., 1990). All WSU WC1
monoclonal antibodies were assigned a number (Nl, N2, N3,...) according to the epitopes of the
WC1 complex recognised. Some epitopes were recognised by more than one monoclonal antibody.
All the available WC1 monoclonal antibodies have not however been assigned N-specificities and a
nomenclature has not yet been agreed upon which would refer to all the different epitopes recognised
on the WC1 molecules. The following diagram is taken from Davis (1990) and describes the size of
the populations of y8 T cells in bovine peripheral blood which expressed the WC1 epitopes Nl, N2,
N3 and N4. The size of the B cell and a(3 T cells populations in the peripheral blood of the bovine
species are included for reference.
The WC1 positive population was defined as those PBL which reacted with the monoclonal
antibodies to the bovine WC1 epitopes Nl and N2. This population could be further split into two
mutually exclusive sub-populations with monoclonal antibodies which recognise the WC1 epitopes
N3 and N4. The populations of lymphocytes in the bovine species which express the N3 and N4
epitopes are similar in size. A summation of the N3 and N4 sub-populations approximates to the size
of the population which expresses the Nl and N2 epitopes. The results submitted to the 1st Workshop
however, showed that the WC1 epitopes termed Nl and N2 are expressed on most, but not all, bovine
and ovine WCl-positive lymphocytes (Sopp et al., 1991; Hein et al., 1991). The epitope recognised
by the monoclonal antibody CC15 is believed to be expressed on all WCl-positive cells though no
reference has been made to the reactivity of CC15 on these cells (Davis et al., 1990).
In this chapter, the expression of the WC1 epitopes Nl, N2, N3 and N4 was examined on ovine PBL.
A comparison was made with the published results for WC1 N-epitope expression by bovine PBL.
The expression of the WC1 N-epitopes on y8 T cells from normal, healthy, 6 month old sheep was
determined. The WC1 epitope-phenotype measures the number of Nx-positive
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PBL which also other N-epitopes. The WC1 N-epitope expression by 6 month old sheep was
compared to the expression of the different WC1 N-epitopes on y5 T cells isolated from animals
of different age. In addition, the WC1 N-epitope expression on PBL from young healthy lambs
was compared to the WC1 N-epitope expression on PBL isolated from young animals which were
subject to different antigenic burdens.
The majority of y5 T cells isolated from the peripheral blood of animals are not activated (Evans,
1993; Evans et al., 1994). Accordingly, it is unknown if the expression of WC1 proteins, or the
different WC1 N-epitopes, is altered on activated PBL. PBL isolated normal animals were
stimulated in vitro with the T cell mitogen ConA and the expression of the different WC1 N-




4.1 Epitopes of the WC1 proteins.
Table 4.1 lists the monoclonal antibodies made available to the 1st and 2nd International
\Nbrkshops on Ruminant Leucocyte Differentiation Molecules which have been assigned N-
specificities in the bovine species. The cross-reactivity with ovine lymphocytes, isotype and
epitope specificity for each monoclonal antibody is also listed. Those monoclonal antibodies
cross-reactive with ovine PBL (Hein et al., 1991; Lund et al., 1993; Chapter 3) were analysed in
this chapter.
4.1.1 N1 and N2 epitopes are both expressed on similar populations of ovine PBL.
The epitopes N1 and N2 are each only recognised by one monoclonal antibody. These epitopes
are expressed on identical populations of bovine PBL (Davis et al., 1990). Two colour
immunofluorescence analysis of the N1 and N2 epitope expression on ovine peripheral blood
lymphocytes is shown in figure 4.1. 85% of lymphocytes expressing the N1 epitope also
expressed the N2 epitope. Similarly, 85% of lymphocytes expressing the N2 epitope also
expressed the N1 epitope. There was a small number of cells, 15%, which were positive for only
one of the epitopes. This is in contrast to the bovine species where it was reported that all WC1
positive cells expressed both epitopes.
4.1.2 N3 and N4 epitopes are expressed on distinct sub-populations of ovine PBL.
In the bovine species, the WC1 epitopes N3 and N4 are expressed on mutually exclusive
populations of lymphocytes. In addition, in the bovine species, N3-positive cells express the N1
and N2 epitopes and similarly N4-positive cells express the N1 and N2 epitopes. Figure 4.2
shows the reactivity of the anti-N3 and anti-N4 monoclonal antibodies with ovine lymphocytes
expressing the N1 and N2 epitopes of WC1. The results show that the N3 and N4 epitopes are
expressed on sub-populations of N1/N2 positive cells in the ovine species. 30% of the N1/N2
positive population also express the N3 epitope and 60% of the N1/N2 population express the N4
epitope. In the ovine species, the N4 positive population of cells is 2-3 times larger than the N3
population. This is in contrast to the results observed in the bovine species were the N3 and N4
positive populations are equivalent in size. In the ovine species, like the bovine species, a
summation of the N3 and N4 populations approximates to the size of that defined by expression
of the N1/N2 epitopes. Figure 4.2 also shows that 20% of ovine lymphocytes which expressed the
N4 epitope did not express the N2 epitope. It has previously been shown in the bovine species
that all lymphocytes which express the N4 epitope co-express the N2 epitope. These results show
significant differences between the two ruminant species in their WC1 epitope expression on y5 T
cells.
The N3 and N4 epitopes are expressed on mutually exclusive populations of lymphocytes in the
bovine species. Figure 4.3 shows the two colour immunofluorescence staining of N3 versus N4
on sheep lymphocytes. There is little dual expression of the N3 and N4 epitopes. Only 14% of
lymphocytes which expressed the N4 epitope also expressed the N3 epitope, and only 26% of
those lymphocytes which expressed the N3 epitope also expressed the N4 epitope. This result is
similar to that observed in the bovine species.
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Table 4.1: N-epitope specificities of WC1 clustered monoclonal
antibodies.
The WC1 specific monoclonal antibodies which have been given N epitope specificities are
listed along with the isotype, N-epitope specificity. The cross-reactivity of the anti-bovine
WC1 monoclonal antibodies with ovine PBL as determined in this thesis and by others (Hein et
al., 1991) is listed.
TABLE 4.1: N-epitope specificities of WC1 clustered
monoclonal antibodies.
Epitope Cross-reactive
Antibody Specificty with ovine PBL Isotype
B7A1 r—Hz1HU£ Yes IgM
BAQ4A WC1 - N2 Yes IgGt
CACTB1A WC1 - N3 Yes IgGi
CACTB15B WC1-N3 Yes IgGi
CACTB32A WC1 - N3 Yes IgGt
CACTB35A WC1 - N3 No IgM
BAQ53A WC1 - N3 No IgM
BAQ72A WC1 - N3 No IgM
BAQ89A WC1 - N4 Yes IgGi
BAQ159A WC1 - N4 Yes IgGi
CACTB7A WC1 - N4 Yes IgGi
BAG25A WC1 - N4 Yes IgM
WSU - Washington State University, Pullman.
Figure 4.1: Two-colour immunofluorescence of anti-Nl (B7A1) versus
anti-N2 (BAQ4A).
106 PBL isolated from 6 month old lambs (n=4) were stained with BAQ4A (anti-N2) and
B7A1 (anti-Nl) followed by anti-IgGl-FITC, and biotinylated anti-IgM and SA-PE. Cells
were analysed by FACScan for two-colour immunofluorescence staining. The figure shows
the positive staining of PBL from one animal compared to the non-specific staining of NMS
versus b-NMS. This experiment was repeated four times and the same trends were seen with
PBL from each animal and on each occasion tested.
FIGURE 4.1: Two-colour immunofluorescence of anti-Nl (B7A1)
versus anti-N2 (BAQ4A).
BAQ4A (N2)
Figure 4.2: Two-colour immunofluorescence analysis of monoclonal
antibodies to N-epitopes.
106 PBL isolated from 6 month old lambs (n=4) were stained with biotinylated BAQ4A (anti-
N2) or B7A1 (anti-Nl) followed by SA-PE, or biotinylated anti-IgM and SA-PE, and either
CACTB1A (anti-N3) or BAQ89A (anti-N4) followed by anti-IgGl-FITC. Cells were analysed
by FACScan for two-colour immunofluorescence staining. The figure shows the positive
staining of PBL from one animal compared to the non-specific staining of NMS versus and b-
NMS. This experiment was repeated four times and the same trends were seen with PBL from
each animal and on each occasion tested.
FIGURE4.2:Two-colourimmunoflu rescenceana ysisfmonoclonaltib diestN-epi p s.
Figure 4.3: Two-colour immunofluorescence analysis of anti-N3
(CACTB1A) versus anti-N4 (BAG25A).
106 PBL isolated from 6 month old lambs (n=4) were stained with CACTB1A (anti-N3) and
BAG25A (anti-N4) followed by anti-IgGl-FITC, and biotinylated anti-IgM and SA-PE. Cells
were analysed by FACScan for two-colour immunofluorescence staining. The figure shows
the positive staining of PBL from one animal compared to the non-specific staining of NMS
versus and b-NMS. This experiment was repeated four times and the same trends were seen
with PBL from each animal and on each occasion tested.









Figure 4.4: Two-colour immunofluorescence analysis of anti-N3
monoclonal antibodies.
106 PBL isolated from 6 month old lambs (n=4) were stained with either BAQ4A (anti-N2) or
CACTB15B (anti-N3) or CACTB32A (anti-N3) then anti-IgGl-FITC. Cells were then
incubated with NMS followed by biotinylated CACTB1A (anti-N3) then SA-PE. Cells were
analysed by FACScan for two-colour immunofluorescence staining. The figure shows the
positive staining of PBL from one animal compared to the non-specific staining of NMS versus
and b-NMS. This experiment was repeated four times and the same trends were seen with PBL
from each animal and on each occasion tested.
FIGURE4.4:Two-colourimmunoflu rescenceanalysisfti-N3monoclo altib die . BAQ4ACACTB15B►
CACTB32A
Figure 4.5: Two-colour immunofluorescence analysis of anti-N4
monoclonal antibodies.
106 PBL isolated from 6 month old lambs (n=4) were stained with either BAQ89A (anti-N4),
BAQ159A (anti-N4) or CACTB7A (anti-N4) then anti-IgGl-FITC, and BAG25A then
biotinylated anti-IgM followed by SA-PE. Cells were analysed by FACScan for two-colour
immunofluorescence staining. The figure shows the positive staining of PBL from one animal
compared to the non-specific staining of NMS versus and b-NMS. This experiment was
repeated four times and the same trends were seen with PBL from each animal and on each
occasion tested.
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4.2 Changes in the expression of the N-epitopes of WC1.
The results in section 4.1 have shown the expression of different epitopes of the WC1 protein on
PBL. The monoclonal antibody CC15 reacted with an epitope found on all WC1 proteins. The
epitopes N1 and N2 are expressed on the majority but not all WC1 proteins, and the epitopes N3
and N4 are expressed on WC1 proteins on mutually exclusive populations of cells. These results
were obtained using resting PBL from sheep of the same age and status. In this section, the
expression of WC1, including the expression of the different N-epitopes, was measured on (i)
PBL isolated from animals of different age; (ii) PBL isolated from animals subject to different
antigenic burdens; and (iii) ConA stimulated PBL. These different in vivo and in vitro conditions
were used to help determine if there were any distinct functional requirements for different WC1
molecules, as determined by the expression of differetn N-epitopes. Three different variables
were measured: a) the size of each N-epitope positive population; b) the level of expression of
each of the N-epitopes on the WC1-positive population of PBL as a whole; and c) the WC1
epitope phenotype of PBL.
4.2.1 Changes in the size of the WCl-positive lymphocyte populations expressing the
WC1 epitopes Nl, N2, N3 or N4.
The size of the PBL populations which expressed the WC1 epitopes Nl, N2, N3 or N4 was
determined using cells from animals of different ages; using cells from animals with different
antigenic burdens; and using cells after culture with ConA. The monoclonal antibody CC15
which recognises all WC1 molecules was included as a control in all assays.
Table 4.2 shows the size of the lymphocyte populations which expressed the WC1 epitopes Nl,
N2, N3 or N4 at various time points during the first two years of a sheeps life. The percentage of
PBL which expressed either Nl, N2, N3 or N4 decreased in the peripheral blood of animals of
increasing age. This decrease in population percentage with age was significant for all the
monoclonal antibodies tested. For example, the Nl positive population decreased from 27% of
the lymphocyte population in 0-3 day old lambs to 4% of the lymphocyte population in year old
sheep. This low level remained constant in older animals (data not shown).
The size of the different WC1 populations was also shown to vary in animals with different levels
of antigenic burden (table 4.3). PBL were isolated from normal animals, animals kept in specific
pathogen free (SPF) conditions and animals kept in gnotobiotic conditions and analysed. All
samples were taken from lambs which were 4 weeks of age. Gnotobiotic lambs, which have the
lowest antigenic burden, had a significantly higher number of lymphocytes expressing the WC1
epitopes CC15, Nl, N2 and N4 when compared to normal and SPF lambs. Though there were a
greater number of PBL from gnotobiotic lambs expressing the N3 epitope of WC1, this was not
significantly different to the number of PBL expressing the N3 epitope of WC1 in normal and
SPF lambs. There were no significant differences in the number of lymphocytes expressing any
of the WC1 epitopes between lambs which were kept in SPF conditions and lambs which were kept
in normal conditions.
The expression of the WC1 epitopes Nl, N2, N3 and N4 on PBL was analysed following T cell
activation with ConA. The results are shown in table 4.4. All of the populations of lymphocytes
which expressed the Nl, N2, N3 and N4 epitopes increased in size following culture with ConA.
There was an increase in the size of all WC1 positive populations after 24hours of culture of PBL
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Table 4.2: Changes in size of N-epitope positive populations of
PBL with age.
PBL were isolated from sheep of various ages (n=6) and 106 cells from each animal were
stained with the monoclonal antibodies CC15, anti-Nl, anti-N2, anti-N3 and anti-N4 then anti-
IgG FITC and analysed by FACScan. The percentages of PBL which were positive for each of
the monoclonal antibodies tested is listed. Staining with the negative control (NMS) was
always <3%. The results shown are the mean values of positive cells from 6 different animals
in each age group. The errors, in the brackets, are the standard deviation of the means. The
significance of the change in number of PBL expressing the various markers with age was
determined by regression analysis of the data. A General Linear Model was used to analyse the
data with age as a covariate. The probability that the differences in the data are significant is
represented at the top of each column.
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Table 4.3: Changes in size of N-epitope positive populations of
PBL with antigenic burden.
PBL were isolated from lambs housed in normal conditions (n=6), gnotobiotic conditions
(n=6) and specific pathogen free conditions (n=6). 106 cells from each animal were stained
with the monoclonal antibodies CC15, anti-Nl, anti-N2, anti-N3 and anti-N4 then anti-IgG
FITC and analysed by FACScan. The percentages of PBL which were positive for each of the
monoclonal antibodies tested is listed. Staining with the negative control (NMS) was always
<3%. The results shown are the mean values of positive cells from 6 different animals in each
group. The errors, in the brackets, are the standard deviation of the means. The significant
differences between animals housed in different conditions and the number of PBL expressing
the WC1 epitopes was determined using two sample t-tests. The probability that the data from
normal and SPF lambs are significantly different to the data from gnotobiotic lambs is
represented in the table.
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Table 4.4: Changes in size of N-epitope positive populations of PBL
following culture with ConA.
PBL were isolated from 6 month old sheep (n=4) and stimulated in vitro with 5pg/ml ConA for
various lengths of time. Viable cells were harvested over Lymphoprep at the time points
indicated. 106 viable cells were stained with the monoclonal antibodies CC15, anti-Nl, anti-
N2, anti-N3 and anti-N4 followed by anti-IgG FITC and analysed by FACScan. The
percentages of positive cells is listed. Staining with the negative control (NMS) was always
<3%. The results shown are the mean of 4 animals and the errors in the brackets are the
standard deviation of the means. This experiment was repeated four times and the same trends
were seen with each animal and on each occasion.



















with ConA. The data presented in table 4.4 show no significant changes in cell population size.
This is due to the large variation in the size of the different WC1-positive T cell populations within
resting PBL. Regression analysis of data from the individual animals showed the changes in size
of the different WC1 populations were significant.
The percentage of the CC15-positive population which expressed the epitopes Nl, N2, N3, and N4
was determined in all of the conditions assayed above. There was no significant change in the
level of expression of the WC1 epitopes Nl, N2, N3 and N4 on CC15-positive PBL from animals
of different ages (data not shown); from animals with different antigenic burdens (data not
shown); and following stimulation with ConA (data not shown). The WC1 epitopes Nl(80-89%)
and N2 (75-86%), like the y8TCR (93-98%), were expressed on the majority of CC15 positive
cells. The WC1 epitope N3 was expressed on 25-30% of CC15 positive cells and the WC1 epitope
N4 was expressed on 45-70% of CC15 positive cells.
4.2.2 Changes in the WC1 epitope phenotype of PBL.
The WC1 epitope phenotype was determined using PBL from animals of different ages. The
results showed that there was no significant change either: i) in the number of Nl-positive PBL
which expressed the epitopes N2, N3 or N4 (data not shown); ii) the number of N2-positive PBL
which expressed the epitopes Nl, N3 or N4 (data not shown); iii) the number of N3-positive PBL
which expressed the epitopes Nl, N2 or N4 (data not shown) or; iv) the number of N4-positive
PBL which expressed the epitopes Nl, N2 or N3 (data not shown). These results were the same
for PBL isolated from animals of all ages analysed and were the same as the results reported in
section 4.1 for animals of 6 months of age.
Table 4.5 shows the expression of the WC1 epitope phenotype of PBL isolated from sheep with
different antigenic burdens. The only differences observed were in the expression of N3 epitope.
20-23% of N4 positive lymphocytes isolated from lambs kept in either normal conditions or SPF
conditions, expressed the N3 epitope). However, with PBL isolated from lambs kept under
gnotobiotic conditions, significantly fewer, 8.5%, of N4 positive lymphocytes expressed the N3
epitope of WC1. In addition, significantly fewer Nl-positive PBL expressed the N3 epitope in
gnotobiotic lambs when compared to normal and SPF lambs.
The WC1 epitope phenotype of PBL following stimulation with ConA was determined. The WC1
phenotype was analysed daily on day 0 through to day 7 and again on day 10 following start of
culture with ConA. The whole data set was statistically analysed for changes over time using a
General Linear Model of regression analysis. Data obtained on days 0, 3, 5, and in some cases
day 10 are shown in table 4.6. The only significant change in WC1 epitope expression over time
was the expression of N3 and N4 on mutually exclusive populations of y5 T cells. There was a
significant decrease in the dual expression of N3 and N4 on populations of PBL following
activation by culture with ConA. 18% of resting, N4-positive PBL expressed the N3 epitope
whereas following culture with ConA this decreased to only 8% after 3days. In addition, 29% of
resting, N3-positive PBL expressed the N4 epitope whereas only 16% expressed N4 after 3days of
culture with ConA.
4.3 An increase in the size of all WC1 populations following in vitro activation.
It was reported that the WC1 epitope recognised by the monoclonal antibody 19-19, is lost from
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Table 4.5: Changes in N-epitope phenotype of PBL with antigenic
burden.
PBL were isolated from lambs housed in normal conditions (n=6), gnotobiotic conditions
(n=6) and specific pathogen free conditions (n=6). lO cells from each animal were stained.
Four different sets of two-colour staining were carried: a) B7A1 (anti-Nl) followed by
biotinylated anti-IgM then SA-PE and either BAQ4A (anti-N2) or CACTB1A (anti-N3)
followed by anti-IgG FITC. b) Biotinylated BAQ4A (anti-N2) then SA-PE and either B7A1
(anti-Nl) followed by biotinylated anti-IgM then SA-PE or BAQ4A (anti-N2) or CACTB1A
(anti-N3) followed by anti-IgG FITC. c) Biotinylated CACTB1A (anti-N3) followed by SA-
PE and, either B7A1 (anti-Nl) or BAG25A (anti-N4) followed by biotinylated anti-IgM then
SA-PE, or BAQ4A (anti-N2) followed by anti-IgG FITC. d) BAG25A (anti-N4) followed by
biotinylated anti-IgM then SA-PE and either BAQ4A (anti-N2) or CACTB1A (anti-N3)
followed by anti-IgG FITC. Cells were analysed by FACScan. The positive staining of cells
was calculated compared to the non-specific staining of NMS versus and b-NMS. The results
shown are the mean values of positive cells from 6 different animals in each group. The errors,
in the brackets, are the standard deviation of the means. The significant differences between
animals housed in different conditions and the number of PBL expressing the WC1 epitopes
was determined using two sample t-tests. The probability that the data from normal and SPF
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Table 4.6: Changes in N-epitope phenotype of PBL after culture with ConA.
PBL were isolated from 6 month old sheep (n=4) and stimulated in vitro with 5gg/ml ConA for
various lengths of time. Viable cells were harvested over Lymphoprep at the time points
indicated and 106 harvested cells were stained. Four different sets of two-colour staining were
carried: a) B7A1 (anti-Nl) followed by biotinylated anti-IgM then SA-PE and either BAQ4A
(anti-N2) or CACTB1A (anti-N3) followed by anti-IgG FITC. b) Biotinylated BAQ4A (anti-
Nl) then SA-PE and either B7A1 (anti-Nl) followed by biotinylated anti-IgM then SA-PE or
BAQ4A (anti-N2) or CACTB1A (anti-N3) followed by anti-IgG FITC. c) Biotinylated
CACTB1A (anti-N3) followed by SA-PE and, either B7A1 (anti-Nl) or BAG25A (anti-N4)
followed by biotinylated anti-IgM then SA-PE, or BAQ4A (anti-N2) followed by anti-IgG
FITC. d) BAG25A (anti-N4) followed by biotinylated anti-IgM then SA-PE and either
BAQ4A (anti-N2) or CACTB1A (anti-N3) followed by anti-IgG FITC. Cells were analysed by
FACScan. The positive staining of cells was calculated compared to the non-specific staining
of NMS versus and b-NMS. The results shown are the mean of 4 animals and the errors in the
brackets are the standard deviation of the means. This experiment was repeated 3 times and the
same trends were seen with each animal and on each occasion. The significance of the change
in number of PBL expressing the various markers after stimulation was determined by
regression analysis of the data. A General Linear Model was used to analyse the data with time
as a covariate. The probability that the differences in the data are significant is represented at
the top of each column.




















































































yS T cells following their activation (Hein and Mackay, 1991). However, it was shown in results
presented here (section 4.2.2) that when stimulated with ConA for various lengths of time, each of
the WC1 populations increased in size (table 4.4). In addition, it was shown that there were no
significant changes in the expression of the epitopes Nl, N2, N3 and N4 on CC15-positive cells
during this time (data not shown). In contrast, the intensity of expression of each of the WC1
epitopes on PBL showed marked changes upon activation. Staining profiles of PBL with the
monoclonal antibodies CC15 and BAQ4A (N2) at the start of the experiment, and subsequently
on day 3 and day 7 are shown in figure 4.6. The changes in these FACS profiles are
representative of all the anti-WCl monoclonal antibodies used in this experiment. The intensity
of staining of PBL by each monoclonal antibody decreased until day 3, and then increased
throughout the remainder of the assay. However, the intensity of staining of each monoclonal
antibody failed to return to starting levels even by day 7 of culture.
60
Figure 4.6: Reactivity of WC1 monoclonal antibodies with PBL
previously cultured with ConA.
PBL were isolated from 6 month old sheep (n=4) then cultured in vitro with 5jig/ml ConA for
various lengths of time. Viable cells were harvested over Lymphoprep at the start of culture,
and on day 3 and day 7 after culture. 106 viable cells were stained with the monoclonal
antibodies CC15 or anti-N2 followed by anti-IgG FITC and analysed by FACScan. Single
colour histograms of positively stained PBL from one animal are shown. Staining with the
negative control (NMS) was always <3%. The experiment was repeated four times and the
same trends were with PBL from each animal and on each occasion tested.





In this chapter, the expression of the WC1 epitopes Nl, N2, N3 and N4 was analysed on ovine
PBL. It has previously been shown that the epitopes Nl and N2 are expressed on the majority of
WC1 positive cells in both the ovine and bovine species (Sopp et al., 1991, Hein et al., 1991). In
the bovine species, the epitopes Nl and N2 are expressed on the same population of cells (Davis et
al., 1991). The results in this chapter show that a similar situation exists in the ovine species with
>90% of reactive cells expressing both the Nl and N2 epitopes. There were a small number of
cells which expressed either the Nl or N2 epitope, but not both. In studies with the anti-bovine
N3- and anti-bovine N4-grouped monoclonal antibodies, the results showed marked differences
in the expression of the N3 and N4 epitopes in the ovine compared to the bovine species. In the
bovine species, the epitopes N3 and N4 are expressed on mutually exclusive populations of PBL
of similar size although both populations express the two epitopes, Nl and N2. In contrast, in the
ovine species the size of the population of cells which expressed the N3 epitope was much smaller
than that which expressed the N4 epitope. In addition, in the ovine species, all the anti-N3
monoclonal antibodies recognised identical or closely overlapping epitopes on the WC1 protein.
In contrast, all the anti-N4 monoclonal antibodies did not recognise identical or closely
overlapping epitopes on the WC1 protein. The anti-N4 monoclonal antibody BAG25A
recognised an epitope on ovine PBL which did not overlap with any of the other anti-N4
monoclonal antibodies. In addition, some cells which expressed the epitope recognised by the
monoclonal antibody BAG25A did not express the N2 epitope. The epitope recognised by
BAG25A was termed N4A and was not analysed any further. The anti-N4 monoclonal antibody
BAQ89A was used to stain N4-positive lymphocytes in the ovine species.
The results shown in this chapter suggest there is a restricted expression of the different WC1
epitopes on ovine PBL. The epitopes Nl and N2 were expressed on 90% of WC1 positive ovine
PBL. Monoclonal antibodies to the epitopes Nl and N2 immunoprecipitated three proteins of
molecular weights 144kDa, 205kDa and 300kDa. In contrast, the epitopes N3 and N4 were
expressed on a small number of WC1 positive ovine PBL yet, like the epitopes Nl and N2, the
epitopes N3 and N4 were expressed on all three proteins. Figure 4.7 is a summation of the results
from chapter 3 and chapter 4 and previous observations (MacKay et al., 1986, 1988, 1989;
Evans, 1994; Evans et al., 1994). The diagram shows the representative size of the populations of
PBL which expressed the different WC1 epitopes. Each circle represents a population of ovine
lymphocytes as defined by the expression of one of the listed epitopes or T cell maricers.
Some of the questions regarding the WC1 protein(s) and its epitopes were partially resolved by the
recent cloning of three cDNA transcripts of different bovine WC1 mRNAs (Wijngaard et al., 1992,
1994). These WC1 cDNAs were found to be 80% homologous at the nucleotide level. Two of the
genes (WC1.1 and WC1.2) were transfected, separately, into mouse L cells and stable transfectants
generated. These cells were shown to express the WC1 cell surface protein(s) and were used for
FACS analysis of all monoclonal antibodies grouped into the WC1 cluster (MacHugh et al., 1993).
The results showed that some monoclonal antibodies recognised both transfectants, whilst other
monoclonal antibodies recognised one or the other transfectant. Some monoclonal antibodies
reacted with neither of the transfectants. The exact number of WC1 genes expressed in the bovine
species is not known, although some reports suggest numerous exist (H. Clevers personal
communication; Wijngaard et al., 1992, 1994). In addition, these studies revealed that the
monoclonal antibody CC15 recognised epitopes expressed by both of the bovine WC1 cDNA
products. The monoclonal antibodies BAG25A and BAQ89A recognised epitopes expressed on
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Figure 4.7: Bubble diagram of WC1 epitope expression on ovine PBL.
Single colour and two-colour immunofluorescence results were analysed. Each circle
represents one population of positively stained PBL. The size of the circle is a representation of
the size of each of the populations within ovine PBL.
FIGURE4.7:BubblediagramofWC1epitopexp essionvinPBL. CC15 N2
the bovine WC1.1 product only, whilst the monoclonal antibodies B7A1, BAQ4A and CACTB1A
recognised epitopes expressed on the bovine WC1.2 product. These results correlated well with
the results obtained using FACS analysis of ovine PBL reported here and elsewhere (Hein et al.,
1991). It was reported here that in sheep, like cattle, that the epitopes recognised by monoclonal
antibodies B7A1 (anti-Nl) and BAQ4A (anti-N2) were expressed on the same sub-populations of
WCl-positive cells. In addition, the epitopes recognised by the monoclonal antibodies BAG25A
(N4A) and CACTB1A (N3) were reported here to be expressed on mutually exclusive populations
of lymphocytes in the ovine species.
Recently, DNA sequences homologous to regions of the bovine WC1.1 cDNA were found to be
highly represented in a sheep genomic library (Walker et al., 1994). Sequence analysis suggested
their DNA segments were each derived from different genes. These results also suggested the
existence of a family of between 50 and 100 genes for WC1 in the sheep genome. The
differences in the reactivity of the monoclonal antibodies specific for different WC1 epitopes
could therefore be due to the expression of antigens encoded by different members of a gene
family, or possibly due to variations in the products of a single gene as a result of alternative
splicing or post-translational modification. It has been hypothesised by Walker and colleagues
(1994) that due to the existence of such a large gene family, individual WC1 proteins may carry
out distinct but related functions in the ovine species. In addition, it has been proposed that WC1
may function as a homing molecule for y8 T cells (Wijngaard et al., 1994). The expression of the
different epitopes on a homing molecule or different WC1 genes may vary according to the
homing requirements of the WCl-positive y5 T cells. It was reported here and elsewhere that y5 T
cells in the epithelium of the gut do not express any of the known WC1 epitopes (MacKay et al.,
1989; Evans 1994). It will be of interest to determine if this population of cells express any of
the WC1 gene products.
It was shown that the percentage of the whole WCl-positive population which expressed each of
the different WC1 N-epitopes did not vary on PBL isolated from animals of different ages, on
PBL isolated from animals with different antigenic burden or on PBL which were activated in
vitro.
There were no differences in the WC1 N-epitope phenotype of PBL isolated from animals of
different age. However, it was shown on PBL isolated from animals with little or no antigenic
burden that the expression of the N3 epitope is less on at least the N1-positive and the N4-positive
populations. This may suggest that there is little requirement for the expression of the N3 epitope
on y8 T cells in animals undergoing little immunological challenge. Following in vitro culture of
PBL with ConA, the N4-positive population became N3-negative and the N3-positive population
became N4-negative. This may imply that these two sub-populations of y5 T cells carry out
different effector functions once activated.
The intensity of staining by all anti-WCl monoclonal antibodies decreased in the initial stages of
culture with ConA, as did all the ratios of N-epitope positive cells to y5 TCR positive cells. The
intensity of staining of all anti-WCl monoclonal antibodies increased after day 3 as did the ratio
of N-epitopc positive cells to y5 TCR positive cells but neither had returned to starting levels by
the end of the assay. The drop in the ratio of N-epitope positive cells/y8 TCR positive cells may be
due to one or more of the following reasons: i) there was a loss of some WC1 epitopes from the
surface of cells following activation. It has previously been reported that the epitope recognised
by monoclonal antibody 19-19 is lost from PBL following activation (MacKay et al., 1989). ii)
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there was a selective outgrowth, in the initial stages of activation, of cells which expressed the y5
TCR but did not express WC1. iii) there is a further set of WC1 proteins whose expression is
increased following activation of y5 T cells. This further set of WC1 proteins do not express any
of the epitopes so far identified.
The change in the intensity of expression of the different WC1 epitopes may be due to an initial
switch off, or slow down, of de novo WC1 synthesis and expression during the initial stages of
activation of the y5 T cell population. Once activated de novo synthesis of WC1 is restarted and
the intensity of expression of the epitopes subsequently increases.
Collectively, the data presented in chapter 3 and chapter 4, along with that published by others
during the course of the thesis has identified WC1 as a protein complex with diversity at least at
the genetic level, and possibly at the post-transciptional or post-translational level. This work has
also confirmed that, with respect to the WC1 proteins, y5 T cell immunochemistry in the ovine
species is similar in some, but not all, respects to that seen in the bovine species. The function of
the WC1 protein complex remains elusive, as does the function of the population of cells which
express them. The following chapters in the thesis will describe attempts to identify a functional
role for y5 T cells in the ovine species.
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CHAPTER 5
Activation of yS T cells.
INTRODUCTION:
y5 T cells are a unique subset of lymphocytes which have been found in all species so far
examined. They express a T cell receptor (TCR) of y and 5 chains which is thought to be specific
for antigen in a manner analogous to the a(3 TCR. y5 T cells however, do not express the co-
receptor molecules CD4 and CD8 which are involved in a(3 T cell activation (Janeway, 1992). In
addition, in the ovine species, y5 T cells do not express the adhesion molecule CD2 which has also
been implicated in the activation of T cells (MacKay et al., 1989; Evans, 1993). Previous work on
ovine peripheral blood y5 T cells has proposed that these observed differences in cell surface
phenotype of the T cell subsets may imply differences in activation (Evans, 1993) between y5 T
cells and CD4-positive and CD8-positive T cells
It is known that one function for the a(3 TCR molecule is to recognise antigenic peptide in
association with an MHC molecule expressed on the surface of an APC. The interaction between
TCR molecule and the antigen/MHC complex occurs simultaneously with either MHC class I or
class II molecules binding the co-receptor molecules CD8 or CD4, respectively. The T cell
tyrosine kinases p56lck and p59fy" are associated with the cytoplasmic portions of the CD4 and
CD8 molecules (Abraham et al.,1992; Janeway 1992; Vega et al., 1990; Danielian et al., 1992).
Following association of the MHC-peptide complex with TCR and co-receptor, the associated
tyrosine kinases are de-phosphorylated and acquire increased kinase activity (Shiroo et al., 1992).
This in turn causes activation of intracellular signal pathways which ultimately induce expression
of T cell specific genes. Genes involved in the proliferation and clonal expansion of T cells
include those encoding IL-2 and the receptor for IL-2 (IL-2R) (Waldmann, 1989).
IL-2 is produced and secreted by T cells when activated and the receptor for IL-2 (IL-2R) is
expressed on T cells when activated. The interaction of IL-2 with the IL-2R initiates the growth,
differentiation and clonal expansion of T lymphocytes (Minami et al., 1993; Takeshita et al.,
1992; Lowenthal and Greene, 1987; Smith, 1988).
The receptor for IL-2 (IL-2R) is a complex transmembrane protein comprising at least three
distinct proteins; termed the a, (3 and y-chains. IL-2Ra is a highly glycosylated protein of 55kDa
and is termed CD25. IL-2R(3 is an IL-2 binding protein of 75kDa. IL-2Ry is a 64kDa protein
whcih was recently identified as the third IL-2 receptor subunit and which plays a pivotal role both
in IL-2 binding by IL-2R0 and in receptor signalling (Minami et al., 1993; Shimizu et al., 1986;
Whldmann, 1989). The expression of the gene encoding IL-2Racan not be detected in resting T
cells. However, following mitogenic stimulation, expression of IL-2Ra can be detected within 4-
8hrs. The maximum level of expression of the IL-2Ra is reached in 2-4 days (30,000-60,000 IL-
2Ra molecules per cell) (Smith, 1988; Depper et al., 1984). The product of the IL-2R(3 gene is
expressed at low levels in resting T cells (600 IL-2Rp-molecules per cell). The level of expression
of the IL-2Rp gene increases in activated T cells though not as dramatically as the level of the IL-
2Ra gene expression. The level of IL-2Ra expressed on activated T cells is approximately 20-
fold higher than the level of IL-2Rp expression (Thuy et al., 1987). IL-2Ry is expressed
constitutively in all lymphoid cells (Takeshita et al., 1992).
In the human species, the IL-2R exists in three forms which are distinguished on the basis of
affinity for the ligand (Minami et al., 1993). The high affinity IL-2R is comprised of all the
subunits (a, |3 and y) and has a dissociation constant (Kd) of 10 nM. The intermediate affinity
IL-2R contains the IL-2p and IL-2y subunits (Kd=10"9M) whereas the low affinity receptor
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comprises IL-2Ra alone (Kd=10~8M). Binding of IL-2 to the IL-2Ra-chain alone docs not
induce signaling nor internalisation (Greene et al., 1985; Hatakeyama et al., 1985). Different
combinations of the three different IL-2R components have been shown to bind IL-2 however, the
only combinations of components which can transduce signals and cause proliferation are the
intermediate affinity ((3 and y) and high affinity (a, (3 and y) receptors.
The IL-2R|3-chain has the largest cytoplasmic domain and plays a critical role along with the IL-
2Ry-chain in IL-2 induced intracellular signaling. It was recently shown using chimeric receptor
constructs that the extracellular domains of the IL-2R[3 and y chains mediate the
heterodimerisation of the IL-2R subunits when IL-2 is bound. It was also shown that this
extracellular heterodimerisation is necessary for the heterodimerisation of the internal domains
and subsequent T cell signaling and proliferation (Nakamura et al., 1994; Nelson et al., 1994).
The binding of IL-2 to the high affinity receptor results in signal transduction mediated by the
75kDa protein (IL-2R[3) and internalisation of the receptor complex. The IL-2R(3 subunit has
been found physically associated with the tyrosine kinase p56lck. Furthermore, IL-2 induces rapid
tyrosine phosphorylation of many cellular proteins including the IL-2R(3-chain (Hatakeyama et
al., 1991; Horak et al., 1991). Two alternative intracellular signalling pathways are thought to
exist. One leads to the induction of the c-myc gene which causes the cell to enter into the S-phase
of the cell cycle and onto cell division. The other involves activation of cytoplasmic protein
tyrosine kinases (e.g p21ras), leading to induction of c-jun and c-fos (Shibuya et al., 1992).
In this chapter, the rate of activation of the different T cell populations was determined. Because
of the features of the different IL-2 receptor components, in particular their differential
expression on resting T cells and increased expression following acivation, the analysis of changes
in the expression of CD25 will provide a good correlation with the state of activation of a T cell.
As a result of cellular activation, ovine T cells express other cell membrane activation molecules
apart from the receptor for IL-2. One such set of proteins are MHC class II molecules. MHC
class II molecules are constitutively expressed on the surface of B cells, macrophages, monocytes,
dendritic cells and endothelium. Following activation, the expression of MHC class II molecules is
increased on ovine T cells (Hopkins et al., 1986). In the human species there are three MHC class
II loci each of which classically express products, these are termed DP, DQ and DR (Benoist and
Mathis, 1990). In the ovine species however, only the DQ and DR loci have been identified (Dutia
et al., 1993; Hopkins et al., 1993). MHC class II glycoproteins in all species so far examined are
expressed as noncovalent heterodimers a and P of integral membrane glycoprotein chains. MHC
class II molecules are expressed on the surface of APC in association with peptides processed from
exogenous proteins. This peptide-MHC complex is recognised by specific T cells so inducing
activation of specific T cells.
In this Chapter, the rates of activation of ovine peripheral blood T cells were analysed. The
expression of CD25 and MHC class II expression on CD4-positive, CD8-positive or y5 T cells was
measured following stimulation with the T cell mitogen ConA. ConA binds to sugar residues on
glycoproteins and causes cross-linking of these glycoproteins on the surface of cells (Beckert and
Sharkey, 1970). One such glycoprotein is the TCR expressed on T cells. B cells are not activated
by treatment with ConA and so the mitogen is T cell specific. Treatment of cells with ConA
provides an in vitro stimulus regarded as analogous to antigen-specific T cell activation, this results
in polyclonal activation, allowing subsequent analysis of complete T cell populations.
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RESULTS:
5.1 Increase in size of yb T cell population following in vitro culture of PBL with
ConA.
Unfractionated PBL were cultured with the T cell mitogen ConA. At various times after the start
of culture, cells were analysed to determine the T cell subset composition of the cultured cells.
Table 5.1 shows there was an increase in the percentage of the yb T cell population after one day
in culture. At this time the y5 T cell population increased in size from 16% to 35% of the
lymphocyte population. The yb T cell population remained at this level throughout the period of
the assay. The CD4-positive and CD8-positive populations also increased in size, and at a similar
magnitude to that of the yb T cell population, but only after 4-5 days of culture. Statistical
analysis showed that there was a significant increase in all T cell populations over the course of the
assay but that there were no significant differences in the size of increase of the three T cell
populations. The ratio of yb T cells to CD4-positive plus CD8-positive T cells emphasised the
observed differences in the rates of increase in the T cell population sizes on the first day. These
results implied that yb T cells are either better predisposed to in vitro culture, or that y5 T cells
proliferate and expand at a faster rate than CD4-positive or CD8-positive T cells. The rate of
proliferation and expansion of a population of cells will be dependent on the rate of activation of
these cells in response to the given stimulus. The rates of expression of CD25 and MHC class II
on the T cell subsets was determined.
5.2 CD25 expression by ovine PBL.
During the course of this thesis a monoclonal antibody to bovine CD25 became available
(Naessens et al., 1992). Nucleotide sequence analysis revealed a 94% level of homology between
ovine and bovine cDNA encoding CD25 (Bujdoso et al., 1992; Weinberg et al., 1988) and
because of the predicted amino acid sequence homology between the ruminant CD25 proteins
(Bujdoso et al., 1993) it seemed likely that monoclonal antibodies generated to bovine CD25
would cross-react with ovine CD25. This monoclonal antibody was used to measure changes in
the expression of the IL-2R on ovine lymphocytes.
Figure 5.1 shows the reactivity of the anti-CD25 monoclonal antibody ILA1-11 with resting and
ConA stimulated ovine PBL. Few resting peripheral blood lymphocytes expressed CD25. In
contrast, following stimulation with ConA for three days, the majority of PBL expressed CD25.
The resting peripheral blood T cells which reacted with the monoclonal antibody ILA1-11 were
determined by two colour FACS analysis using T cell subset specific monoclonal antibodies.
Figure 5.2 shows the results obtained. CD25 was expressed on <8% of resting peripheral blood yb
T cells, on <8% of resting peripheral blood CD8-positive T cells and on 25% of resting peripheral
blood CD4-positive T cells.
5.3 All ovine peripheral blood yb T cells express CD25 following culture with ConA.
The level of expression of CD25 on the different T cell subsets from unstimulated peripheral
blood of sheep was low. However, most peripheral blood lymphocytes expressed CD25 following
treatment with ConA. The expression of CD25 on each of the T cell subsets was analysed for 14
days following treatment of PBL with ConA. Two-colour immunofluorescence FACS analysis was
performed with subset specific monoclonal antibody versus the anti-CD25 monoclonal antibody.
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Table 5.1: Subset composition of ovine PBL after culture with ConA.
PBL were isolated from 6 month old sheep (n=5), cultured with 5(ig/ml ConA, and at the time
points indicated, viable lymphocytes were harvested. 106 viable cells were stained with anti-yS
TCR, anti-CD4, anti-CD8 or anti-B cell then followed by anti-IgG FTTC and analysed by
FACScan. The percentages listed are positive cells with respect to NMS used as a negative
control (always <5%). The results shown are the mean of 4 animals and the errors in the
brackets are the standard deviation of the means. The ratio of CD4-positive and CD8-positive T
cells to y5 T cells is also shown. This experiment was repeated three times and the same trends
were seen with each animal and on each occasion. The significance of the change in number of
PBL expressing the various markers after stimulation was determined by regression analysis of
the data. A General Linear Model was used to analyse the data with time as a covariate. The
probability that the differences in the data are significant is represented below each column.
TABLE5.1:SubsetcompositionfovinePafterul urwithCA. Percentageoflymphocytpopulation.RatifCD4-p sitive+8- i i
toy5Tcells.
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Figure 5.1: Reactivity of monoclonal antibody to CD25 with ovine PBL.
PBL were isolated from 6 month old sheep (n=3) and then cultured with 5(ig/ml ConA for 3
days. After culture, viable stimulated lymphocytes were harvested and at the same time fresh
unstimulated PBL were isolated from 6 month old sheep (n=3). 106 unstimulated cells and 106
stimulated cells were stained with anti-CD25 followed by anti-IgG FITC and analysed by
FACScan. The figure shows positive staining of PBL from one animal in each group with
respect to NMS used as a negative control (always <5%). This experiment was repeated five
times and the same trends were seen with each animal and on each occasion.
FIGURE5.1:ReactivityofmonoclonalantibodtCD25withov nePBL. RestingStimulated CD25expression
Figure 5.2: CD25 expression by resting peripheral blood T cell subsets.
PBL were isolated from 6 month old sheep (n=3) and then stained with anti-CD25 followed by
anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or biotinylated anti-CD8
then SA-PE. The cells were analysed by FACScan and two-colour immunofluorescence profile
are shown. The figure shows the positive staining of PBL from one animal compared to the
non-specific staining of NMS versus and b-NMS (always <5%). This experiment was
repeated five times and the same trends were seen with each animal and on each occasion.
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The results in table 5.2 show there was an increase in expression of CD25 on each T cell subset.
The rate of expression of CD25 in the first 24hours was significantly greater on y8 T cells
compared to CD4-positive and CD8-positive T cells. The maximum level of CD25 expression by
the y5 T cell population occurred within 24 hours of treatment with ConA. The CD4-positive and
CD8-positive T cell subsets also showed an increase in CD25 expression, but unlike y5 T cells, the
maximum level of expression occurred 2-4 days after the start of the culture.
5.3.1 y5 T cells express CD25 and MHC class II with faster kinetics than do CD4
positive and CD8-positive T cells following in vitro culture with ConA.
Almost all yS T cells expressed CD25 within the first 24 hours of activation. The first 24 hours
after treatment with ConA showed the biggest changes in levels of CD25 expression by the
different T cell subsets with the level of expression of CD25 on yS T cells significantly higher than
that observed on CD4-positive and CD8-positive T cells. Expression of CD25 by the different T
cell subsets was therefore analysed at time points within the first 24 hours. The results obtained
are shown in figure 5.3. All y5 T cells expressed CD25 within 8 hours of treatment with ConA. In
contrast, the greatest number of CD4-positive and CD8-positive T cells which expressed CD25 was
not seen until 24 hours after the start of culture with ConA. In addition, not all CD4-positive and
CD8-positive T cells expressed CD25 within 24 hours. The rate of increase in expression of CD25
by y5 T cells was significantly different to that of CD4-positive and CD8-positive T cells after
4hours and 8 hours of culture with ConA. There was no significant difference in the rate of
increase in CD25 expression at any other time points. Figure 5.4 shows the two-colour
immunofluorescence profiles of CD25 versus WC1 or CD4 at the time points 0, 8 and 24 hours.
All y5 T cells expressed CD25 at high intensity after only 8 hours in culture with ConA. In
contrast, all CD4-positive T cells only expressed CD25 at high intensity after 24 hours of
treatment. CD8-positive T cells showed similar two-colour immunofluorescence profiles to CD4-
positive T cells (data not shown).
MHC class II expression was compared with the increased expression of CD25 on the different T
cell subsets during the first 24 hours of culture with ConA. The monoclonal antibody SW73.2
recognises an epitope on all known ovine MHC class II p-chains (Hopkins et al., 1986) and was
used here to detect MHC class II expression. Figure 5.5 shows that the greatest number of y8 T
cells which expressed MHC class II occurred within 12 hours of culture with ConA. MHC class II
was expressed at significantly higher levels on resting populations of CD4-positive and CD8-
positive T cells compared to y5 T cells and concurs with results previously reported (Dutia et al.,
1993). The rate of increase in expression of MHC class II molecules by the remaining CD4-
positive and CD8-positive T cells appeared to occur at a slower rate than was seen for y5 T cells.
The significance of any differences in the rate of increase of MHC class II expression by the
different T cell subsets could not be assessed because of the high starting levels of MHC class II
expression on CD4-positive and CD8-positive T cells.
5.3.2 Expression of MHC class II p-chain on y5 T cells is different to the expression of
MHC class II a-chain on y5 T cells following stimulation with ConA.
Unlike reagents which detect ovine MHC class II P-chains, there is no monoclonal antibody
available which recognises an epitope on all ovine MHC class II a-chains. In the ovine species
there are monoclonal antibodies which are specific for products of the two different loci (Dutia et
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Table 5.2: CD25 expression on T cell subsets after culture with ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5|ig/ml ConA. At the times
indicated viable lymphocytes were harvested and 106 cells were stained with anti-CD25
followed by anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or
biotinylated anti-CD8 then SA-PE. The cells were analysed by FACScan and the percentage of
each T cell subset which expressed CD25 calculated. The table shows the percentage of
positive staining of cells compared to the non-specific staining of NMS versus and b-NMS
(always <5%). The results shown are the mean of three animals with the standard deviation of
the mean shown in the brackets. This experiment was repeated 6 times and the same trends
were seen with each animal and on each occasion. The significant differences between each T
cell population was determined by calculating the rate of increase in expression of CD25
between two points and performing a two sample t-tests. The probability that the rate of
increase of CD25 expression by the different T cell subsets is significantly different is
represented in the table.
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Figure 5.3: CD25 expression by T cell subsets of PBL following culture
with ConA.
PBL were isolated from a 6 month old sheep and cultured with 5pg/ml ConA. At the times
indicated, viable lymphocytes were harvested and lO cells stained with anti-CD25 followed by
anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or biotinylated anti-CD8
then SA-PE. The cells were analysed by FACScan and the percentage of each T cell subset
which expressed CD25 calculated. The figure shows the percentage of positive staining of cells
compared to the non-specific staining of NMS versus and b-NMS (always <5%). The results
shown are the mean of three animals with the error bars showing the standard deviation of the
mean. This experiment was repeated 6 times and the same trends were seen with each animal
and on each occasion. The significant differences between each T cell population was
determined by calculating the rate of increase in expression of CD25 between each time point
and the start of the experiment and performing a two sample t-tests. The probability that the
rate of increase of CD25 expression by the different T cell subsets is significantly different is
represented in the table.
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Figure 5.4: CD25 expression by T cell subsets of PBL following culture
with ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5pg/ml ConA. At the times
indicated, viable lymphocytes were harvested and 106 cells stained with anti-CD25 followed by
anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or biotinylated anti-CD8
then SA-PE. The cells were analysed by FACScan and the two-colour immunofluorescence
profiles are shown. The figure shows the positive staining of PBL from one animal compared
to the non-specific staining of NMS versus and b-NMS (always <5%). This experiment was
repeated five times and the same trends were seen with each animal and on each occasion.
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Figure 5.5: MHC class II expression by T cell subsets of PBL following
culture with ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5|ig/ml ConA. At the times
indicated, viable lymphocytes were harvested and 106 cells stained with anti-MHC class II
followed by anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or
biotinylated anti-CD8 then SA-PE. The cells were analysed by FACScan and the percentage of
each T cell subset which expressed CD25 calculated. The figure shows the percentage of
positive staining of cells compared to the non-specific staining of NMS versus and b-NMS
(always <5%). The results shown are the mean of three animals with the error bars showing
the standard deviation of the mean. This experiment was repeated five times and the same
trends were seen with each animal and on each occasion.











al., 1993; Hopkins et al., 1993). The monoclonal antibody VPM36 recognises products of the
DR locus and monoclonal antibody VPM54 recognises products of the DQ locus. The changes in
the levels of expression of these different a-chains on the T cell subsets was determined during the
first 24 hours of culture with ConA. The results in table 5.3 showed differences in the expression
of the a and (3 chains on the different T cell subsets. There were no significant changes in the
level of expression of both DQ and DR a-chains on any T cell subset following stimulation with
ConA. In contrast, there was a significant increase in the level of MHC class II (3-chain expression.
This was similar to results previously reported (see figure 5.5).
5.3J All subsets of y8 T cells express CD25 with similar kinetics.
The monoclonal antibody CC15 has been used to define the y§T cell population expressing
CD25 in all experiments so far. CC15 reacts with a WC1 epitope on cells which also express the yS
TCR (chapter 3). The WCl/y5 TCR positive population can be divided into two mutually exclusive
populations expressing either of the determinants N3 or N4, these cells defined by the co-
expression of determinants N1 and N2 (chapter 4). The kinetics of activation were investigated
for each of the WCl/y5 TCR positive T cell sub-populations. PBL were treated with ConA and the
expression of CD25 on the different populations of cells analysed. Table 5.4 shows that all sub-
populations of WCl/y8 TCR positive cells expressed CD25 with similar kinetics and with kinetics
similar to those seen with the monoclonal antibody CC15 which recognises all WC1 positive cells.
5.4 Activation of y5 T cells is a specific response to ConA.
In the above experiments (section 5.3), all viable cells were harvested on Lymphoprep prior to
immunostaining and FACS analysis. Because of this procedural step, and the in vitro culture, a
number of possible explanations can be given for the results obtained other than a difference in
the kinetics of activation of y5 T cells and, CD4-positive and CD8-positive T cells. These are: i)
the different peripheral blood T cell subsets are not equally viable during in vitro culture, ii) y5 T
cells may be concentrated in the harvested population, i.e. populations of CD4-positive and CD8-
positive T cells may pass through the Lymphoprep either when resting or once activated, iii) y8 T
cells may be non-specifically activated by the isolation procedures or culture. This section of the
chapter reports the results obtained in testing these three possibilities.
5.4.1 All T cell populations remain viable during the first 24 hours of culture with
ConA.
The viability of the different T cell subsets during in vitro culture was measured with fluorescein
di-acetate (FDA). Upon internalisation by viable cells FDA, which is lipid soluble, is cleaved by
non-specific esterases into a non-lipid soluble moiety and emits green fluorescence (Balding et al.,
1983). This enables two-colour immunofluorescence to be performed using T cell subset specific
monoclonal antibodies detected with red fluorescence. The data is shown in Table 5.5. A
significantly greater proportion of the y5 T cell population remained viable for the period of the
assay. 87% of y5 T cells were viable after 24hrs of culture whereas only 79% of CD4-positive and
74% of CD8-positive T cells were viable after 24hrs of culture. Whilst the level of viabiliy of y8 T
cells remains significantly higher in culture than the level of viability of either CD4-positive or
CD8-positive T cells this represents only a very small proportion of the T cell populations. It
should also be noted that the measure of viability used in this experiment does not take account of
cells which may have died and not being detectable on the FACS using the gates already set. The
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Table 5.3: MHC class II a- and P-chain expression by T cell subsets of
PBL following culture with ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5jig/ml ConA. At the times
indicated, viable lymphocytes were harvested and 106 cells stained with anti-MHC class Hoc-
chain or anti-MHC class lip-chain followed by anti-IgG FITC and either biotinylated anti-WCl,
biotinylated anti-CD4 or biotinylated anti-CD8 then SA-PE. The cells were analysed by
FACScan and the percentage of each T cell subset which expressed MHC class II a- or p-chains
calculated. The figure shows the percentage of positive staining of cells compared to the non¬
specific staining of NMS versus and biotinylated NMS (always <5%). The results shown are
the mean values obtained and the standard deviation of the means are shown in the brackets.
This experiment was repeated three times and the same trends were seen with each animal and
on each occasion. The significance of the change in number of PBL expressing the various
markers after stimulation was determined by regression analysis of the data. A General Linear
Model was used to analyse the data with time as a covariate. The probability that the
differences in the data are significant is represented below each column.





































































Table 5.4: CD25 expression by WC1 subsets following culture with
ConA.
PBL were isolated from 6 month old sheep (n=3) and then cultured with 5pg/ml ConA. At the
times indicated, viable lymphocytes were harvested and lO cells stained with anti-WCl or anti-
N1 or anti-N2 or anti-N3 or anti-N4 followed by anti-IgG FITC and biotinylated anti-CD25
then SA-PE. The cells were analysed by FACScan and the percentage of each N-epitope
positive subset of cells which expressed CD25 was calculated. The figure shows the
percentage of positive staining of cells compared to the non-specific staining of NMS versus
and b-NMS (always <5%). The results shown are the mean values of three animals and the
standard deviation of the means are shown in the brackets. This experiment was repeated three
times and the same trends were seen with each animal and on each occasion.
TABLE5.4:CD25expressionbyWC1sub etsaft rc l urewithonA. PercentageofWC1positivTellp pulationsexpres ingCD25.



























Table 5.5: Viability of lymphocyte subsets after culture with ConA
PBL were isolated from 6 month old sheep (n=5) and cultured with 5|ig/ml ConA. At the times
indicated, viable lymphocytes were harvested on Lymphoprep and analysed elsewhere. Cells
which passed through the Lymphoprep were collected and 106 cells were stained with either
biotinylated anti-yS, biotinylated anti-CD4, biotinylated anti-CD8 or biotinylated anti-B cell
followed by SA-PE and FDA then analysed by FACScan. The percentages listed are positive
cells with respect to NMS versus b-NMS used as a negative control (always <5%). The results
shown are the mean values of five animals and the standard deviation of the means is shown in
the brackets. This experiment was repeated twice and the same trends were seen with each
animal and on each occasion. The significance of any differences in viability of each T cell
population was determined by performing a two sample t-test. The probability that the
differences in viability of the T cell population is significantly different is represented in the
table.









Viability of lymphocyte populations.
y5 T cells CD4+ cells CD8+ cells
100 (0.0) 100 (0.0) 100 (0.0)
[99.2 (0.3)] ** 94.4 (1.3) 91.1 (3.5)
[98.5(1.1)] * 89.7 (4.1) 72.9 (15.0)
[97.4 (0.4)] ** 93.7 (0.8) 86.3 (6.8)
[97.2(1.4)] * 87.1 (3.3) 78.4(11.5)
[87.0 (2.2)] ** 79.3 (5.1) 74.4 (6.4)
[ ] significantly different to CD4+ and CD8+ cells
* p<0.05 ** p<0.01
differences in viability may have better been addressed by continually monitoring the cell number
also.
5.4.2 A proportion of each lymphocyte population was not harvested on Lymphoprep.
It was proposed that not all CD4-positive and CD8-positive T cells were harvested on Lymphoprep,
unlike y5 T cells. Table 5.6 shows the T cell composition of the lymphocytes which passed
through the Lymphoprep following treatment with ConA. The size of the y§ T cell and CD4-
positive T cell populations which passed through the Lymphoprep did not change significantly
during the course of the assay. In contrast, the size of the CD8-positive T cell population which
passed through the Lymphoprep decreased significantly from 18% after 4hours in culture with
ConA to 8% after 18hours in culture with ConA.
The level of expression of CD25 and MHC class II on the T cells which passed through the
Lymphoprep was also determined and the results are shown in table 5.7. There was an increase in
CD25 and MHC class II expression by all T cell populations. The increase in expression of CD25
was significantly different on the different T cell subsets. Fewer CD4-positive and fewer CD8-
positive T cells expressed CD25 following culture with ConA compared to y5 T cells. A similar
pattern was seen with the expression of MHC class II on the different T cell subsets though no
significant differences were observed.
These results in table 5.6 and table 5.7 indicated that after treatment with ConA, there was no
selective bias for harvesting CD25-positive or/and MHC class II-positive y5 T cells on Lymphoprep
following culture with ConA.
5.4.3 CD25 is not expressed on T cell subsets when cultured without ConA.
The level of expression of CD25 increased on all T cell subsets following culture with ConA. To
determine the specificity of this increase, the level of CD25 expression on the T cell subsets
following in vitro culture with medium alone was determined. Figure 5.6 shows that 12% of the
y5 T cell population expressed CD25 at the start of the culture whereas 33% expressed CD25 after
24 hours of culture. The CD4-positive and CD8-positive T cell subsets showed no significant
changes in their level of CD25 expression. There was no significant increase in the expression of
CD25 by y8 T cells after 8 hours of in vitro culture in medium alone though the increase in CD25
expression was significant after 16 hours and 24 hours.
The results in this section have indicated that the activation of the T cell subsets appears to be a
specific response to the culture of the cells with ConA. It would appear that the y5 T cell
population becomes activated quicker than either the CD4-positive or CD8-positive T cell
populations in response to ConA stimulation.
5.5 No change in the expression of CD4 and CD8 by y8 T cells following activation.
The proteins CD4 or CD8 are expressed on resting and activated a(3 T cells in the human and
murine species, and presumably the ovine species. CD4 and CD8 are required as co-receptor
molecules for a(3 T cell responses to antigen. No co-receptor molecules have generally been
identified on y5 T cells therefore the expression of CD4 and CD8 molecules on y5 T cells was
investigated following the activation of these cells. The changes in expression of the co-receptor
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Table 5.6: Composition of cells passing through Lymphoprep.
PBL were isolated from 6 month old sheep (n=5) and cultured with 5(ig/ml ConA. At the times
indicated, viable lymphocytes were harvested on Lymphoprep and analysed elsewhere. Cells
which passed through the Lymphoprep were collected and 106 cells were stained with anti-y8
TCR, anti-CD4, anti-CD8 or anti-B cell followed by anti-IgG FITC and analysed by FACScan.
The figure shows the percentage of positive staining of cells compared to the non-specific
staining of NMS versus and b-NMS (always <5%). The results shown are the mean values
obtained and the standard deviation of the means are shown in the brackets. This experiment
was repeated twice and the same trends were seen with each animal and on each occasion. The
significance of the change in number of each T cell subset which passed through Lymphoprep
was determined by regression analysis of the data. A General Linear Model was used to
analyse the data with time as a covariate. The probability that the differences in the data are
significant is represented below each column.
TABLE 5.6: Composition of cells passing through Lymphoprep.
Hours after
treatment.
Percentage of each cell population
found in lymphocyte gate.
76 T cells CD4+ cells CD8+ cells
4 8.6(3.1) 32.2(6.5) 18.4(1.5)
6 16.0(2.3) 43.2(3.9) 10.5(4.4)
8 24.2(7.4) 44.0(7.0) 10.9(3.3)
10 24.5(12.3) 40.4(6.2) 13.0(1.2)
18 12.0(3.5) 33.2(4.7) 8.3(1.7)
N.S.D. N.S.D. *
p<0.05
♦ - significant decrease over time
N.S.D. - no significant change over time
Table 5.7: CD25 and MHC class II expression of lymphocytes passing
through Lymphoprep.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5pg/ml ConA. At the times
indicated, viable lymphocytes were harvested on Lymphoprep and analysed elsewhere. Cells
which passed through the Lymphoprep were collected and 106 cells stained with either anti-
MHC class II or anti-CD25 followed by anti-IgG FITC and either biotinylated anti-WCl,
biotinylated anti-CD4 or biotinylated anti-CD8 then SA-PE. The cells were analysed by
FACScan and the percentage of each T cell subset which expressed either CD25 or MHC class
II was calculated. The table shows the percentage of positive staining of cells compared to the
non-specific staining of NMS versus and b-NMS (always <5%). The results shown are the
mean values of three animals and the standard deviation of the means is shown in the brackets.
This experiment was repeated twice and the same trends were seen with each animal and on
each occasion. The significance of any differences in the number of each T cell population
which expressed either CD25 or MHC class II was determined by performing a two sample t-
test comparing the different T cell populations. The probability that the differences in viability
of the T cell population is significantly different is represented in the table.
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Figure 5.6: CD25 expression by T cell subsets of PBL following culture
in the absence of ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured in RPMI medium with no
ConA. At the times indicated, viable lymphocytes were harvested and 106 cells stained with
anti-CD25 followed by anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4
or biotinylated anti-CD8 then SA-PE. The cells were analysed by FACScan and the two-colour
immunofluorescence profiles are shown. The figure shows the positive staining of cells
compared to the non-specific staining of NMS versus and b-NMS (always <5%). The results
shown are the mean of three animals with the error bars showing the standard deviation of the
mean. This experiment was repeated twice and the same trends were seen with each animal and
on each occasion. The significance of any differences in the number of each T cell population
which expressed either CD25 was determined by performing a two sample t-test comparing the
various time points with the value at the start of the experiment. The probability that the
differences in viability of the T cell population is significantly different is represented in the
table.
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molecules CD4 and CD8 was measured and compared with the changes in expression of CD25
during the first 24 hours after stimulation with ConA. Figure 5.7 shows the results obtained.
There was no significant change in the levels of co-receptor molecule expression by yS T cells.
The y5T cell population remained 8-10% CD4-positive and 5-7% CD8-positive during the assay
period. In the same assay, the size of the y5 T cell population which expressed CD25 increased
from 17% to 90%.
5.6 CD45RA and CD25 expression on resting peripheral blood T cells does not
influence the kinetics of y5 T cell, CD4-positive and CD8-positive T cell activation.
The different populations of lymphocytes in resting peripheral blood differ in the expression of a
number of cell surface proteins. Two of these proteins are markers of activation (CD25) (Tsudo et
al., 1986, 1987) and antigenic experience (CD45) (Clement, 1992). T cells having responded to
antigen have a different cell surface phenotype (Horgan et al., 1992) and will respond more
rapidly to the same antigen than naive T cells from the same animal. The best studied marker
delineating naive and memory T cells is CD45 (Leucocyte Common Antigen) and its various
isoforms (Merkenschlager et al., 1989). Figure 5.2 showed that <8% of resting peripheral blood
y5 T cells and <8% CD8-positive T cells expressed CD25 whereas 25% of CD4-positive T cells
expressed CD25. Figure 5.8 shows that only 1% of peripheral blood y8 T cells expressed the
naive phenotype marker CD45RA. In contrast, 66% of CD4-positive and 83% of CD8-positive T
cells expressed CD45RA.
It was proposed that the differences in CD25 and CD45RA phenotype of resting peripheral blood
T cell subsets may account for the observed differences in rates of activation. To determine if this
was the case, peripheral blood lymphocytes were depleted of all CD45RA positive and all CD25
positive cells and cultured as before with ConA. Figure 5.9 shows the histogram profiles of
lymphocytes before and after the depletion of CD45RA positive cells and CD25 positive cells. All
positively stained cell were removed. The remaining lymphocytes, which now had the same
phenotype with respect to CD45RA and CD25, were treated with ConA as previously described.
The expression of the activation markers CD25 and MHC class II was analysed on the different
subsets as well as the re-expression, if any, of CD45RA. Table 5.8 shows the percentage of each
subset of cells which were positive for the three markers; CD25, MHC class II and CD45RA. The
level of expression of CD25 and MHC class II increased on all T cell subsets. This increase in
expression occurred at a significantly faster rate on yS T cells compared with CD4-positive and
CD8-positive T cells between 8hours and 4 hours after the start of culture. The expression of
CD45RA did not change significantly on any of the T cell subsets.
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Figure 5.7: Expression of T cell markers by y5 T cell after culture with
ConA.
PBL were isolated from 6 month old sheep (n=3) and cultured with 5pg/ml ConA. At the times
indicated, viable lymphocytes were harvested and 106 cells stained with either anti-CD25, anti-
CD4 or anti-CD8 followed by anti-IgG FITC and biotinylated anti-WCl then SA-PE. The cells
were analysed by FACScan and the two-colour immunofluorescence profile are shown. The
figure shows the positive staining of cells compared to the non-specific staining of NMS versus
and b-NMS (always <5%). The results shown are the mean values of 3 animals with the error
bars showing the standard deviation of the mean. This experiment was repeated three times and
the same trends were seen with each animal and on each occasion. The significance of the
change in number of yS T cells which expressed CD4 or CD8 was determined by regression
analysis of the data. A General Linear Model was used to analyse the data with time as a
covariate. The probability that the differences in the data are significant is represented below
each column.
FIGURE5.7:ExpressionofTcellmarkersbyySl saftcultu ewithC nA.
Figure 5.8: CD45RA expression by resting peripheral blood T cell
subsets.
PBL were isolated from 6 month old sheep (n=3) and stained with anti-CD45RA followed by
anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-CD4 or biotinylated anti-CD8
then SA-PE. The cells were analysed by FACScan and the two-colour immunofluorescence
profile are shown. The figure shows the positive staining of PBL from one animal compared to
the non-specific staining of NMS versus and b-NMS (always <5%). This experiment was
repeated five times and the same trends were seen with PBL from each animal tested and on
each occasion.
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Figure 5.9: Single colour immunofluorescence analysis of MACS
depleted PBL.
PBL were isolated from 6 month old sheep (n=3) and stained with anti-CD25 and anti-CD45
followed by biotinylated anti-IgG and streptavidin-microbeads and SA-PE. Single colour
immunofluorescence profile of cells before fractionation and after depletion of CD25-positive
and CD45RA-positive cells by passage through a MACS column are shown. The figure shows
the positive staining of PBL from one animal compared to the non-specific staining of NMS
(always <5%). This experiment was repeated three times and the same trends were seen with
PBL from each animal and on each occasion tested.
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Table 5.8: Phenotype of MACS-depIeted PBL after culture with ConA.
PBL were isolated from 6 month old sheep (n=3) and depleted of CD25-positive cells and
CD45RA-positive cells and cultured with 5(ig/ml ConA. At the times indicated, viable
lymphocytes were harvested and 106 cells stained with either anti-CD25, anti-MHC class II or
anti-CD45RA followed by anti-IgG FITC and either biotinylated anti-WCl, biotinylated anti-
CD4 or biotinylated anti-CD8 then SA-PE. The cells were analysed by FACScan and the
percentage of each T cell subset which expressed either CD25, MHC class II or CD45RA was
calculated. The Figure shows the percentage of positive staining of cells compared to the non¬
specific staining of NMS versus and b-NMS (always <5%). The results shown are the mean
values of three animals. The standard deviation of the mean is shown in the brackets. This
experiment was repeated twice and the same trends were seen with each animal and on each
occasion. The significance in the rate of expression of CD25 by each T cell subset was
determined by performing a two sample t-test comparing the level of expression at different
time points. The probability that the differences in rates are significant is represented in the
table. The significance of any re-expression of CD45R was determined by regression analysis
of the data. A General Linear Model was used to analyse the data with time as a covariate. The
probability that the differences in the data are significant is represented below each column.
TABLE5.8:PhenotypeofMACSdeple edaft rcul urewi hCo A.
CD25expression.MHClasIIexpres ion.




















































Following in vitro stimulation with the T cell mitogen ConA, the yd T cell population within
unfractionated ovine PBL increased in size during the first day of culture. Comparatively similar
increases in size of the CD4-positive and CD8-positive T cell sub-populations were also seen,
though this took up to 4 days. The ratio of CD4-positive plus CD8-positive T cells subsets to yd T
cells emphasises the marked differences in rates of population expansion observed. These
differences in population sizes following stimulation suggested that there may be differences in
the rates of activation of the different T cell subsets. An analysis of CD25 (IL-2Ra) and MHC
class II expression by the different T cell subsets was performed. The cell surface expression of
these proteins is increased upon activation. Initial experiments showed differences in CD25
expression by the yd T cell subset compared to CD4-positive and CD8-positive T cells after 24
hours culture of PBL with ConA. An analysis of the kinetics of activation during the first 24
hours of culture with ConA revealed a faster rate of activation by yS T cells compared to CD4-
positive and CD8-positive T cells. Similar results were seen for both of the markers analysed, yd
T cells can be divided into subsets based on the type of WC1 epitopes expressed on their cell
surface. The various sub-populations of yd T cells all showed similar kinetics of activation
following treatment with ConA.
The expression of the MHC class II (3-chain on activated yd T cells showed similar kinetics to that
of CD25 expression. The monoclonal antibody SW73.2 recognises all ovine MHC class II p-
chains products from both of the identified loci (Hopkins et al., 1986). MHC class II a-chain
expression could not be analysed with one monoclonal antibody. The products of the two
different loci were identified with two different monoclonal antibodies (Dutia et al., 1993;
Hopkins et al., 1993). MHC class II P-chains were expressed on all T cell subsets following
stimulation with ConA. In contrast, the products of the two MHC class II a-chain loci were
expressed on less than 30% of each T cell subset after culture with ConA. Each MHC class II
protein comprises an a-chain and a P-chain. These results therefore, indicate that more MHC
class II loci may exist in the ovine species than have so far been identified. Possibly a DP loci
exists as in the human species.
Control experiments revealed the following: i) a small increase in CD25 expression on all
lymphocyte subsets following culture without ConA. ii) each lymphocytes subset remained
equally viable during culture, iii) each subset of cells which passed through the Lymphoprep
expressed a similar level of CD25 and MHC class II. These results clearly indicated that the
apparent faster rate of activation by y5 T cells was not the result of the purification procedure, or
culture conditions used. Therefore, it can be stated that in response to the mitogen ConA, yd T
cells become activated at a much faster rate than do CD4-positive or CD8-positive T cells. Recent
observations (Verhagcn et al., 1993) concurred with the results presented in this chapter. In these
results however, a period of preculture was required before differences in the activation of y5 T
cells compared to CD4-positive or CD8-positive cells was observed when cultured with ConA. In
our observations, no preculture of PBL was required and furthermore, culture of PBL in medium
alone resulted in a modest increase in CD25 expression by yd T cells in contrast to CD4-positive
or CD8-positive T cells did.
It may be assumed from the observations presented in this chapter that activation of yd T cells in
vivo will occur more quickly than activation of CD4-positive or CD8-positive T cells. Recent
observations (A. Anderson, personal communication) suggest this to be the case. The appearance
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of CD25-positive yd T cells in an inflamed joint occurred earlier, and more markedly, than did the
appearance of CD4-positive or CD8-positive T cells expressing CD25.
In the human species, naive cells can be distinguished from recently activated cells by the
expression of two of the different CD45 isoforms, CD45RA and CD45RO respectively (Clement,
1992). The external domain of CD45 is divided into four sub-domains (Pingel and Thomas
1989). The differential exon usage of CD45 results in changes in the O-linked carbohydrate
region in the amino terminus of the external domain. These changes will result in differences in
the structure of the protein. If the different isoforms of CD45 bind different ligands, then
expression of the different epitopes may have a significant impact on lymphocyte function.
Resting peripheral blood yd T cells express both CD45RA and CD25 at low levels whereas resting
peripheral blood CD4-positive and CD8-positive T cells express much higher levels of CD45RA
and CD25. It was shown here that these phenotypic differences in the two T cell lineages did not
account for the differences observed in rates of activation between these cells. PBL depleted of all
CD45RA-positive and CD25-positive cells were cultured in the presence of ConA. yd T cells
expressed higher levels of CD25 at a faster rate than did CD4-positive and CD8-positive T cells.
The concentration of ConA used routinely throughout this thesis was 5|ig/ml. It should however
be noted that the responses of T cell subsets to ConA may not be optimal as no titration of a dose
response was carried out. The results detailed in this chapter therefore only detail the responses of
T cell subsets under one set of conditions. The responses of the different T cell subsets may be
different in alternative conditions.
There are a number of explanations for the observed differences in CD25 and MHC class II P~
chain expression by yd T cells, CD4-positive T cells and CD8-positive T cells. Firstly yd T cells
may be in a pre-activated state compared to CD4-positive and CD8-positive T cells. This was
suggested by the CD45 isoform expression of yd T cells compared to CD4-positive and CD8-
positive T cells and by the expression of CD25 on yd T cells when cultured without ConA. The
majority of ovine yd T cells do not express CD45RA and therefore display a memory phenotype.
In contrast, the majority of the CD4-positive and CD8-positive T cell populations express
CD45RA. Secondly, different signal transduction pathways may exist for the two T cell lineages.
In the ovine species, yd T cells do not generally express the proteins CD2, CD4 or CD8 (MacKay
et al., 1989; Evans, 1993). This suggests that there is either no associated p56lck or p59f>n activity
and no requirement for dephosphorylation by the CD45 associated phosphatase or that
dephosphorylation of these molecules occurs by another signal transduction pathway.
Furthermore, it has been reported that human yd and a(3 T cells exhibit differences in their TCR
associated signal transducing element, the CD3 complex (Brenner et al., 1988). Since ConA
induces some of its mitogenic effects on T cells via proteins such as those of the CD3 complex,
variability in this structure between cell types may result in different responses to stimuli. Thirdly,
the transcriptional and translational control of, at least CD25 and MHC class II molecules may be
different between the two T cell subsets. It was shown that the faster rate of activation observed by
Verhagen (1993) was not as a result of an accumulation of CD25 mRNA or translated products. It
was proposed that the faster rate of activation by yd T cells may be as a result of accumulation of
specific transcription factors for the CD25 gene such as NFkB and KBF1. The transcription
factors NFkB and KBF1 bind the CD25 kB sequence (Hemar et al., 1991). Alternatively, yd T
cells may constitutively express higher levels of the CD25 specific transcription factors. This
constitutive expression by yd T cells would enable an increase in the level of expression of this
molecule to occur very rapidly.
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The results presented in this chapter have focussed on the response of y8 T cells to autogenic
stimulation. These intriguing results led to the proposition that in an antigen-specific response, y8
T cells would similarly respond at a quicker rate than do CD4-positive or CD8-positive T cells.
The following chapter investigated the response of y8 T cells to antigen.
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CHAPTER 6
yS T cell responses to antigen
INTRODUCTION:
The T cell receptor for antigen (TCR) consists of a heterodimeric structure of either a(3 or y8
polypeptide chains (Brenner et al., 1986). The receptor for antigen on ap T cells recognises
fragments of antigen presented on the surface of APC in association with the classical
presentational element MHC class I or MHC class II molecules (Kronenberg et al., 1986).
Associated non-covalently with the TCR are five polypeptide chains (y,S,e£,r|) which comprise the
CD3 complex. The CD3 complex has been implicated in signal transduction (Clevers et al.,
1988). CD3 proteins are invariant in sequence and assemble in the same combination on T cells,
irrespective the TCR expressed by the cell.
Most cell-mediated immune responses appear to be carried out by the ap T cell population.
Because of the similarity between ap and y5 T cell receptor genes, and their predicted proteins, it
has been assumed that y5 T cells would recognise antigen in an analogous manner to ap T cells.
However, this has not been established (Haas et al., 1993). In addition, it has been suggested that
the contribution of y5 T cell to the immune system is distinct to that of aP T cells (Schild et al.,
1994). The only examples of y5 T cell antigen recognition are those observed with cloned y5 T
cell lines (Haas et al., 1993). These y5T cell lines recognise a diverse array of antigens including
tetanus toxoid (Kozbor et al., 1989), a synthetic polypeptide polyglutamate tyrosine (GAT)
(Vidovic et al., 1989), bacterial superantigens such as staphylococcal enterotoxin A (Rust et al.,
1990) and mycobacterial antigens (Kabelitz et al., 1990, Janis et al., 1989) including
mycobacterial heat shock proteins (O'Brien et al., 1989). Some reports have proposed that y8T
cells respond to self proteins including immunoglobulin (Wright et al., 1989) and autologous
stress proteins (O'Brien et al., 1991).
Antigen recognition by aP T cells involves non-covalent interaction between CD4 and MHC class
II molecules, or between CD8 and MHC class I molecules. Since the majority of y5 T cells do not
express CD4 or CD8, it is suggested that y8 T cells do not respond to antigen in a manner
analogous to aP T cells. Work with many of the proposed antigen-specific y8 T cell clones
detailed above concurred with this and showed no MHC restriction (Holoshitz et al., 1993; Schild
et al., 1994)
It has further been hypothesised that y8 T cells recognise antigen in association with presentational
elements other than MHC molecules. There is evidence that yS T cell clones recognise antigen via
presentational elements which are non-polymorphic (Tonegawaet al., 1989; Janeway et al.,
1988). These molecules are similar to the classical MHC class I molecules and are termed MHC
class lb molecules. Genes for these molecules are found within the MHC locus. In humans these
loci are HI.A-E, HLA-F and HLA-G (Rothbard et al., 1989). In mice these are the Qa and Tla
loci (Flaherty et al., 1990). MHC class lb recognition by y8 T cells was seen with cloned mouse y8
T cell lines. These y8 T cell lines were found to recognise non-polymoiphic molecules mapping
to the Tla region of the mouse genome (Ito et al., 1989, Vidovic et al., 1989). CD1 has also been
proposed as a presentational element for human y8 T cells (Porcelli et al., 1991). This molecule is
evolutionarily related to classical MHC class I molecules, but is encoded by genes outwith the
MHC locus (Calabi and Milstein, 1986). The CD1 molecules, like MHC class I, associate non-
covalently with p2-microglobulin.
Distinct differences between ap and y8 T cells becomes apparent when the alloreactivity of these
populations is studied. Allorecognition, is the in vitro cross-reactivity of lymphocytes with
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foreign MHC and peptide. It is believed that a structure, or shape, on the MHC/peptide complex
of allogeneic cells is recognised by the TCR. This structure, or shape, is similar to that of the
conventional MHC/antigen which the T cell would recognise. Most of an allogeneic response is
due to the recognition of structures, or shapes, on MHC class II molecules although a small
amount of proliferation to MHC class I can occur (Sherman and Chattopadhyay, 1993). A large
proportion of a(3 T cells show alloreactivity in a mixed lymphocyte culture, in contrast, yS T cells
do not show alloreactivity (Cabone et al., 1991).
Sheep have a higher proportion of peripheral blood y8 T cells and these have a greater diversity
within the variable region of their TCR than do either the human or murine species (Hein and
Dudler, 1993). This suggests that yS T cells in the ovine species have developed, or retained,
different levels of genetic and functional complexity, and that the ovine species relies more on the
function of y5 T cells within its immune system. It was recently reported in sheep (Bujdoso et al.,
1993) that 60-70% of y5 T cells in the afferent lymph expressed the receptor for IL-2. This
observation might be explained by the recirculatory patterns of y5 T lymphocytes which may
concentrate activated y5 T cells into the afferent lymphatics (Bujdoso et al., 1993). Alternatively,
y5 T cells may recognise ligands at the epithelial sites from which these lymphatics drain and
become activated. Subsequently, these cells may drain through the afferent lymphatics to
disseminate the immunological response to the antigen.
This chapter has concentrated on determining the antigen specificity of the y5 T cell population in
the sheep. If the role of yS T cells within the immune response is similar to that of ap T cells it
will be necessary to define a requirement for foreign antigen by y5 T cells and that which results
in an active and proliferative response by yS T cells. Secondly any potential requirement for
presentational elements by y8 T cells which may be required for specific recognition of antigen
need to be identified. The activation and proliferation of ovine y5 T cells both as a discrete
population of cells and also as part of an unfractionated population of PBL was assessed in
response to both antigen and allogeneic PBL.
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RESULTS:
6.1 Proliferative response of unfractionated PBL to antigen.
Sheep were immunised with both ovalbumin (Ova) and Mycobacterium paratuberculosis purified
protein derivative (M.tb-PPD). The secondary in vitro proliferative response by PBL from these
primed animals was investigated. Figure 6.1 shows the typical dose response seen by PBL from
each of the animals tested. The optimum concentration of Ova to which the PBL responded was
500pg/ml whilst that of M.tb-PPD was in the range 6.4pg/ml - 66.7pg/ml.
6.2 Counts per minutes (CPM) versus stimulation index (SI).
In considering responses to antigen, a common way to present proliferation data is to express the
results as a stimulation index (SI). The SI is calculated as the number of times greater the
response to the stimuli is than the response to medium alone. This method of representation is
appropriate when comparing the responses of the same population of cells to different stimuli.
However, this method is not useful when comparing the response of different populations of cells
to the same stimuli. Figure 6.2 shows the proliferative responses of the various T cell populations
to ovalbumin. The same data are presented as the SI (Fig 6.2A) and as specific CPM values (i.e.
CPM experimental minus CPM control) (Fig 6.2B). The data expressed as SI showed little
difference between the responses to antigen by the y5 T cell and a(3-T cell populations. However
when the data was expressed as specific CPM values, the ap-T cell population showed significant
responses to antigen whereas y5 T cell responses to antigen were insignificant. The use of specific
CPM was regarded as a more accurate representation of the data and is used to represent data in
all of the proliferation assays reported in this chapter.
6.3 Lymphocyte populations change in size after culture with antigen.
Ovine PBL were cultured with 500pg/ml ovalbumin and the phenotype of viable lymphocytes was
analysed before and at various times after the start of culture. Table 6.1 shows the subset
composition of the viable lymphocyte population on each day of culture with or without antigen.
When PBL were cultured in the presence of ovalbumin there was a significant increase in the size
of the y5 T cell population on day 2 with no corresponding increase in the CD4-positive and
CD8-positive T cell populations. This was reflected in the CD4-positive plus CD8-positive T
cell/yS T cell ratio on day 2 of culture which was significantly less than that seen at the start of the
experiment. A similar trend was seen when cells were cultured in the presence of Af.r6.-PPD (data
not shown). When cells were cultured in the absence of antigen no significant increase in the y5 T
cell population was seen on day 2 and no significant changes were seen in the CD4-positive plus
CD8-positive T cell/y8 T cell ratio during the culture period. At all time points, and when cells
were cultured in the presence or absence of antigen, the yS T cell population were positive for cell
surface expression of WC1 (data not shown).
6.3.1 All y8 T cells become activated when unfractionated PBL are cultured with
antigen.
yS T cells become the predominant T cell population following culture of ovine PBL from
animals primed with antigen. Accordingly, the activation of y5 T cells in response to antigen was
determined. The assay for T cell activation was cell surface expression of CD25 and MHC class II
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Figure 6.1: Proliferative response of unfractionated PBL to antigen.
105 purified ovine PBL were cultured in round-bottomed microculture plates with various
concentrations of either (A) ovalbumin (—#— ) or (B) M.tb.-PPD (—*— ). Cultures were
incubated for 5 days and the proliferation measured by the uptake of 3H-thymidine over the last 5
hours of culture. The proliferative response to medium alone is also shown (—□— ). The data is
expressed as the arithmetic mean of cpm from triplicate cultures. This experiment was repeated


























Figure 6.2: Counts per minute versus stimulation index.
Unfractionated PBL (■), y8 positive Tcells (0) and yS depleted T cells (0) were prepared from
antigen primed sheep (n=3). 105 cells of each population were cultured with optimum
concentrations of antigen. In addition, y8 positive T cells were cultured in the presence (0) or
absence (E2) of 104 irradiated autologous PBL as antigen presenting cells. Cultures were
incubated for 3, 4 or 5 days. The proliferative responses were measured by the incorporation of
3H-thymidine over the last 5 hours of culture. Figures 6.2A and 6.2B show the same sets of data
from one animal. The stimulation index (fig 6.2A) is calculated as the number of times the
response to antigen is greater than the response in medium alone. Figure 6.2B show the specific
CPM values which are the CPM of the response to antigen minus the CPM of the response in
medium alone. The values are given as the arithmetic mean of triplicate cultures; error bars in
figure 6.2B show the standard deviation. This experiment was repeated five times and the same
trends were seen with PBL from each animal and on each occasion tested.




















































































molecules. Figure 6.3 shows the proportion of each T-cell subset which expressed the CD25 after
culture with antigen. The results show that >80% of yS T cells expressed CD25 after culture with
either ovalbumin or M.tb.-PPD. Only 40-45% of CD4-positive T cells, and 20-25% of CD8-
positive T cells, expressed CD25 in the same cultures. The results also showed that the greatest
number of y5 T cells expressed CD25 on day 1. An analysis of the kinetics of activation during
the first 24 hours of culture showed that the greatest number of y5 T cells expressed CD25 only
after 24 hours of culture with antigen (data not shown). The greatest number of CD4-positive,
and CD8-positive T cells, which expressed CD25 was seen on day 2 of culture. Similar trends
were seen for MHC class II expression on the T cell subsets after culture with antigen (data not
shown). It was also observed that yd T cells did not remain more viable in in vitro culture with
antigen than did any of the other T cell subsets (data not shown). In addition, no significant
increase in activation of any T cell subset was seen when PBL were cultured without antigen (data
not shown). This implied that the activation of the yS T cell subset was due to the presence of the
antigen and not due to an artifact of the tissue culture system used.
6.4 Isolation of purified populations of y5 T cells.
The majority of ovine yS T cells become activated when unfractionated PBL are cultured with
antigen. This is indicative of antigen-specific activation of yS T cells. The distinction between
antigen-specific polyclonal activation of y5 T cells or by-stander activation of these cells as a
consequence of antigen specific a[3 T cell activation was investigated.
Ovine y5 T cells were purified from the peripheral blood of animals previously immunised with
ovalbumin and M.tb.-PPD. Selection of y8 T cells was made via the WC1 surface proteins using
the biotinylated anti-WCl monoclonal antibody CC15 linked to magnetic microbeads. It was
shown in chapter 3 that the anti-WCl monoclonal antibody CC15 recognises an epitope expressed
on all y8 T cells. In addition, it was shown during the course of this thesis (data not shown) and
previously (Evans, 1993) that purification of y5 T cells via the WC1 molecule does not activate
these cells. SA-PE was used to identify those cells labelled with magnetic beads. Figure 6.4 shows
the immunofluorescence profiles of MACS fractionated cells. During purification, WC1-positive
cells were retained on the MACS column, whilst those cells not expressing WC1 passed through
the column. The purification procedure always yielded WCl-positive T cell populations of >95%
purity which were used in subsequent assays.
Single colour FACS analysis of the purified WCl-positive cells is shown in Figure 6.5. The
majority (96%) of the cells expressed the yS TCR epitope recognised by the monoclonal antibody
86D. A small percentage cells reacted with either the anti-CD4, anti-CD8, or anti-B cell
monoclonal antibodies. The CD4-positive, CD8-positive, and B cell marker-positive purified cells
are described as the 'contaminating population' and on each occasion represented 10-12% of the
positively selected cells. Figure 6.6 shows that all of the purified cells which stained with either
anti-CD4, anti-CD8, or anti-B cell monoclonal antibodies also expressed the WC1 protein. The
intensity of WC1 expression on these contaminating cells was lower than that seen on the other
positively selected WC1 cells. The MACS purified yS T cells were used as purified populations in
the following assays. The percentage of purified WCl-positive cells which expressed CD4, CD8,
or the B cell marker was similar to observations with peripheral blood (data not shown). Two-
colour immunofluorescence showed that there was always a small percentage of peripheral blood
WCl-positive cells which expressed CD4, CD8, or the B cell marker.
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Figure 6.3: CD25 expression by T cell subsets after culture with antigen.
Purified ovine PBL were cultured with either 500p.g/ml ovalbumin (—«— ), 66.7pg/ml M.tb-
PPD ( - ** ) or no antigen (—□—) for the times indicated. Viable cells were harvested and 106
cells and stained with biotinylated anti-WCl, biotinylated anti-CD4 or biotinylated anti-CD8
followed by SA-PE and anti-CD25 followed by anti-mouse IgGl FITC and analysed by FACScan.
The percentage of each T cell subset which expressed CD25 was calculated at the various time
points. The values shown were determined with reference to staining of NMS versus b-NMS
(always <5%). The figure shows the mean values obtained from three animals. The error bars
show the standard deviation of the results. This experiment was repeated five times and the same
trends were seen with each animal and on each occasion tested.
FIGURE6.3:CD25expressionbyTc llsub etsaft rl urewithnt g . -*—Ovalbumin5(X)(ig/ml. 'i®'—Af.r6.-PPD67( g/ml. <3—Noantigeniculture. Daysinculture
Figure 6.4: Purification of y5T cells.
Flow cytometric analysis of ovine PBL before and after positive selection of y8 T cells. Each
histogram shows PBL from one animal stained with biotinylated anti-WCl monoclonal antibody
then SA-PE. Cells analysed by FACScan were: i) before addition to the MACS column (Pre-
MACS); ii) cells positively retained on the MACS column; and iii) cells which had passed
through the MACS column. The percentage of positive cells was determined with respect to NMS
as a negative control (always <5%). This experiment was repeated ten times and the same trends























Figure 6.5: Single colour immunofluorescence of positively selected y8T
cells.
Flow cytometric analysis of positively selected y5 T cells. Positively selected y8 T cells were
stained with either NMS, anti-y5 TCR, anti-CD4 or anti-CD8 followed by anti-isotype specific
FITC. The histograms show the percentage of positive PBL from one animal with respect to NMS
as a negative control (always <5%). This experiment was repeated ten times and the same trends
were seen with PBL from each animal and on each occasion tested.
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Figure 6.6: Two-colour immunofluorescence of positively selected y5 T
cells.
Two-colour flow cytometric analysis of positively selected 75 T cells from one animal. Cells were
stained with either NMS, anti MHC class I, anti-CD4, anti-CD8 or anti-WCl followed by anti-
isotype specific FITC. Cells were selected on the MACS column by reactivity with biotinylated
anti-WCl monoclonal antibody and were therefore already stained with SA-PE. The quadrants
were set with respect to the NMS staining as shown. This experiment was repeated five times and
the same trends were seen with PBL from each animal and on each occasion tested.
FIGURE 6.6: Two-colour immunoflourescence of positively
selected yS T cells.
The only other T cells which will be found in the yS-depleted lymphocyte population are CD4-
positive and CD8-positive ap T cells. The y8-depleted lymphocyte population is termed the ap T
cell population. The presence of other peripheral blood mononuclear cells subsets is not
neglected.
6.4.1 Purified yS T cells proliferate in response to ConA.
y8 T cells purified by MACS separation are cell-surface labelled with monoclonal antibody,
magnetic beads and streptavidin-phycoerythrin. It was determined that this had no affect on the
ability of y5 T cells to proliferate under normal circumstances. Unfractionated cells, and purified
y5 T cells, were assayed in vitro in the presence, and absence, of the T cell mitogen ConA to
determine proliferative responses. The results are shown in figure 6.7. Purified yS T cells
responded significantly in the presence of ConA (Fig 6.7A). The response of purified y5 T cells
in the presence of ConA was however, less than the proliferative response seen with unfractionated
cells (Fig 6.7B). These results indicated that the procedure for purification of y5 T cells did not
abrogate proliferative responses by these cells to ConA. It had previously been shown (Evans,
1993) that ConA stimulation of the purified y8 T cells had no effect on the phenotype of this
population. In experiments in this thesis, similar results were observed. The yS T cell population
constituted 96% or more of the cells both before and after stimulation with ConA (data not
shown).
6.4.2 Purified y8 T cells do not proliferate in response to antigen.
y5 T cells as part of an unfractionated population of PBL were shown to become activated
following in vitro culture in the presence of antigen. In addition, purified y5 T cells were shown
to proliferate in response to ConA. In this section, the proliferative response of purified y5 T cells
to antigen was determined. The response of purified y5 T cells to antigen was measured both in
the presence and absence of irradiated autologous PBL as antigen presenting cells (APC). The
proliferative responses of purified y5 T cells were compared to those of unfractionated PBL and
the a(3-T cell population. Figure 6.8 shows the proliferative responses of the different cell
populations when each was cultured with an optimum concentration of either ovalbumin or M.tb-
PPD. The response by y5 T cells to the antigen, whether APC are present or not, was very low and
often negligible. In addition, when y5 T cells are removed from PBL, the proliferative response of
the remaining a(3-T cell population was significantly greater than that seen by the unfractionated
population. The background level of 3H-thymidine incorporation by the a(3-T cell population
was also higher than seen by y8 T cells or unfractionated PBL (data not shown).
The response by ovine PBL to antigen was enhanced following the removal of y5 T cells. This
may be due to either an increase in the number of antigen specific cells in the resultant culture or
removal of a regulatory function mediated by y5 T cells. The proliferative response of a(3 T cells
reconstituted with various numbers of y8 T cells was examined to determine if any regulatory
function could be observed. The a(3 T cell population constitutes PBL which have been depleted
of y8 T cells. All known APC found in peripheral blood will be present in the ap T cell
population therefore there is no requirement for autologous APC to be added to this assay.
Figure 6.9 shows the results obtained when cells from three different animals were cultured with
ovalbumin. Though reconstitution of ap T cells with y8 T cells affected the actual observed
counts of proliferative responses to antigen these observations were not significant. The observed
increase in proliferation appeared to be dependent on the number of yS T cells added back to the
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Figure 6.7: Proliferative response of purified y5T cell populations in the
presence of ConA.
Unfractionated ovine PBL and purified y8 T cells were prepared and 105 cells from each
purification were incubated with 5p.g/ml ConA or in medium alone. Cultures were incubated for 5
days and proliferation was measured by the uptake of 3H-thymidine over the last 5 hours of culture.
Figure 6.7A shows the proliferative responses of purified y5 T cells to ConA and medium. Figure
6.7B compares the proliferative responses of purified y5 T cells in the presence of ConA to that of
unfractionated PBL in the presence of ConA. Data are given as the arithmetic mean of triplicate
cultures. Each symbol represents data from one animal. Errors were always <15% of the
proliferative values.




















Figure 6.8: Proliferative response of T cell subsets to antigen.
PBL were isolated from immunised animals (n=3) and y8 positive T cells (E3), y8-depleted T cells
(0) and unfractionated lymphocytes (■) were prepared. 105 cells/well of each population were
cultured with 500|ig/ml of ovalbumin (A) or 66.7(ig/ml M.tb. (B). In addition, y8 positive T cells
were cultured in the presence (H) or absence (E3) of lO4 irradiated autologous PBL as antigen
presenting cells. Cultures were incubated for 1 to 5 days and proliferation was measured by the
uptake of 3H-thymidine over the last 5 hours of culture. Data are given as the arithmetic mean of
the specific CPM values. Error bars show the standard deviations of the mean. This experiment
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Figure 6.9: Proliferative response of T cell subsets to ovalbumin.
Ovine PBL were isolated from immunised animals (n-3) and populations of y8 T cells and y8-
depleted T cells prepared. 105 y8-depleted T cells per well were cultured with 500jig/ml of
ovalbumin in the presence (—©—) or absence ( ) of different numbers of y6 T cells. The
proliferative response of the same populations of cells to medium was included as a control
(—□—). Cultures were incubated for 5 days and proliferation was measured by the uptake of
3H-thymidine over the last 5 hours of culture. Data are given as the arithmetic mean of the specific
CPM values. Error bars show the standard deviations of the mean. This experiment was repeated
twice and similar trends were seen on each occasion. The significance of any differences in the
proliferative responses in the presence of different numbers of y5 T cells was determined by
performing a two sample t-test comparing the proliferative response of test assays to the
proliferative response of y8 T cells only. The probability that the proliferative responses in the
presence of different numbers of y8 T cells are significantly different is represented in the figure.
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culture. When reconstituted in vitro at concentrations similar to those observed in the peripheral
blood (<25%) y8 T cells inhibited the proliferative responses of the aP T cell population in two
out of three sheep though only one of these observations was statistically significant. In contrast,
when reconstituted in vitro at concentrations in excess of those observed in vivo (30-90%) sheep
y8 T cells enhanced the responses of the a(3 T cell population in all animals examined. It should
be noted though that only two of these observations were significantly greater than the control.
6.5 CD25 expression by purified y5 T cells.
It has been shown that the level of CD25 and MHC class II expression on y5 T cells, within a
population of unfractionated PBL, increased following culture in the presence of antigen.
Purified y8 T cells however did not proliferate when exposed to antigen, both in the presence and
absence of APC (Fig.6.8). The expression of CD25 by purified y8 T cells and by yS T cells within
unfractionated PBL was compared following culture with antigen or ConA. Table 6.2 shows the
percentage of y5 T cells in each population which expressed CD25 during the first 24 hours of
each culture.
The data shows that 76% of y5 T cells within unfractionated PBL expressed CD25 in response to
antigen. In contrast, only 48% of purified y8 T cells expressed CD25 following culture with
antigen. 84% of purified y8 T cells and 98% of yS T cells within unfractionated PBL expressed
CD25 after 24 hours in culture with ConA. The rate of increase in CD25 expression on purified
y8 T cells was significantly slower than the rate of increase in CD25 expression on yS T cells
within unfractionated PBL in all of the conditions assayed. In additon, the final percentage of
purified yS T cells which expressed CD25 at the end of the assay was significantly lower than the
final percentage of y8 T cells within unfractionated PBL which expressed CD25.
6.5.1 y8-depleted T cells, precultured with antigen, activate yS T cells in the absence of
antigen.
Most y8 T cells within unfractionated PBL become activated following culture with antigen. To
test if this activation was through direct recognition of antigen, the response of y8 T cells when in
culture with antigen pulsed y8 depleted T cells was determined. All known APC found in
peripheral blood will be present in the y8 depleted T cell population therefore there is no
requirement for autologous APC to be added to this assay. y8 depleted T cell were cultured with
antigen, extensively washed and subsequently cultured with y8 T cells at the y8 T cell:ap T cell
ratio of unfractionated PBL. Table 6.3 shows that there was a marked increase in the expression
of CD25 on y8 T cells after culture with antigen pulsed y8 depleted T cell. The increase in CD25
expression on purified y8T cells occurred at a significantly greater rate during the first 12hours
than on y8 T cells within unfractionated PBL when cultured with antigen. 35% of purified y8 T
cells expressed CD25 after 6 hours in culture with antigen pulsed yS depleted T cells whereas only
20% of y8 T cells within unfractionated PBL expressed CD25 after 6 hours in culture with
antigen. The number of y8 T cells (72-76%) which expressed CD25 after 24 hours was similar
following both treatments.
6.5.2 yS T cells express CD25 at a higher intensity following culture with ConA
compared to culture with antigen.
Purified y8 T cells and y8 T cells within unfractionated PBL expressed markers of activation
79
Table 6.2: CD25 expression by y5 T cells.
Populations of unfractionated PBL and purified y8 T cells were prepared (n=3) and cultured in the
presence of either antigen, 5pg/ml ConA, or neither. Cells were harvested at the time points
indicated and stained with biotinylated anti-WCl followed by SA-PE and anti-CD25 followed by
anti-mouse IgGl FITC. The cells were analysed by FACScan and the percentage of y5 T cells
expressing CD25 calculated with respect to NMS and b-NMS staining (always <5%). Data is the
mean of three animals with errors shown in brackets. This experiment was repeated three times
and the same trends were seen with PBL from each animal and on each occasion tested. The
significance of any differences in the expression of CD25 by y5 T cells was determined by
performing a two sample t-test comparing the expression of CD25 by y5 T cells within an
unfractionated population to the expression of CD25 by purified y5 T cells in the absence of APC.
The probability that the expression of CD25 by different y5 T cell preparations is significantly
different is represented in the figure.
TABLE6.2:CD 5expressionbyyScells
Hoursafter
startofcultu e. 12 18 24
UnfractionatedPurified78Tti tedPurifinfract ona 78Tcellsplul llsc lelu ConA.Antigen.Mediumi 17.5(3 6) 71.6(4.8) 95.4(2 5) 96.4(1.2) 97.8(0 5)8.3(0.9) [9.1(4.0)]*** [35.1(16.4)]*** [59.5(12.2)]* [83.9(2.4)]**13.8(1.0) 20.4(1.6) 44.4(12.5) 64.1(3.4) 75.7( .1)8.3(0.9) [13.1(5.1)]* [16.1(8.8)]** [31.7(17.4)]* [47.8(24.6)]*
14.7(1 3) 18.4(2.6) 17.3(5.9) 14.1(4.3) 15.7(1.5)
8.3(0.9) 8.3(2.0) 10.7(2 3) 10.7( 0) 18.3(3.2)
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Table 6.3: CD25 expression by y8 T cells.
Populations of y8-depleted T cells were prepared (n=3) and cultured in the presence of antigen for 2
days. Viable cells were harvested and cultured with purified y5 T cells. The final percentage of y8
T cells in the culture matched the percentage of y8 T cells within unfractionated PBL at the start of
the experiment. At the time points indicated, viable cells were harvested and stained with
biotinylated anti-WCl followed by SA-PE and anti-CD25 followed by anti-IgGl FITC. The cells
were analysed by FACScan and the percentage of y8 T cells which expressed CD25 was calculated
with respect to the staining of NMS and b-NMS. Data is the mean values from three animals with
the standard deviation from the mean shown in brackets. This experiment was repeated three times
and the same trends were seen with PBL from each animal and on each occasion tested. The
significance of any differences in the expression of CD25 by y5 T cells was determined by
performing a two sample t-test comparing the expression of CD25 by y8 T cells within an
unfractionated population to the expression of CD25 by purified yS T cells in the presence of
autologous antigen pulsed PBL. The probability that the expression of CD25 by different yS T cell
populations is significantly different is represented in the figure.
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following culture with antigen. However, purified yS T cells did not exhibit any proliferative
responses to the same antigen. In contrast, purified yS T cells when cultured with ConA expressed
markers of activation and a proliferative response was measured. Figure 6.10 shows a comparison
in the level of CD25 expressed by y5 T cells within unfractionated PBL in response to either
antigen or ConA. y5 T cells expressed CD25 at high intensity after 24 hours of culture in the
presence of ConA. This was associated with a proliferative response. In contrast, yS T cells
expressed CD25 at intermediate intensities when cultured with antigen and no proliferative
responses were observed. Similar results were seen with purified y5 T cells when cultured with
either antigen or ConA (data not shown). These results indicated that proliferation by y5 T cells
only occurred when high levels of CD25 were observed.
6.6 Mixed lymphocyte reactions.
y§ T cells showed no proliferate response when cultured with soluble protein antigen in the
presence or absence of APC's. This suggested that either i) antigen is not presented to yS T cells
in a manner analogous to a(3 T cells (i.e. via MHC molecules) or ii) PBL do not express the
correct antigen presenting molecules for y5 T cells and were therefore the wrong choice of APC.
Allorecognition of MHC molecules is believed to occur in an MLR, where a population of
lymphocytes is cultured with and reacts to a population of irradiated allogeneic lymphocytes. It
has previously been reported in the human and murine species that y5 T cells have very little
alloreactivity. The alloreactivity of sheep yS T cells was therefore assessed to determine if y8 T
cells have the capacity to recognise classical MHC molecules.
Allorecognition by cells within the unfractionated PBL population was shown. Ovine PBL
proliferated in response to two different populations of allogeneic PBL in a mixed lymphocyte
reaction (data not shown). The proliferative response of purified yS T cells to each of the
allogeneic PBL populations was determined. Figure 6.11 shows the response of y5 T cells to
different numbers of allogeneic PBL after five days in culture. The responses of a[3 T cells and
unfractionated PBL to allogeneic PBL were included for a comparison of the response by
different populations of cells. y5 T cells showed little, if any, response to allogeneic PBL. The
proliferative responses of y5 T cells to allogeneic PBL were not significantly greater than the
response to autologous PBL. In contrast, the responses of a() T cells and unfractionated PBL to
allogeneic PBL were significantly greater than the responses to autologous PBL. The response by
a(3 T cells to autologous PBL was higher than the responses seen by unfractionated PBL to the
same stimulatory cells.
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Figure 6.10: Comparison of CD25 expression on yST cells.
PBL from immunised sheep (n=3) were incubated with either 500pg/ml ovalbumin or 5|ig/ml
ConA for 24 hours. Viable cells were harvested and stained with biotinylated anti-WCl followed
by SA-PE and anti-CD25 followed by anti-mouse IgGl FITC. Cells were analysed by FACS and
the quadrants were determined by staining of NMS versus b-NMS. Two clour
immunofluorescence profiles of PBL from one animal are shown. This experiment was repeated
five times and the same trends were seen with PBL from each animal and on each occasion tested.
FIGURE6.10:ComparisonofD25receptorexpr si nny8Tcell . CD25expression
Figure 6.11: Allogeneic and autologous proliferative responses of T cell
subsets.
Populations of y8 positive T cells, 78-depleted T cells and unfractionated lymphocytes were isolated
from ovine PBL (n=3). 105 cells/well of each population were cultured with different numbers of
irradiated allogeneic PBL from two different animals (—b—) and (—$—), and with different
number of autologous PBL (——). Cultures were incubated for 5 days and the proliferative
response was measured by the uptake of 3H-thymidine over the last 5 hours of culture. The data
are given as the geometric mean of the specific CPM values; errors shown are the standard
deviations of these values. This experiment was repeated five times and the same trends were seen
with PBL from each animal and on each occasion tested.






















y5 T cells were discovered by identification of their rearranged TCR genes, and not from any
observed biological function. The gene sequences of the y5 TCR are similar to those of the ap
TCR. Accordingly, the functions and specificities of y5 T cells were predicted to be similar to
those of a(3 T cells. Research into a(3 T cells function has therefore defined a paradigm which
dictated the experimentation, theory and approach to identifying the function of yS T cells.
The results presented in this chapter indicated that responses by ovine peripheral blood yS T cells
to antigen are different to the responses by ovine peripheral blood a(3 T cells to antigen. y5 T
cells did not proliferate when cultured in vitro with antigen, whilst unfractionated PBL and PBL
depleted of y5 T cells showed a significant proliferative response to antigen. However, all yS T
cells within an unfractionated population of PBL showed an increase in expression of CD25 in the
presence of antigen whereas only 50% of purified y5 T cells expressed CD25 following culture
with antigen. In the presence of allogeneic lymphocytes, the proliferative responses by yS T cell
were very small when compared to those of unfractionated PBL and a(3 T cell populations. When
y5 T cells became activated in response to antigen they all expressed an intermediate level of
CD25 and did not proliferate. In contrast the proliferation of y8 T cells in response to ConA was
coupled with an high intensity of CD25 expression. It would appear that there is critical threshold
level of expression of CD25 above which cells will proliferate.
Following exposure to antigen, all yS T cells within an unfractionated population of PBL became
activated. It was therefore expected that purified y5 T cells would become activated and
proliferate in a similar manner. In contrast, purified y5 T cells did not proliferate in response to
antigen but did become activated though at a slower rate than y5 T cells within an unfractionated
population of PBL. It was recently shown that y8 T cells could differentiate in vivo into a
functional nonproliferative state during a normal immune response (Spancr et al., 1993). In
contrast to observations reported in this chapter however, there was an initial proliferative response
by y5 T cells. It should be noted that these results were obtained with a scid mouse carrying a
single y5 TCR transgene and that this single gene rearrangement would account for an infinitely
small part of the y5 TCR repertoire of the mouse.
There are several possible explanations for purified y5 T cells becoming activated but not showing
any measurable proliferative response. Three follow; Firstly, some of the contaminating ex¬
positive or CD8-positive T cells may have specifically recognised the antigen and subsequently
activated yS T cells in a bystander manner. It was shown that purified y5 T cells were >96% WC1-
positive and that some of these cells expressed the molecules CD4 or CD8. It was also shown that
96% of the WC1-positive cells also expressed the y5 TCR. The TCR usage of the WC1-positive
cells which coexpressed either CD4 or CD8 is unknown, these cells may express an up TCR
molecule which is specific for antigen. Secondly, some y5 T cells may have recognised antigen
directly in a manner analogous to immunoglobulin, but may still require costimulation by other
cells within PBL. It is known that the complementarity determining regions 3 (CDR3) of ap TCR
molecules are critical for contact between the TCR and the antigenic peptide bound in the MHC
groove (Jorgensen et al., 1992). These regions are also critical in immunoglobulin binding of
antigen (Davies ct al., 1990). It has been found that the lengths of CDR3 in a and P chains are
nearly identical, both the length and distribution within the chain however are very limited. In
contrast, the CDR3 lengths on the 5 and y TCR resembled those of the immunoglobulin heavy
chain (long and variable) and light chain (short and less variable) respectively. It was therefore
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proposed that y5 TCR may recognise antigen in a manner similar to that of immunoglobulins.
Any MHC restricted antigen recognition so far observed by y5 T cell clones may simply be due to
fortuitous cross-reactivity with a structural feature of the MHC molecule. Finally, purified y8 T
cells may recognise antigen directly or via presentational molecules when in culture but may not
respond because they are unable to synthesise the cytokines required to enter the cell cycle and
undergo DNA synthesis. It has been shown that numerous bovine and ovine y8 T cell clones can
not be induced to synthesise the cytokines IL-2, IL-4 and y-IFN (W.I.Morrisson and H.
Takamatsu, personal communication).
When ap T cells were reconstituted with purified y5 T cells at cell concentrations higher than
would normally occur in the peripheral blood of an animal, the proliferative responses to antigen
appeared to be enhanced though most of these data points were not significantly greater than the
control response of ap T cells. It should be noted though that there was a measurable increase in
proliferative response which correlated with an increase in the number of y5 T cells added to the
culture. Activated or stimulated T cells are known to secrete numerous cytokines (Ottenhoff,
1991; Liew, 1989; Beckman, 1992) and, in this thesis, yS T cells were shown to become activated
in the presence of antigen. Therefore, when more y5 T cells are added to cultures of a(3 T cells
and antigen, there will be an increasing amount of cytokine secreted by cells in the cultures.
Consequently, the proliferative response of a|3 T cells would be enhanced.
67% of purified yS T cells became activated within 12 hours when cultured with ap T cells which
had previously been exposed to antigen. This was a faster response than that by y8 T cells in
unfractionated PBL and cultured with antigen. The activation of yS T cells in the absence of
antigen has not previously been reported to our knowledge. The activation of yS T cells may be a
response to either a factor secreted by cells which have specifically recognised antigen or to a cell-
surface factor expressed by cells which have specifically recognised antigen. It has been reported
thatyST cells specifically recognise autologous and mycobacterial heat shock proteins (O'Brien
et al., 1989). In the results reported in this chapter, y5 T cells may have recognised and responded
to an autologous 'stress protein' expressed on antigen specific cells ap T cells.
The intensity of expression of CD25 on y8 T cells correlated with the proliferative responses of
these cells. There was a threshold level of expression of CD25 above which cells proliferated.
CD25 is the a-chain of the IL-2R complex and exhibits low affinity for IL-2 (Waldmann, 1993).
It is known that expression of CD25 is increased on T cells when activated but for the IL-2R to
bind IL-2 with high affinity, expression of the p-chain and the y-chain of the IL-2R complex must
be increased too (Tsudo et al., 1986, 1987). yS T cells when cultured with ConA showed an
increase in intensity of CD25 expression; this may correlate with an increase in the IL-2R P-chain
and IL-2R y-chain expression and subsequent proliferation caused by binding of IL-2. In
contrast, yS T cells when cultured with antigen showed an increase in intensity of CD25
expression; this may not have correlated with an increase in IL-2R p-chain and IL-2R y-chain
expression and therefore subsequent proliferation did not occur.
The results observed in this chapter may also be explained by differences in the signal
transduction mechanisms of ap and y5 T cells. There is a milieu of proteins on the surface of
lymphocytes of which at least three have been shown to be associated with cell association, signal
transduction and activation of ap T cells, namely CD2, CD4 and CD8. These proteins are not
expressed on the surface of most ovine peripheral blood y8 T cells (MacKay et al., 1989) however,
human and murine peripheral blood y5 T cells do express CD2. It is assumed there are numerous
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other proteins involved in the process of T cell activation and proliferation and that the
requirements for these proteins vary from cell to cell. It was seen that purified y8 T cells did not
proliferate in response to antigen. This may be due to: i) the lack of a cell surface protein on y8
T cells which is required for antigen specific proliferation in a manner analogous to ap T cell; ii)
the lack of a ligand on yS T cells specific for co-stimulatory molecules present on antigen
stimulated PBL. B7/BB1 is expressed on antigen presenting cells and has been shown to be
essential for ap T cell antigen specific proliferation. The ligands for this B7/BB1 are CD28 which
is expressed on naive CD4+ T cells (Linsley et al., 1991a; Koulova et al., 1991) and CTLA-4
which is expressed on antigen-experienced T cells (Linsley et al., 1991b; Brunet et al., 1987).
There is no citation detailing the expression of either of these two molecules on the yS T cell
population, or iii) the lack of internal signal transduction molecules in the cytoplasm of y5 T cells
which are interconnected with the TCR molecule. Molecules such as p56lck or p59fy" or even
transcription factors such as NFkB or KBF1 (Hemar et al., 1991). y5 T cells may become
activated upon recognition of antigen in a manner analogous to ap T cells but lack a second or
additional signal which will trigger a switch from the resting GO phase enabling the proliferation
of the cells.
PBL depleted of y5 T cells (ap T cells) proliferated in response to both antigen and allogeneic
cells with far greater magnitude than either unfractionated PBL or purified y8 T cells. This
intriguing observation may have been due to one or a combination of the following factors.
Firstly the y8 T cell population may have a suppressive role on the response of other PBL. The
proliferative responses of ap T cells in medium alone were much higher than unfractionated cells.
Secondly, each assay performed used the same number of effector cells. By removing y8 T cells,
the PBL population is depleted of 10-15% of the starting cells and the number of antigen specific





In this thesis a number of novel observations were made about the peripheral blood y8 T cell
population of sheep. These observations can be divided into two main areas. The first set of
observations details aspects of the y8 T cell phenotype, in particular the expression of the WC1
molecule. The second set of observations details the specific and non-specific responses of y8 T
cells following culture with either mitogen or antigen.
7.1 Expression of WC1 epitopes by peripheral blood yS T cells.
The cell surface glycoprotein WC1 was identified as a unique molecule expressed on ruminant y5
T cells (MacKay et al., 1986, 1989; Clevers et al., 1990). In this thesis it was shown that, although
the bovine and ovine species are closely related, not all the WC1 epitopes expressed in the bovine
species were expressed in the ovine species. All WC1 monoclonal antibodies recognised epitopes
of WC1 which were expressed on subpopulations of y8 T cells. In addition, some WC1
monoclonal antibodies recognised WC1 epitopes which were expressed on mutually exclusive
populations of yS T cells. All of the WC1 monoclonal antibodies immunoprecipitated one or
more proteins of molecular weights, 144kDa, 215kDa or 300kDa and the intensity of protein
bands seen using the different WC1 monoclonal antibodies correlated with the intensity of
staining seen in FACS analysis of PBL. It was also shown, by FACS analysis and
immunohistology, that no one sub-population of WC1 positive cells predominated in any tissue
and that all WC1 monoclonal antibodies reacted with cells in the same regions of the lymph node,
spleen and thymus. In the thymus, WC1 epitopes was expressed predominantly on medullary
thymocytes with few reactive cells seen in the cortex. This distribution is indicative of mature
thymocytes and it has been proposed that WC1 is a marker of maturation of yS T cells (MacKay et
al., 1989). The distribution of WC1 positive cells in the lymph node and the spleen was indicative
of cells in transit and verified preliminary studies of others (MacKay et al., 1986, 1989; Evans et
al., 1994). These observations may help in delineating a function for y8T cells. Two potential
roles for y8 T cells have been suggested here. In the first role y8 T cells may function as antigen
presenting cells. In the afferent lymph, y8 T cells were shown to be activated (Bujdoso et al.,
1993) and furthermore it was shown in this thesis that activated y8 T cells have increased levels of
MHC class II of expression. yS T cells may actively take up antigen in the afferent lymph (or in
the tissues which drain into the afferent lymph) and subsequently pass to the subscapular and
trabecular regions of the lymph node were they may present antigen to incoming lymphocytes.
In an alternative role, y8 T cells, due to their observed distribution in the lymph node, may be the
first cells to respond to antigen-bearing, antigen presenting cells such as afferent lymph dendritic
cells. y8 T cells may then either respond in an analogous manner to a(3 T cells or may help in
sequestering antigen specific lymphocytes to the lymph node.
The function of the WC1 protein is unknown. It was first proposed that WC1 may fulfil the role
of an accessory molecule on the surface of y8 T cells (MacKay et al., 1986; Evans, 1993) as ovine
yS T cells do not express any of the known co-receptor molecules which are involved in a(3 T cell
activation (MacKay et al., 1988, 1988a). More recently complex WC1 gene families have been
found in cattle, sheep, goats, pigs and horses (Wijngaard et al., 1992, 1994; Metzelaar et al., 1992)
and it has been proposed that WC1 may control tissue-specific homing of y8 T cells (Wijngaard et
al., 1994). Genes encoding WC1 were also found in the human and mouse genomes though no
expressed product was been observed (Wijngaard et al., 1994). Wijngaard and colleagues (1992,
1994) cloned and sequenced three different bovine WC1 gene constructs which were 80%
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homologous at the nucleotide level. A putative structure for the WC1 protein was subsequently
predicted in which the extracellular domain appears to be a single polypeptide chain consisting of
11 non-identical repeats of a 110 amino acid consensus sequence of a cysteine rich region. The
exact number of WC1 genes expressed in the bovine species is not known, although some
researchers suggest they could be very numerous (H. Clevers personal communication;
Wijngaard et al., 1992, 1994). Recently, DNA segments homologous to part of the bovine WC1
cDNA were found to be highly represented in a sheep genomic library (Walker et al., 1994).
Sequence analysis of these gene segments revealed that the proteins products were WCl-like, and
it was suggested that each DNA segment corresponded to a different gene. These results, and
studies by others (W. Kimpton, personal communication), suggested the existence of a large
family of between 50 and 100 genes for WC1 in the sheep genome. It was proposed by Walker
and colleagues (1994) that individual WC1 proteins may carry out distinct but related functions in
the ovine species. The differences in the reactivity of the different monoclonal antibodies to WC1
observed through the course of this thesis may be due to the expression of different members of
the WC1 gene family.
Cysteine rich regions analogous to WC1 were found in the extracellular domains of CD5 (Jones et
al., 1986; Huang et al., 1987), CD6 (Aruffo et al., 1991) and the macrophage scavenger receptor
cysteine rich (SRCR) domain (Freeman et al., 1990). CD5 is known to be involved in T cell
activation (Geppert et al., 1990) and interacts with its ligand, CD72, via the SRCR domains (van de
Velde et al., 1991). Therefore, by analogy, WC1 may be involved in the activation of y5 T cells
and may interact with a membrane bound ligand via the SRCR domains. The specificities of each
of the different SRCR domains is unknown although it has been proposed that they may differ
(H. Clevers, personal communication).
It is interesting to speculate on a function for WC1 from the results obtained in this thesis. No
specific homing of any of the WC1 subpopulations identified by monoclonal antibodies used in
this thesis was observed in any of the tissues analysed. It was seen in this thesis, and by others
(MacKay et al., 1989; Evans 1993), that y8T cells in the epithelium of the gut do not express any
of the identified WC1 epitopes. The monoclonal antibodies used in this thesis and by others
(MacKay et al., 1989; Evans 1993) will only recognise a small number of WC1 epitopes. It will
be of interest to determine if y8 T cells in the epithelium of the gut do express any WC1 gene
products. In addition, it was shown in this thesis, that the proportion of y5 T cells in sheep
peripheral blood which expressed each of the WC1 epitopes remained constant on PBL isolated
from animals of different ages. Changes were however detected in the WC1 phenotype of PBL
isolated from animals with varying levels of antigenic burden and of activated PBL. The changes
were observed with the mutually exclusive WC1 subpopulations N3 and N4. In normal animals
30% of the N3-positive population express N4 and 20% of the N4-positive population express
N3. With PBL isolated from antigenic naive lambs and with PBL stimulated with ConA, these
WC1 subpopulations became more segragated (i.e fewer cells expressed both the N3 and N4
epitope). Though it is difficult to intrpret the functional significance of these observations, the
results may suggest that these two sub-populations of y5 T cells may carry out different functions
in the sheep.
The tissue distribution of all the different WC1 epitopc-positive cells and the WC1-epitope
phenotype of y5 T cells may remain constant in healthy animals and only be changed in diseased
animals when cells are stimulated or carrying out effector functions. It is known that the size of
the peripheral blood y8 T cell population is increased in a number of diseased states in the murine
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and human species (Haas et al„ 1993).
If WC1 functions a homing molecule then it will be necessary to identify a ligand. It will then be
of interest to determine if the different WC1 genes encode molecules with different homing
properties, and secondly, if the various SRCR domains of the WC1 proteins bind different ligands.
An ideal way to identify the ligands recognised by WC1 will be to use the protein product of the
different WC1 genes. The different SRCR domains of the bovine WC1.1 gene have been cloned
into an expression vector which will couple the SRCR domain to an immunoglobulin heavy chain
(H. Clevers, personal communication). The product will be a chimeric SRCR-Ig molecule with the
immunoglobulin heavy chain acting as a reporter protein. Using purified SRCR-Ig, the
distribution of the ligand(s) for the different SRCR domains can be determined. These ligands
may subsequently be identified and the function of the WC1 protein postulated. This would
potentially delineate a function for yS T cells in the ruminant species.
7.2 Specific and non-specific responses of y8 T cells.
A series of experiments carried out in this thesis examined the response of y8 T cells to the T cell
mitogen ConA and to the antigens Ova and M.tb.-PPD. The four most significant observations
made were: 1) y5 T cells became activated at a much faster rate than did CD4-positive or CD8-
positive T cells following culture with either the antigens ovalbumin or M.tb.-PPD, or the T cell
mitogen ConA. 2) Purified y8 T cells, though activated, did not proliferate when cultured with
antigen, both in the presence and absence of APC. 3) y5 T cells became activated in the absence
of antigen when cultured with ap T cells which had previously been exposed to antigen. 4) PBL
depleted of y5 T cells proliferated in response to both antigen and allogeneic cells with far greater
magnitude than unfractionated PBL.
The concentration of ConA used routinely throughout this thesis was 5pg/ml. It should however
be noted that the responses of T cell subsets to ConA may not be optimal as no titration of a dose
response was carried out. The results detailed in this chapter therefore only detail the responses of
T cell subsets under one set of conditions. The responses of the different T cell subsets may be
different in alternative conditions.
The activation of y5 T cells following culture with either ConA, ova or M.tb.-PPD was measured
by the increase in cell surface expression of CD25 and MHC class II molecules. The activation
was shown by control experiments to be mitogen or antigen specific. Verhagen and colleagues
(1993) also reported a faster rate of activation of yST cells compared to CD4-positive or CD8-
positive T cells. Results presented in this thesis and elsewhere (Bujdoso et al., 1993), along with
those of Verhagen (1993), have lead to the proposal that in vivo, yS T cells may become activated
in response to a stimuli at a faster rate than either CD4-positive or CD8-positive T cells. Recent
observations (A. Anderson, personal communication) suggested this to be the case. The level of
CD25 expression on y5 T cells infiltrating an inflamed joint of a sheep which had artificially
induced arthritis increased at a faster rate and more markedly than did the level of CD25
expression on CD4-positive or CD8-positive T cells.
It was interesting to note that following stimulation of PBL, MHC class II P-chains were expressed
on all T cell subsets whereas, the products of the two MHC class II a-chain loci so far identified in
the ovine species were expressed on less than 30% of each T cell subset. Each MHC class II
protein comprises an a-chain and a p-chain therefore this observation lead us to propose that
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more MHC class II loci must exist in the ovine species than have so far been identified
A number of explanations for the differences in rates of activation between yS T cells and, CD4-
positive T cells and CD8-positive T cells may be proposed. Firstly, yS T cells may be in a pre-
activated state compared to CD4-positive and CD8-positive T cells. This was suggested by the
observation that there was a modest increase in CD25 expression by yS T cells within PBL when
cultured in the absence of ConA or antigen as a stimuli. In contrast, CD4-positive and CD8-
positive T cells did not increase their expression of CD25. It has also been seen that resting
peripheral blood y5 T cells in the bovine species express low levels of CD25 (H. Takamatsu, W.I.
Morrison, personal communication). Secondly, different signal transduction pathways may exist
for the three T cell lineages. The cell surface phenotype of yS T cells is different to the cell
surface phenotype of CD4-positive or CD8-positive cells (MacKay et al„ 1989). Thirdly, the
transcriptional and translational control of genes including those used when cells become
activated and undergo proliferative responses may be different in the three T cell subsets.
These observations of a faster rate of activation by y5 T cells compared to a(3 T cells fit well with
theories regarding the role of y8 T cells put forward by others (Kaufamn, 1990, Pfeffer et al.,
1990, 1992). In these hypothesis, y5 T cells are proposed to act as the first line of defence in the
immune response to infections. It is reasonable to assume if this were the case, then yS T cells
would respond to at a faster rate than ap T cells to the pathogenic challenge.
Purified y5 T cells did not proliferate when cultured with antigen, both in the presence and
absence of autologous PBL as APC. y8 T cells within an unfractionated population of PBL, and
purified y8 T cells alone, did however become activated following culture with antigen. The
intensity of expression of CD25 on y8 T cells following culture with antigen was lower than the
intensity of expression of CD25 on y8 T cells following culture with ConA. This suggested that
there may be a threshold level of expression of CD25 on y8 T cells which signifies a proliferative
response. Cells expressing CD25 at a lower intensity may remain non-proliferative.
An explanation for the lack of proliferation by yS T cells in the assays reported here may lie in
the choice of APC. In all the assays presented in this thesis, irradiated autologous PBL were used
as APC for yS T cells. Unfortunately there are no positive controls in the ovine species for antigen
recognition by y8 T cells, as is the case for y8 T cells other species. It was unknown if autologous
PBL were the correct APC to be used in such assays. It is also not possible to categorically decide
that the activation of yS T cells in the cultures with antigen was in fact a direct response to the
antigen or some other factor present in the culture system. It was observed that during in vitro
culture in the absence of antigen, yS T cells expressed increased levels of CD25. This has also
been observed in analysis of the responses of y8 T cells from the bovine species (H. Takamatsu,
WI. Morrison, personal communication). It appears that yS T cells show a modest increase in
their level of CD25 expression simply as a consequence of the isolation of PBL. An hypothesis
presented here for these observations is that on the luminal surfaces of the peripheral blood
vasculature, ligands specific for surface molecules of y8 T cells may be expressed. When in
contact with these ligands, activation of y8 T cell may be suppressed. The vasculature of other
lymphoid vessels such as the afferent lymph may not contain the necessary ligands for
suppression of y8 T cell activation and this may explain the observation that y8 T cells express
higher levels of CD25 in the afferent lymph compared to peripheral blood or efferent lymph.
An alternative reason for the lack of proliferation by yS T cells may be that y8 T cells are unable
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to synthesise the cytokines required to enter the cell cycle and undergo DNA synthesis. It has
been shown that numerous bovine and ovine y8 T cell clones can not be induced to synthesise the
cytokines IL-2, IL-4 and y-IFN (W.I.Morrisson and H. Takamatsu, personal communication)
Result presented in this thesis showed that yS T cells became activated when cultured with a(3 T
cells which had previously been exposed to antigen. This occurred at a faster rate than was seen
for the activation of y8 T cells within unfractionated PBL when in culture with antigen. Activation
also occurred to a greater extent than was seen on unfractionated PBL, and purified yS T cells
alone, following their culture in the absence of antigen. The activation of ovine peripheral blood
y8 T cells in the absence of exogenous antigen has not previously been reported and may be a
response to either a factor secreted by cells which have specifically recognised antigen or to a
factor expressed by cells which have specifically recognised antigen. One such factor may be
self-ligands which are expressed by APC. It has been reported that y5 T cells specifically
recognise autologous and mycobacterial heat shock proteins (O'Brien et al., 1989).
7.3 Future prospects.
A significant absence in y5 T cell immunology is the identification of the presentational element
or ligand recognised by the y8 TCR molecule. It was assumed that y8 T cells recognised antigen
in a similar manner to ap T cells: i.e recognising peptide in association with the presentational
molecules MHC class I and MHC class II. However, it has been shown that most y8 T cells
recognise ligands independent of MHC molecules (Haas et al., 1993; Allison and Havran, 1991;
Raulet, 1989; Kronenbcrg, 1994) and that y8T cells can recognise single molecule ligands rather
than peptides bound to larger molecules (Schild et al., 1994; Weintraub et al., 1994; Sciammas et
al., 1994). Furthermore it was recently shown that ySTCR heterodimers appear more
immunoglobulin like in their CDR3 region (Rock et al., 1994). A significant point to stress is that
although numerous ligands for individual yST cell clones have been identified (Haas et al., 1993;
Kronenberg, 1994) and recognition of whole molecules by individual y8T cell clones has been
reported (Schild et al., 1994; Weintraub et al., 1994; Sciammas et al., 1994) these observations
account for only a limited number of the possible range of yS TCR specificities. All experiments
performed in this thesis used PBL as APC for y8 T cells. PBL express both MHC class I and MHC
class II molecules which are the classical antigen presenting molecules for a(3 T cells (Kronenberg
et al., 1986). As has been reported by others (Schild et al., 1994; Weintraub et al., 1994;
Sciammas et al., 1994) during the course of this thesis, y8 T cells may not recognise antigen in a
manner analogous to ap T cells therefore this choice of APC may not only be incorrect, but APC
may not be required for stimulation of yS T cells.
In the sheep, yS T cells are known to be activated to a greater extent in the afferent lymph
compared to peripheral blood or efferent lymph (Evans et al., 1993). CD25 is expressed at an
intermediate intensity although, as previously proposed in this thesis, this does not necessarily
mean that the y8 T cells are proliferating. It is unknown what ligand is responsible for activating
y8 T cells, which migrate via afferent lymph, and on which cells this ligand is found. The ligand
recognised by yS T cells, may not only be different from that recognised by aP T cells, but also
may vary from tissue to tissue. It is known that afferent lymph contains a population of cells not
seen in other lymphatic and peripheral vessels. These are dendritic cells and are potent antigen
presenting cells (Steinman, 1991). In addition to MHC class I and MHC class II molecules, ovine
afferent lymph dendritic cells express other presentational elements such as CD1 (Bujdoso et al.,
1989). It may be hypothesised that either in the afferent lymph, or in the tissues, dendritic cells
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stimulate y5 T cells either via antigen presenting molecules and peptide or via the expression of a
ligand specific for y8 T cells. y5 T cells are subsequently found with an activated phenotype in
the afferent lymph (Bujdoso et al., 1989; Evans et al., 1993). It will be of great interest to
determine the proliferative response of y5 T cells to antigen in the presence of purified afferent
lymph dendritic cells. In the sheep, cannulation of the afferent lymphatics allows for the
collection of large numbers of afferent lymph dendritic cells, which may readily be purified by
conventional means for use in in vitro assays (Bujdoso et al., 1989).
Because of the large number of yS T cells in ruminants such as the sheep, these experimental
animals will play an important role in defining the function of y5 T cells within the immune
system. These studies will supplement those ongoing in the murine system.
Functional studies of y5 T cells in the murine system are beginning to define a role for this
population of cells. A potential way to identify the function of y5 T cells is to analyse their
function in animals devoid of other T cell subsets (e.g. a(3 T cells). aP-depleted mice have been
generated by treatment of animals from birth and onwards with an anti- a[) TCR monoclonal
antibody (Carbone et al., 1991). Transgenic mice have also been generated by genetic
recombination or disruption of genes in embryonic stem cells (Ishida et al., 1990; Mombaerts et
al., 1992; Philpott et al., 1992). Using a(3 T cell depleted animals, and transgenic animals, it may
be possible to determine both a specific ligand for y§ T cells and also a fundamental function for
this population of lymphocytes. It has already been shown with transgenic mice that ccf) T cells
can develop normally in y5 T cell deficient mice (Ishida et al., 1990); that the homing of y5 T cell
subsets to epithelia is independent of y5 TCR expression (Bonneville et al., 1990); and that
negative selection, (Bonneville et al., 1990a; Dent et al., 1990) and positive selection, (Pereira et
al., 1992; Wells et al., 1991,1993) of y8 T cells occurs. It has also been demonstrated that there
are different requirements for MHC class I expression for the development of y5 T cells in
transgenic animals (Correa et al., 1992; Pereira et al., 1992) and that MHC class II molecules are
not involved in the positive selection of intraepithelial V84+ y5 T cells (Schleussner and Ceredig,
1993). In addition, it was shown that the tyrosine kinase p56lck is required for the thymic
development of y5 T cells in transgenic mice (Penninger et al., 1993). The function of y5 T cells
can be more directly ascertained in animals transgenic animals devoid of the ap T cell subset and
in aP-depleted animals. It has already been shown that y5 T cells are not helper cells for B cells
(Philpott et al., 1992); that yST cells show no proliferative response to allogeneic cells (Carbone et
al., 1991); and that yST cells are required for recovery from Listeria and Malaria infection
(Mombaerts et al., 1993; Tsuji et al., 1994). More recently, it was shown in y5 TCR transgenic
animals that y5 T cells expressing the TCR Vyl.lJy4Cy4 conferred resistance to acute T cell
leukaemias (Penninger et al., 1995). This resistance occurred independent of MHC class I or
MHC class II molecules, the TAP-2 peptide transporter protein or heat-shock proteins.
The results obtained with transgenic mice however are questioned by some (Routtenberg, 1995).
It should be noted, that when a particular gene or cell population is deleted from an individual, the
individual will compensate for this loss by the increased expression of molecules or cells which
carry out similar functions. The transgenic animal will therefore be unnatural and the
significance of any results may therefore be difficult to interpret. Similarly, it may be difficult in
some instances to speculate as to the requirement of a molecule or cell population by merely
deleting it from the individual.
The development of the transgenic mouse has given the immunologist an immensely powerful
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tool which will undoubtedly help in deciphering the function of yS T cells within the immune
system and the potential of the transgenic animal should not be overlooked.
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APPENDIX
COS cell cloning system
i
Results and Discussion.
The initial aim of this thesis was to clone and sequence the ovine WC1 gene. Two approaches
were taken. The first involved the direct molecular cloning of the WC1 cDNA. An already
prepared cDNA library was to be used in the COS cell transfection system (Seed and Aruffo,
1987; Aruffo and Seed, 1987) with the aim of identifying the cDNA encoding WC1 by selective
panning with the anti-WCl monoclonal antibodies. A positive control for transfection and cDNA
recovery for this system used cDNA encoding rat CD2, and the monoclonal antibody 0X34,
which is specific for rat CD2 (kindly provided by Dr. Neil Barclay, University of Oxford). The
second approach was to affinity purify the WC1 protein and obtain the N-terminal amino acid
sequence. This would be used to generate a WC1 cDNA probe. The affinity purification of the
WC1 protein is described in Chapter 3.
A.l Establishing the cDNA transfection and recovery system.
A.1.1 Kpn I and Xba I restriction endonucleases linearise the plasmid vector CDM8 containing
the cDNA encoding rat CD2.
cDNA encoding rat CD2, ligated into the shuttle vector CDM8 (CDM8-CD2) (a gift from Dr. Neil
Barclay, University of Oxford), was used to establish the molecular cloning system as previously
described (Seed and Aruffo, 1987; Aruffo and Seed, 1987). The shuttle vector, CDM8, with
stuffer DNA, is ~4.8Kb in size and the rat CD2 cDNA ~1.2Kb. When rat CD2 cDNA was inserted
into the vector instead of the stuffer fragment, the vector is ~5.0Kb in size. The restriction
endonucleases Xba I, Kpn I and BamHl were used to digest preparations of the supplied plasmid
construct. Figure A.l shows the ethidium bromide staining bands of CD2-CDM8 following
restriction digestion with the named enzymes. In lanes 1 and 2 (Xba I), and 3 and 4 (Kpn I), one
major band and numerous smaller bands were seen. The major band was of ~5.0kbp and
corresponds to the expected size of the linearised CDM8-CD2 plasmid. The other bands were
comparable to the bands observed with uncut plasmid control (lanes 7 and 8). Figure 1 also
shows that the restriction enzyme BamHl cleaves the CDM8-CD2 plasmid at three sites (lanes 5
and 6). Any of the restriction enzymes used here can therefore be used to determine that CDM8-
CD2 is present in the prepared sample.
A.1.2 Polymerase chain reaction analysis of the CD2 cDNA contained within the CDM8-CD2
construct.
To further confirm that the plasmid DNA prepared and analysed in A. 1.1 was CDM8-CD2, a
polymerase chain reaction (PCR) of the CD2 construct was developed. Figure A.2 shows the
results of a PCR when MgCl2 was titrated. The expected PCR product of 750bp was seen in lanes
5 and 6 which correspond to 4mM and 5mM MgCl2 respectively. This result was taken as
confirmation that the designated CDM8 vector did in fact contain rat CD2. The plasmid
preparations used in this and the previous experiment were used as control plasmids in future
restriction digests.
A.1.3 COS cells maximally express CD2 48 hours after transfection.
The conditions for transfection where as previously described by Seed and Aruffo (1987) with
minor modifications as detailed in Chapter 2. Cells were transfected with the CD2-CDM8 plasmid
and incubated for various lengths of time. At various time points after transfection, the expression
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Figure A.l Restriction endonuclease digestion of CDM8-CD2.
The two different plasmid preparations were used. Lanes 1, 3, 5 and 7 shows results with a
miniprep of transformed E.Coli. and lanes 2, 4, 6 and 8 show results with a large scale
preparation of transformed E.Coli. A sample of each DNA preparation was incubated with the
restriction enzymes Xbal (lanes 1 and 2), Kpnl (lane 3 and 4) and BamHl (lanes 5 and 6)
according to the suppliers instructions and with no restriction enzyme (lanes 7 and 8). The
DNA was then analysed on a 1% agarose gel by ethidium bromide staining following
electrophoresis. DNA size markers are shown to the left of the figure.
Figure A.l: Restriction endonuclease digestion of CDM8-CD2.
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Figure A.2 Polymerase chain reaction of rat CD2.
CDM8-CD2 plasmid DNA was analysed by PCR. Lanes 1 through to 6 are PCR reactions
performed with increasing final concentrations of MgCl2 in the PCR reaction of 0, 1, 2, 3, 4
and 5mM respectively. The PCR products of each reaction were analysed on a 1% agarose gel
by ethidium bromide staining following electrophoresis. DNA size markers are shown to the
left of the figure.
Figure A.2: Polymerase chain reaction of rat CD2.
of CD2 was measured by FACS to determine the optimum time to be used for harvesting of
transfected cells and subsequent recovery of plasmid DNA. Cells were stained with the
monoclonal antibody 0X34 (a gift from Dr. Neil Barclay, University of Oxford) which is specific
for rat CD2. Figure A.3 shows the single colour immunofluorescence profiles of COS cells at
various time points after transfection with the CDM8-CD2 plasmid. After 48 hours 40% of the
harvested cells expressed the rat CD2 molecule. This decreased throughout the remainder of the
assay with only 20% expressing rat CD2 72 hours after transfection. None of the mock
transfected cells were reactive with the anti-CD2 monoclonal antibody (data not shown). The
number of reactive cells decreased at time points after 72 hours and the number of viable cells
also decreased. This is indicative of the transient expression system used by the CDM8 vector
(Seed and Aruffo, 1987; Aruffo and Seed, 1987)
A.1.4 CD2 encoding cDNA can be recovered from transfected cells.
Following transfection and culture for 48 hours, COS cells were harvested and plasmid DNA
recovered from transfected cells. It was possible to select the cells expressing the protein encoded
by the transfected DNA using a monoclonal antibody specific for rat CD2 which was coupled to
magnetically labelled beads. These positively selected cells were subsequently lysed and the
plasmid DNA recovered by Hirt precipitation (Hirt, 1967). This plasmid DNA was then
transformed into competent MC1061/p3 bacteria. The plasmid CDM8 contains a SupF element.
Sup F plasmids can be selected in nonsuppressing host bacteria containing a second plasmid, p3.
This plasmid contains amber mutated ampicillin and tetracycline drug resistance elements (Seed
and Aruffo, 1987; Aruffo and Seed, 1987). These mutations are suppressed in the presence of a
Sup F element and therefore bacteria transformed with a Sup F containing plasmid are resistant to
the drugs ampicillin and tetracycline.
The transformed bacteria were grown on agar plates containing 12.5pg/ml ampicillin and
7.5pg/ml tetracycline. The following day, plasmid DNA was prepared from selected colonies and
treated with the restriction endonuclease Kpnl prior to analysis by agarose gel electrophoresis.
The results are shown in figure A.4. In each case (lanes 1-5), two bands were seen: a band of
~5.0kb corresponding to linearised CDM8-CD2 plasmid; and a larger size band which
corresponds to uncut plasmid DNA (lane 7) non digested plasmid. Lane 6 shows the comparative
agarose gel electrophoresis patterns of the control plasmid DNA prior to transfection and
recovery. The similarity of these results shows that the transfection, expression and subsequent
recovery of plasmid DNA from COS cells had been successfully established using the control
plasmid. The next section deals with the transfection of the ovine cDNA library.
A.2 COS cells do not appear to express WC1 following transfection with an ovine cDNA
library.
The protocol used to transfect and recover plasmid DNA encoding CD2 was used in an attempt to
isolated cDNA encoding the ovine WC1 protein. A cDNA library, prepared from ConA
stimulated ovine lymphocytes, by Dr. Raymond Bujdoso (University of Edinburgh) was used.
COS cells where grown to optimal conditions and transfected with the CDM8 plasmid containing
ovine cDNA. As a positive control, COS cells were transfected with CDM8-CD2 and as a negative
control, no DNA was added to the transfection medium. Cells where left for 48 hours post
transfection and then harvested. To determine whether the transfection protocol had been
successful, some COS cells from each transfection experiment were stained with the specific
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Figure A.3 Time course of COS cell transfection with CD2-CDM8.
COS cells were transfected with the control plasmid CD2-CDM8 and cultured for various
lengths of time. The cells were then harvested and stained with anti-rat CD2 monoclonal
antibody followed by anti-Ig FITC then analysed by FACScan. Single colour
immunofluorescence profiles are shown. The figure shows positive cells to the right of the
marker which was set on the non-specific staining of NMS (always <3%). This experiment
was repeated three times and the same trends were seen on each occasion.





Figure A.4 Kpttl restriction digest of recovered CDM8-CD2.
Plasmid minipreps were made from five different colonies of E.Coli which were transformed
with plasmid DNA recovered from transfected COS cells. The plasmid minipreps were
incubated with the restirction enzyme Kpnl (lanes 1-5) according to the suppliers instructions.
Control CDM8-CD2 plasmid was also incubated with the restirction enzyme Kpnl (lane 6)
according to the suppliers instructions and with no restirction enzyme (lane 7). The DNA was
then analysed on a 1% agarose gel by ethidium bromide staining following electrophoresis.
DNA size markers were run in lane 8 and are also shown to the left of the figure. The plasmid
DNA in each reaction was analysed on a 1% agarose gel by ethidium bromide staining
following electrophoresis.
FigureA.4:Kpn1restrictiond estofr cover dCDM8-CD2
monoclonal antibodies and analysed by FACS. Figure A.5A shows the FACS profiles of COS
cells transfected with CDM8-CD2 with the monoclonal antibody 0X34. As was previously
observed, 40% of cells transfected with the CD2 cDNA expressed this protein. COS cells
transfected with the ovine cDNA library did not react with the monoclonal antibody specific for
WC1 (figure A.5B).
It was unknown at the time that a collaborative project between the International Laboratory for
Research into Animal Diseases (ILRAD), Kenya and the Department of Immunology, Utrecht
Hospital, Netherlands was already underway to clone the gene encoding bovine WC1. Their
project was successful and the results were recently published (Wijngaard et al., 1992, 1994;
Metzelaar et al., 1992). The knowledge of a successful conclusion to this work became apparent
during my initial attempts to clone ovine WC1. It was also revealed that a second collaborative
project was underway with the Basel Institute for Immunology which was in the process of cloning
the ovine gene. Due to these circumstances, the work in this thesis aimed at cloning the ovine
WC1 gene was curtailed.
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Figure A.5 Reactivity of transfected COS cells.
COS cells were transfected with the ovine cDNA library (figure A.5A) and the control plasmid
CD2-CDM8 (figure A.5B) and cultured for 48 hours. The cells were then harvested and
stained with either anti-WCl (figure A.5A) or anti-rat CD2 (figure A.5B) monoclonal antibody
followed by anti-Ig FITC then analysed by FACScan. Single colour immunofluorescence
profiles are shown. The figure shows positive cells to the right of the marker which was set on
the non-specific staining of NMS (always <3%). This experiment was repeated three times and
the same trends were seen on each occasion.
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Abstract
We have used the monoclonal antibodies IL-A111, CACTI 16A, to investigate the expression of
interleukin 2 receptors (IL-2R) by ovine peripheral blood T cells. Monoclonal antibodies (mAbs)
IL-A111 and CACTI 16A reacted with concanavalin A (Con A) activated ovine lymphocytes and
both mAbs did so with similar FACS (fluorescence activated cell sorting) profiles and fluorescence
intensity. Following activation by Con A all three major ovine T cell subsets, namely CD4+, CD8 +
and y/5 T cells, express the IL-2R. All y/d T cells express IL-2R within 12 h following activation by
Con A in vitro whereas a/fIT cells do not express the IL-2R until 24 h after the start of culture with
the mitogen. In freshly isolated peripheral blood a small percentage of lymphocytes, which are almost
all CD4+, express the IL-2R.
Introduction
Cross-linking of the antigen receptor on T cells results in the expression of
several activation molecules including the interleukin 2 receptor (IL-2R). The
function of this molecule is to bind IL-2 and allow the activated T cell to
progress through the cell cycle during clonal expansion. In the human system
high affinity IL-2R comprise at least two proteins: a 55 kDa protein desig¬
nated CD25 (or a chain) and a 75 kDa protein which is believed to be re¬
sponsible for signal transduction. Monoclonal antibodies (mAbs) have been
generated which are known to react with bovine IL-2Ra chain (Naessens et
al., 1992). cDNA encoding CD25 protein has been cloned and sequenced
from several species including ovine (Bujdoso et al., 1992) and bovine
(Weinberg et al., 1988). Based on the predicted homology of CD25 proteins
between the ruminant species we have used workshop antibovine temporary
cluster TC24 (CD25) mAbs to investigate the expression of IL-2R by periph¬
eral blood T cells in the ovine species.
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Materials and methods
Monoclonal antibodies
The mAbs IL-A111 and CACTI 16A (both IgG! isotype) which were in¬
cluded in the temporary workshop cluster TC24 (CD25 cluster) were used in
this study. Ovine T cell subset-specific monoclonal antibodies used were SBU-
T4 and SBU-T8, which recognize OvCD4 and OvCD8, respectively, and are
both of the IgG2a isotype (Maddox et al., 1985). Ovine y/d T cells were iden¬
tified by the WC1 mAb CC15 (IgG2a isotype) which reacts with all of these
cells in sheep. MHC Class II expression was identified by the mAb SW73.2
(IgG2a isotype) which reacts with /? chains of all known ovine MHC Class II
molecules (Hopkins et al., 1986).
Preparation ofperipheral blood mononuclear cells (PBMC) and
immunofluorescence staining
PBMC were prepared from heparinized venous blood by centrifugation over
Lymphoprep. Cells were cultured with 5 pg ml -1 Con A for the specified time
in RPMI 1640 supplemented with 10% fetal calf serum, 2 mM L-glutamine,
100 U ml-1 benzylpenicillin, 100 U ml-1 streptomycin, 5x 10-5 M 2-mer-
captoethanol and 2 g 1~1 sodium bicarbonate.
Immunofluorescence staining and FACScan analysis of unstimulated or Con
A-activated PBMC were as described elsewhere (Bujdoso et al., 1989).
Results and discussion
We have generated by polymerase chain reaction a 1.3 kb cDNA that con¬
tains the entire 825 bp coding region of the IL-2R protein CD25. The nucleo¬
tide sequence of this cDNA is detailed elsewhere (Bujdoso et al., 1992). Fig¬
ure 1 shows the bestfit alignment of the predicted amino acid sequence of
ovine CD25 in comparison with the predicted amino acid sequences of bo¬
vine, human and murine CD25. The precursor sequence of ovine CD25
(Bujdoso et al., 1992) has 94%, 72% and 63% homology with bovine (Wein¬
berg et al., 1988), human (Nikaido et al., 1984) and murine (Miller et al.,
1985) CD25 protein, respectively. Because of the predicted amino acid se¬
quence homology between the ruminant CD25 proteins it seemed likely that
mAbs generated to bovine CD25 would cross-react with ovine CD25. The
mAbs IL-A111 and CACTI 16A were used to test this prediction. Our prelim¬
inary experiments showed that both mAbs reacted with native CD25 protein
expressed on Con A-activated ovine PBMC. Approximately 60% of cells were
stained by both mAbs. The control staining for these experiments was the
reactivity of the mAbs IL-A111 and CACTI 16A with unstimulated PBMC
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Fig. 1. The predicted amino acid sequences (in single letter symbols) of ovine, bovine, human
and murine CD25 protein in a best-fit alignment.
which showed that approximately 10% of unstimulated cells bound both
mAbs, suggesting that a significant number of activated cells are already, and
probably continually, present in the peripheral blood of sheep (data not
shown). mAbs IL-A111 and CACT11 6A are known to react with mouse L
cells transfected with cDNA encoding bovine IL-2R a chain (Naessens et al.,
1992) which strongly suggests these reagents react with the equivalent mole¬
cule expressed by ovine cells. The availability of known antibovine CD25
mAbs will complement those mAbs raised specifically to the ovine CD25 pro¬
tein (Verhagen et al., 1992).
To determine which subset of T cells in peripheral blood expressed IL-2R
in the absence of any in vitro stimulation, two colour immunofluorescence
analysis using T cell subset-specific mAbs and IL-A111 mAb was carried out
using PBMC isolated from lambs 6 weeks old. Figure 2 shows that the major¬
ity of CD25 expression in peripheral blood of these young lambs occurs on
CD4+ T cells as is the case in other species (Taga et al., 1991). Very few
CD8+ cells or y/<5TCR cells express IL-2Ro; chains in animals of this age. We
have noticed in subsequent experiments using peripheral blood obtained from
older animals that the percentage of CD4+ cells expressing CD25 was greater
than that shown here for relatively young animals. The failure to see signifi¬
cant IL-2R expression by CD8+ or y/d TCR+ cells may indicate that these


















Fig. 2. Two colour immunofluorescence profiles of sheep PBMC stained with either CC15 (to
detect y/ST cells), SBU-T8 or SBU-T4, and in each case with IL-A111. mAbs were detected by
isotype specific second layer reagents and analysed by FACScan. Background gates were set with





















Fig. 3. Sheep PBMC were cultured with 5 /rg ml-1 Con A for 8 days. At time zero, and every 24
h thereafter, viable cells were harvested from culture and stained with either CC15 (to detect
y/d T cells), SBU-T8 or SBU-T4, and in each case with IL-A 111. mAbs were detected by isotype
specific second layer reagents and analysed by FACScan. The percentage positive cells repre¬
sents those cells coexpressing CD25 and a subset specific molecule. Background gates were set
with use of irrelevant IgG! and IgG2a mAbs.
012345678
Days after Con A stimulation
cells do not express this particular receptor molecule, or that the mAb IL-
A111 does not react with the IL-2Ra chains expressed by these cells. To test
these alternatives PBMC were cultured with Con A for 7 days during which
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Fig. 4. Sheep PBMC were Cultured with 5 /rg ml"1 Con A for 24 h. At time zero and at the times
shown viable cells were harvested from culture and stain with either CC15 (to detect y/5 T
cells), SBU-T8 or SBU-T4, and in each case with IL-A111 or SW73.2. mAbs were detected by
isotype specific second layer reagents and analysed by FACScan. The percentage positive cells
represents those cells coexpressing CD25 and a subset specific molecule. Background gates were
set with use of irrelevant IgG! and IgG2a mAbs.
time the IL-2R expression by CD4, CD8 and y/d T cells was assessed at 24 h
intervals by two colour immunofluorescence analysis. Figure 3 shows the per¬
centage of each T cell subset expressing CD25 following activation by Con A.
All three T cell subsets showed IL-2R expression following activation by Con
A, and maximal numbers of cells within each subset expressed CD25 after
24-48 h of culture with the mitogen. The percentage of cells which expressed
IL-2R within each subset decreased after 48 h ofculture and returned to levels
seen before the addition of Con A by Days 5-8. It is clear from these data
that, firstly, all of the major T cell subsets of the sheep can express IL-2Rai
chains, and secondly, that the acquisition, and the loss, of cell surface expres¬
sion of this receptor protein appears to occur more rapidly with y/d T cells
compared with both CD4+ and CD8+ T cells.
To investigate the apparent different rates of IL-2R expression by y/d and
a/P T cells the time course for CD25 expression by Con A-activated cells was
investigated over 24 h. Figure 4 shows that all y/d T cells expressed the IL-2R
by 12 h following the start of culture with Con A. In contrast, the maximal
number of CD4+ and CD8+ cells which expressed the IL-2R was not seen
until 24 h after the start of culture with mitogen. It can also be seen that not
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all the a//? T cells express CD25 after activation. This was most evident with
CD8+ cells where only approximately 80% of the cells manage to express
CD25. Figure 4 also shows that the rapid expression of IL-2R by y/8 T cells
was not restricted to this activation molecule. MHC Class II molecules de¬
tected by the mAb SW73.2 showed as equally a rapid rise in expression as
CD25. The maximal number of y/d T cells which expressed MHC Class II
molecules was reached at the same time as the maximal number of cells which
expressed the IL-2R. Significantly higher percentages of CD4+ and CD8+ T
cells, compared with y/d T cells, already expressed MHC Class II molecules
but the rate of expression of these molecules by the remaining a/p T cells
occurred at a slower rate than was seen for y/d T cells.
These observations suggest the rate of activation is more rapid in y/dT cells
than it is in a/fl T cells, y/d T cells generally lack the coreceptor molecules
CD4 and CD8 which are intimately associated with tyrosine kinases and dis¬
tinct activation pathways. The likelihood exists that different activation path¬
ways involving other regulatory molecules exist in y/d T cells which account
for their more rapid rate of activation. Our future experiments will focus on
these mechanisms.
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Abstract
Workshop clusters WC1 and WC2 monoclonal antibodies (mAbs) were tested for their reactivity
with ovine peripheral blood mononuclear cells (PBMC). The populations of ovine lymphocytes de¬
fined by these mAbs were found to be part of the population of T19 + (WC 1+) cells, and the y/S T
cell receptor (TCR) (WC2) expressing T cells. The expression of cell surface WC1 antigens following
mitogen stimulation of ovine PBMC was studied. Whilst the size of the WC1 populations increased
during culture with concanavalin A, the changes in the ratio of WC1 :y/<5TCR percentages observed
suggested either a loss of WC1 molecules or a selective expansion of WC1~ cells.
Introduction
In the ovine species the T19 molecule defines a distinct population of T
cells which expresses a y/8 T cell receptor (TCR) (Mackay et al., 1986) in
association with CD3 and is negative for CD2, CD4, and CD8. A similar
population of cells has since been identified in the bovine species by use of
antiovine and antibovine T19 monoclonal antibodies (mAbs) (Mackay and
Hein, 1989; Clevers et al., 1990). The mAbs recognize non-covalently linked
protein species with molecular weights of 215 kDa and 300 kDa (Clevers et
al., 1990; Morrison and Davis, 1991; Hein et al., 1991a). Results obtained
from the first workshop on ruminant leukocyte differentiation molecules
placed all the anti-T19 mAbs into workshop cluster WC1 and mAbs to the y/
8 TCR WC2 (Hein et al., 1991; Howard et al., 1991b). These clusters are
referred to in the Second Workshop 2 as temporary clusters TC22 and TC36,
respectively. The antigen is often referred to as T19 and the antibody cluster
as WC1. In this paper all references made to either the antigen or antibody
cluster will use the term WC 1. Results from the First Workshop showed that,
Corresponding author.
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of all the WC1 clustered mAbs, CC15 reacted with most peripheral blood
mononuclear cells (PBMC) in cattle and sheep (Mackay et al., 1991; Sopp et
al., 1991). This mAb was submitted to the Second Workshop as a WC1 stan¬
dard. It has also been shown that the WC1+ population in cattle, defined by
the coordinately expressed determinants termed N1 and N2, can be further
split into two subpopulations with mAbs describing the determinants N3 and
N4 (Davis et al., 1990). The determinants Nl, N2, N3 and N4 are defined
by mAbs to the WC1 complex. mAbs recognize determinants expressed on
subpopulations of the CC15 defined WC1+ cells and all immunoprecipitate
proteins of the same molecular weight. mAbs that recognize the same deter¬
minants, or determinants on the same molecular complex, either block labell¬
ing of PBMC by other mAbs or yield diagonal staining patterns upon dual
staining of PBMC. Not all WC1 mAbs have been assigned N specificities and
a nomenclature has not yet been agreed upon to refer to the different deter¬
minants recognized on WC1 molecules. The ovine and bovine species are
closely related in evolutionary terms and there is a strong likelihood that the
N3 and N4 subpopulations may exist in the sheep. Here we report the reactiv¬
ity of some of the TC22 and TC36 mAbs with resting and activated ovine
peripheral blood lymphocytes. Our results suggest that the N3 population is
not as prominent in the sheep as it is in cattle.
Materials and methods
Monoclonal antibodies (mAbs)
The WC1 (TC22) and WC2 (TC36) mAbs used are listed in Section 1.
The ovine y/ST cell receptor mAb used was 86D (Mackay et al., 1989).
Immunofluorescence staining and FACScan analysis
Immunofluorescence staining and FACScan analysis of PBMC were car¬
ried out as described elsewhere (Bujdoso et al., 1989). PBMC were dual
stained with unconjugated WC1 or WC2 clustered mAb followed by isotype-
specific immunoglobulin-FITC and then normal mouse sera. Cells were then
stained with either biotinylated CC15 or 86D followed by streptavidin-phy-
coerythrin and analyzed by FACScan. The proportion of the CC15 or 86D
defined population reacting with the cross-reactive WC1 and WC2 mAbs, re¬
spectively, is given as a percentage of those populations. Background gates
were set with use of irrelevant IgG! and IgG2a mAbs.
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Preparation and culture ofperipheral blood mononuclear cells (PBMC)
PBMC were prepared from heparinized venous blood by centrifugation over
Lymphoprep. Cells were cultured for the times indicated with 5 pg ml-1 con-
canavalin A (Con A) in RPMI 1640 supplemented with 10% fetal calf serum,
2 mM L-glutamine, 100 U ml-1 benzylpenicillin, 100 U ml-1 streptomycin,
5x 10-5 M 2-mercaptoethanol and 5 mM HEPES.
Results
Reactivity ofWCl mAbs with ovine lymphocytes
WC1 (TC22) mAbs submitted to the Second Workshop on ruminant leu¬
kocyte differentiation molecules were analyzed for their reactivity with ovine
lymphocytes. Table 1 and Fig. 1 show the results obtained with some of these
mAbs by single colour immunofluorescence analysis of PBMC from a lamb
approx. 6 months old and an adult sheep approx. 18 months old. The reaction
patterns of the same mAbs on calf PBMC were included as a positive control
and for a comparison of the results between the ovine and bovine species. All
of the WC1 mAbs tested, apart from BAQ72A, reacted with PBMC from young
and adult sheep. Smaller percentages of positive cells were seen using PBMC
from older sheep. CC15, the workshop standard, reacted with 32% of lamb
cells and gave a profile similar to that observed with bovine PBMC. BAQ89A
and CACTB7A, like BAG25A (shown), reacted with 14-20% of lamb PBMC
and were seen to have similar patterns of reactivity on both ovine and bovine
PBMC. In contrast, the mAbs CC101 and CC117, like CC115 (shown), all
stained 10-12% of lamb lymphocytes with similar immunofluorescence pro¬
files though the reactivity was not the same across species. The mAbs
CACTB15B and CACTB1A only reacted with small populations of lamb
PBMC; the immunofluorescence profiles seen were different from lamb to
lamb. In addition, the size of the population defined by these mAbs within
ovine PBMC is much smaller than that defined within bovine PBMC.
Of all the WC 1 clustered mAbs tested, CC15 reacted with the greatest num¬
ber of ovine PBMC. Two colour immunofluorescence analysis was performed
using CC 15 versus other cross-reactive WC 1 clustered mAbs to determine the
subgroup profiles of these reagents. Table 2 and Fig. 2 show the results ob¬
tained using PBMC from an approx. 6-month-old lamb. All the workshop
mAbs reacted with subpopulations of CC15+ cells though none reacted with
the same percentage as CC15. BAQ89A, CACTB7A, BAG25A (shown),
CC101, CC117 (shown) and CC115 reacted with 58-67% of the population
defined by CC15, whilst CACTB15B stained only 20% of CC15 + cells. Cells
stained at high to intermediate intensity with CACTB1A all reacted with
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Table 1










CC15 (45) 32 8 25
CC101(9&18) 10 5 17
CC117 (30) 12 4 19
CC115 (31) 10 3 17
CACTB1A (146) 6 2 13
CACTB15B (147) 4 6 12
BAQ72A (148) 0 0 9
BAQ89A (149) 14 4 11
CACTB7A (150) 14 4 11
BAG25A (151) 20 4 15
WC2 (TC36)
86D 34 8 19
CACTB6A (136) 10 3 14
CACT16A (142) 0 0 16
CACTI7A (143) 0 0 16
CACTB12A (144) 0 0 16
CACTB44A (145) 0 0 17
CACT71A (141) 0 4 7
CACTI8A (139) 0 0 28
CACT61A (140) 0 0 26
CACT77A (167) 0 6 4
CACT26A (166) 0 2 8
CACT63A (189) 0 0 5
Cells were stained for single colour fluorescence analysis with the mAbs listed and analysed by FAC-
Scan. The percentages listed are positive cells with respect to normal mouse sera used as a negative
control. The results shown are a representative set of data from one of five different experiments
which all showed the same trends as those seen here.
CC15, but of those cells stained with a low intensity of CACTB1A only a
proportion reacted with CC15 (data not shown).
Reactivity ofWC2 mAbs with ovine lymphocytes
Of all the WC2 (TC36) mAbs tested only CACTB6A showed clear reactiv¬
ity with ovine cells where 10% of lamb and 3% of adult sheep PBMC were
immunofluorescently labelled by the mAb (Table 1 and Fig. 1). The immu¬
nofluorescence profiles observed with this mAb on sheep PBMC were differ¬
ent to those seen on bovine PBMC. In particular, CACTB6A did not stain
ovine PBMC with the high intensity fluorescence observed on bovine cells.
CACT71A, CACT77A and CACT26A reacted with 2-6% of adult sheep cells











Fig. 1. Representative single colour immunofluorescence profiles of the reactivity of WC1 and
WC2 mAbs with ovine PBMC isolated from a 6-month-old lamb and a 6-month-old calf. These
immunofluorescence profiles show the staining patterns for some of the mAbs listed in Table 1.
The results shown are a representative set of data from one of five different experiments which
all showed the same trends as those seen here.
but failed to stain both ovine and bovine cells with high intensity immunoflu¬
orescence. PBMC from lambs were not reactive with these mAbs and they
were not analyzed further. The mAb 86D identifies the y/S TCR molecule in
ruminants. Table 2 and Fig. 2 show the results of two colour fluorescence
analysis of 86D versus CACTB6A. The staining pattern shows clearly that
CACTB6A defines a subpopulation of cells within the 86D population.
Changes in WC1 expression by Con A activated lymphocytes
WC1 is reported to be lost from ovine WC1+ cells following activation
(Hein and Mackay, 1991). Figure 3(a) shows the reactivity of some of the
WC1 defined workshop mAbs and 86D (anti-y/d TCR) with ovine PBMC
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Tabic 2
Two colour immunofluorescence analysis of WC1 and WC2 monoclonal antibodies with lamb PBMC
Monoclonal
antibody
Percentage of CC15 population reacting
with WC1 monoclonal antibody
WC1 (TC22)
















Percentage of 86D population reacting
with WC2 monoclonal antibody
WC2 (TC36)
CACTB6A (136) 21
The results shown are a representative set of data from one of three different experiments which all
showed the same trends as those seen here.
CACTB15B CACTB6A
Fig. 2. Immunofluorescence profiles of two colour immunofluorescence analysis of the cross-
reactive WC1 and WC2 mAbs. The FACS profiles shown here are for some of those reactivities
shown in Table 2. The results are a representative set from three experiments all of which showed
the same trends as shown here.
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Fig. 3. Single colour fluorescence analysis of Con A stimulated ovine PBMC. Sheep PBMC were
cultured with 5 jug ml-1 Con A for 7 days. At time zero, and the shown times, viable cells were
harvested from culture and stained with either 86D (anti-y/<5 TCR), CC15 (workshop stan¬
dard), 197 and 19-19 (these are the two mAbs in the WC1 cluster which have been raised
against sheep lymphocytes). This was followed by antimouse immunoglobulin-FITC and anal¬
ysis by FACScan. Normal mouse serum was used as a negative control, (a) Percentage staining
observed with CC15, ST197, 19-19 and 86D. (b) Ratio between the percentage cells stained
with the WC1 clustered mAbs and the percentage of cells stained with 86D (WC1 :y/<5TCR).
after their stimulation with the T cell mitogen Con A. It can be seen that the
cell populations defined by the different WC1 mAbs and 86D all increased in
size during the first 24 h of culture. The same was seen with all WC1 clustered
mAbs (data not shown). The increase is more marked than that seen with the
CD4+ and CD8+ T cell populations (data not shown). These observations
support the notion of a faster rate of activation or proliferation by y/8 com¬
pared with a/pT cells (Bujdoso etal., 1993).
After a slight fall in the percentage of WC1+ cells between Days 1 and 3 the
percentage of cells in the culture reacting with the WC1 mAbs increases there¬
after during the culture period. Figure 3(b) shows the ratio of WC1 :y/<STCR
staining of PBMC following activation by Con A. Over the first 3 days the
ratio falls, returning to starting levels over the next 4 days. These data suggest
that the WC1 molecule, or WC1 epitopes, may be lost during expansion of
y/d TCR+ cells, or that there is a more rapid proliferation of WC1~ cells
during the initial period of culture.
Discussion
The mAb CC15 is believed to define a population of cells which represent
all of the T19+ (WC1) cells in cattle. This would also appear to be the case
in the sheep for at least two reasons. Firstly, of all the WC1 mAbs tested,
CC15 defines the largest numbers of PBMC in the ovine species. Secondly,
the populations of cells defined by WC1 clustered mAbs tested here are sub-
populations of CC15+ cells. In cattle the N3 and N4 defined populations are
of approximately equal size and their percentages summate to equal that of
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N1+ /N2+ cells, the N1+/N2+ population being slightly smaller in size than
the CC15 population. The mAbs defining the N4 population in bovine
(BAQ89A and BAQ159A from the First Workshop and BAG25A and
CACTB7A from the Second Workshop) also define a population of cells in
ovine though the mAbs recognize different epitopes (our own unpublished
observations). BAG25A consistently reacts with the largest number of cells
and using two colour immunofluorescence analysis it can be shown that no
other N4 grouped mAb blocks the reactivity of BAG25A or has its own reac¬
tivity blocked by BAG25A. Instead, all other anti-N4 mAbs reacted with sub-
populations of the BAG25A defined cells. Of the mAbs defining the N3 pop¬
ulation in bovine (BAQ53A, BAS1A, CACTB32A, CACTB35A from the First
Workshop and CACTB1A, CACTB15B, BAQ72A from the Second Work¬
shop ) only CACTB32A (very weakly), CACTB1A and CACTB15B react with
ovine cells. From two colour immunofluorescence analysis it was seen that
biotinylated CACTB 1A reactivity was blocked by preincubation with either
CACTB15B or CACTB32A. These N3 cross-reactive mAbs showed different
staining profiles on ovine PBMC compared to those seen with bovine PBMC.
Furthermore, the size of the N3 population in ovine PBMC is much less than
the N4 population although the ovine N3 and N4 percentages still summate
to the percentage of N1+ /N2+ cells as is the case in bovine (our unpublished
observations).
In summary, our results reported here indicate that the CC15 defined, sheep
WC1+ PBMC comprise mainly N4+ cells with a small N3+ population and
possibly a third N3~/N4~ minor population. The reason(s) for the differ¬
ences observed in the staining patterns across species with the N3 mAbs, and
the mAbs CC101, CC117 and CC115 such as lower staining intensities and
smaller number of positive cells are unclear. This may be a result of (1) dif¬
ferent post-translational modifications of some protein determinants in sheep
compared with cattle, (2) different levels ofWC1 antigen expression in ovine
compared with bovine, (3) a weak cross-reactivity of the mAbs, (4) simply
a low representation of the homologous cell subpopulations in different
species.
We have investigated the expression of WC1 on ovine T cells in an attempt
to determine if this molecule is lost from the surface of cells following acti¬
vation. The WC 1 population increased in size following stimulation with
Con A. However, it could not be determined if the reductions in the ratios of
WCl:y/<5 TCR was a result of loss of cell surface WC1, conformational
changes of the molecule leading to determinant loss, or selective and rapid
outgrowth of WC1~~ cells during the initial phase of the culture. This may be
resolved using homogeneous populations of WC1+ cells and WC1 mRNA
studies together with an analysis of the cell surface expression of WC1.
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Antigen recognition and activation of ovine y5 T cells
l. W. EVANS, B. T. LUND, I. McCONNELL & R. BUJDOSO Department of Veterinary Pathology, University of
Edinburgh, Edinburgh
SUMMARY
We have investigated several aspects of yd T cells in sheep. yd T cells of sheep express a unique
transmembrane protein termed T19 but lack the expression of particular cell-surface molecules
such as CD2, CD4 and CD8 which are typically associated with a/? T cells. The majority of yd T
cells isolated from animals of all ages examined lacked the expression of CD45RA. A faster rate of
activation by yd T cells compared to either CD4 or CD8 T cells was seen in the time-course of IL-2
receptor a chain (CD25) cell-surface expression. All yd T cells expressed the CD25 protein within
8 hr of activation whereas the majority of CD4 or CD8 T cells did not express CD25 until 24 hr
post-concanavalin A (Con A) stimulation. This difference in the rate of expression of activation
molecules was not restricted to CD25, as a similar trend was seen with cell-surface expression of
major histocompatibility complex (MHC) class II molecules. We have used the distinct phenotypic
profile of ovine yd T cells to purify these cells by positive selection via the T19 molecule to assess
their in vitro proliferative response to various antigens. Routinely, cell populations comprising
more than 93% yd T cells with yields of approximately 55% were obtained. Purified yd T cells were
capable of responding to Mycobacterium tuberculosis antigen in a primary and secondary in vitro
proliferation assay and to ovalbumin in a secondary response. Ovine yd T cells showed little, if any,
proliferative response to allogeneic stimulator cells.
INTRODUCTION
he receptor for antigen on T cells is a heterodimeric structure
jnsisting of either a/? or yd polypeptide chains. The ligand for
le a/1 T-cell receptor (TcR) is known to comprise a complex of
ntigen in association with a presentational molecule.1,2 In
sntrast to a/1 T cells the ligand for the yd TcR remains to be
efined. Several presentational molecules have been described
>r yd T cells which include major histocompatibility complex
vlHC) class I, class II,3"5 77 antigens6 and CD1.7 The function
f the receptor for antigen on T cells is to bind its ligand and
low transmembrane signal transduction to promote clonal
cpansion. The signal transduction event in a/? T cells is
:gulated, in part, by the co-receptor molecules CD4 and CD8
hose cytoplasmic domains interact with the src-related
'rosine kinase p56/tA:.8 The co-receptor molecules are believed
> associate physically with the TcR and cause tyrosine
liosphorylation of the CD3 £ chain.9 The majority of
;ripheral blood yd T cells do not express the accessory
Received 9 December 1993; revised 9 February 1994; accepted 12
:bruary 1994.
Abbreviations: BSA, bovine serum albumin; Con A, concanavalin
; FCS, fetal calf serum; FITC, fluorescein isothiocyanate; MHC,
ajor histocompatibility complex; PBMC, peripheral blood mono-
lclear cells; PBS, phosphate-buffered saline; PPD, purified protein
:rivative; TcR, T-cell receptor.
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molecules CD4 or CD810'11 and while they do express CD45 the
role of y>56lck in these cells remains to be established.
Collectively, this information might suggest that yd T cells
recognize presentational elements other than classical MHC
molecules, and that different pathways of activation may occur
in these cells compared to a/1 T cells.
The majority of these findings have been made using human
and mouse yd T cells which comprise only 1-5% of the total
circulating lymphocyte population in these species. Two
significant features of ovine yd T cells exist. Firstly, there is a
high level of yd T cells in the peripheral blood of sheep,
especially in young animals where they may represent 50% of
all T cells present.12,13 Secondly, analysis of the expressed V
region repertoire of ovine yd T cells has shown a greater
selection and diversity of Vy and V<5 genes compared to humans
and mice.14 These observations imply a much more prominent
role for ovine yd T cells in immune responses by these animals.
Here we report our initial findings on responses to antigen, and
activation of y^ T cells from the ovine species which will help




Male and female Finnish Landrace x Dorset, Grey Faced x
Suffolk and Dorset x Suffolk sheep of various ages were
obtained from the Moredun Research Institute, Edinburgh.
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One- to 2-year old Finnish Landrace x Dorset sheep and 6-
month-old Grey Face x Suffolk lambs were immunized with
1 mg ovalbumin and 1 mg heat-killed Mycobacterium tubercu¬
losis injected over two sites intramuscularly in a 1-ml mixture
(1 : 1) of phosphate-buffered saline (PBS) and complete
Freund's adjuvant.
Antigens
Ovalbumin (grade V, cat. no. A5503) was obtained from Sigma
Chemical Co. (Poole, U.K.). Purified protein derivative of
human tuberculin (PPD, batch 298) was obtained from the
Central Veterinary Laboratory (Weybridge, U.K.). Heat-killed
M. tuberculosis strain H37RA was obtained from Difco
(Detroit, MI).
Medium
RPMI-1640 (cat. no. 074-1800; Gibco Biocult, Uxbridge,
U.K.) was supplemented with 2mM L-glutamine, lOOU/ml
benzylpenicillin and lOOU/ml streptomycin, 5x 10~5m
2-mercaptoethanol and 2 g/1 sodium bicarbonate. Culture
medium consisted of RPMI-1640 with supplements and 10%
fetal calf serum (FCS; Ato-Tek Ltd, Glasbury, U.K.). Wash
medium consisted of RPMI with supplements and 1% FCS.
Isolation ofperipheral blood mononuclear cells (PBMC)
PBMC for FACS analysis and proliferation assays were
isolated by centrifugation of heparinized venous blood at
800# for 20min to obtain buffy coat cells which were
subsequently centrifuged at 600 g for 20min at room
temperature over Lymphoprep (Nycomed, Oslo, Norway).
Cells collected at the Lymphoprep density medium interface
were washed three times in PBS plus 1% FCS prior to any other
treatment.
Monoclonal antibodies and immunofluorescence staining
The monoclonal antibodies used are described in detail in
Table 1. All the monoclonal antibodies were obtained from
their originators as generous gifts except 19.19, SBU-T4 and
Table 1. The monoclonal antibodies used in this investigation are listed
with their specificity and isotype
Antibody Specificity Isotype Reference
86D y<5 TcR IgGl 15
19.19 T19 IgGl 15
ST 197 T19 IgG2b 16
CC15 T19 IgG2a 17
ST4 CD4 IgGl 18
SBU T4 CD4 IgG2a 18
ST8 CD8 IgM 18
SBU T8 CD8 IgG2a 18
36F CD2 IgG2a 19
VPM8 Ig light IgGl I. McConnell, unpublished data
chain
73B CD45RA IgGl 20
SW73.2 MHC IgG2a 21
class II
IL-A111 CD25 IgGl 22
SBU-T8 which were purchased. Cell-surface phenotype w
assessed using aliquots of 1 x 106 PBMC washed with PI
containing 1% FCS and 01% sodium azide (PBS-FA). F
single-colour fluorescence analysis cells were incubated wi
50^1 of monoclonal antibody at the appropriate dilution f
30min on icc, washed three times with PBS-FA and tlr
incubated with 50 pi of FITC conjugated F(ab')2 fragment
rabbit anti-mouse immunoglobulin (cat. no. F313; Dakopat'
Glostrup, Denmark) for 30min on ice. For two-colo
immunofluorescence, cells were stained with two monoclon
antibodies of different isotypes then treated with a biotinylafi
sheep anti-mouse IgGl (cat. no. PB273; The Binding Sit
Birmingham, U.K.) followed by streptavidin-phycoerythr
(cat. no. STAR 4A; Serotec, Oxford, U.K.) and either shee
anti-mouse IgG2a-FITC (fluorescein isothiocyanate) coi
jugate (cat. no. PF274; The Binding Site) or goat anti-mou
IgG2b-FITC conjugate (cat. no. SBA 1090-02; Sera La
Crawley, U.K.) for 30min on ice. Alternatively, when dua
colour fluorescence was carried out with two IgGl monoclon
antibodies, cells were stained with the first antibody an
anti-IgGl-FITC as described above and then with 10°
normal mouse sera. Cells were reacted with the second IgG
antibody, which was biotinylated, followed by streptavidin
phycoerythrin. In all cases, cells were finally washed three timt
and analysed by flow cytometry using a Becton Dickinso
FACScan system gating on mononuclear cells (Becto
Dickinson, Cowley, U.K.). Ten thousand cells were analyse
per sample with dead cells excluded on the basis of forwar
light scatter. Background fluorescence, which was routinel
1-3%, was established with normal mouse serum in single
colour fluorescence analysis and irrelevant isotype-specifi
monoclonals in two-colour immunofluorescence analysis.
Activation of PBMC by concanavalin A (Con A J
PBMC prepared as described above were washed once wit
PBS and twice with wash medium then resuspended in cultur
medium at 2 x 106/ml with either 5/rg/ml Con A (cat. nc
C2010; Sigma) in T25 tissue culture flasks (Life Technologic
Ltd, Paisley, U.K.). At the various times indicated, cells wer
removed from culture, harvested over lymphoprep an
analysed by immunofluorescence analysis for either CD25 c
MHC class II expression.
Purification of yS T cells by positive selection using MACS
Lymphocytes were resuspended in PBS supplemented with 1°/
FCS at 4 x 107/ml and incubated with biotinylated anti-Tl
monoclonal antibodies CC15 and ST 197, simultaneously, fo
30min at 4° then washed with PBS supplemented with 5 mi
EDTA (PBS-EDTA). Cells were further incubated wit
avidin-coated microbeads for 15min on ice followed b
washing with loading buffer (PBS-EDTA supplemented wit
1% FCS). The labelled lymphocyte pellet was resuspended i
loading buffer and loaded onto a MACS separator (Becto
Dickinson, Oxford, U.K.) which consisted of a ferromatri
column, precooled by washing with ice-cold loading buffei
located within a strong magnetic field. Unlabelled cells wer
washed out of the column by a series of back flushes wit
loading buffer in the absence of the magnetic field, followed b
subsequent washing with 3-4 column volumes of loading buffe
in the presence of the magnetic field. Positively selected cell
were subsequently recovered by removal of the magnetic fiel
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rid eluting the column with loading buffer, yd T-cell-depleted
■mphocytes were obtained by removal of CC15+ cells by
HACS separation of PBMC. The yd T-cell-depleted popu-
itions are referred to as a/? T cells.
'roliferation ofpurified yd T celts
Antigen-specific proliferation to soluble protein antigen.
urified yd T cells were resuspended in culture medium at
x 106/ml and dispensed in 100-/(1 aliquots in 96-well flat-
ottom microculture plates (Life Technologies Ltd). Triplicate
ultures were stimulated where appropriate with the indicated
oses of antigen and 1 x 105/well irradiated autologous PBMC
s antigen-presenting cells.
Allogeneic mixed lymphocyte cultures. Purified yd T cells, or
d T-cell-depleted populations, were resuspended in culture
nedium at 1 x 106/ml and dispensed in 100-/d aliquots in
'6-well round-bottom microculture plates (Life Technologies
Hd). Triplicate cultures were stimulated with varying concen-
rations of irradiated unfractionated allogeneic PBMC in a
inal volume of 200/d. Cultures were incubated at 37° in a
lumidified atmosphere of 5% C02/95% air for 5 days in the
use of allogeneic responses, and 3 days for responses to soluble
>rotein antigen, then pulsed with 1 /xCi [3H]thymidine (specific
ictivity 2Ci/mM; Amersham International, Amersham, U.K.)
>ver the last 5 hr. Cells were collected onto glass filter paper
ising a semi-automated harvester and [3H]thymidine incor-
>oration was assessed by liquid scintillation counting. The data
ire expressed as the geometric mean for the triplicate cultures
ind SD was generally less than 10% of the mean.
Cray irradiation of antigen-presenting cells
'BMC were resuspended in culture medium to a concentration
if 2 x 106/ml and irradiated with 5000 rads using a cobalt-
aesium source.
Statistical analysis
Itatistical analysis was carried out by Student's t-test.
RESULTS
^acli of CD45RA expression by yd T cells
Ve have noticed in our analysis of T-cell subsets in sheep that
'BMC of young lambs are characterized by relatively high
svels of yd T cells compared to those in other non-ruminant
pecies. The large number of yd T cells, rather than CD4+ or
7D8+ cells, in peripheral blood of young lambs at a time of
arly antigenic experience may lead to preferential clonal, or
iligoclonal, selection and expansion of yd T cells. Antigen-
pecific activation of yd T cells in the periphery may result in an
ltered cell-surface phenotype for these cells. In the human
pecies it has been suggested that naive and memory yd T cells
an be distinguished on the basis of differential expression of
Ax isoforms of CD45 [or leucocyte common antigen (LCA)].23
Ve have used the monoclonal antibody 73B which recognizes a
:igh Mr isoform of sheep CD45 (Mr 220,OOO)20 and is therefore
egarded as an anti-CD45RA monoclonal antibody, to
ivestigate any differences between sheep peripheral blood yd
'
cells and CD4 and CD8 T cells in their expression of this
iD45 isoform. Table 2 shows that the majority of yd T cells in
oung animals did not express CD45RA when stained with the
Table 2. Percentage (with standard deviation in brackets) of cells in
each lymphocyte subset expressing CD45 p220. PBMC were prepared
from Suffolk x Dorset animals, both fetal lambs (day 130 gestation)
and sheep of various ages (n = 6/group). Cells were stained with the
monoclonal antibody 73B in association with either 86D, CC15, SBU-
T4, SBU-T8 or VPM8 which were all biotinylated
Percentage of cells expression CD45 p220 isoform
Age of

























monoclonal antibody 73B, irrespective of the age of the animal.
In contrast, the majority of CD4+ and CD8+ subsets, in young
animals 6 days old, did express this isoform of CD45. 73B"
cells decreased within the CD4^ and CD8+ subsets in older
sheep.
Expression of activation molecules by y5 T cells
It has been reported that human memory, but not naive, T cells
express IL-2 receptor subunits.24 As the majority of sheep yd
but not CD4" and CD8+ lack CD45RA expression, and
therefore resemble memory cells as described in other species,
we reasoned that differences may occur in the rate of activation
between these cells types. This was investigated by studying the
time-course of CD25 expression by ovine yd T cells following
activation by Con A. While PBMC were cultured with Con A,
CD25 expression by yd, CD4 and CDS T cells was assessed by
two-colour immunofluorescence analysis. Figure 1 shows that
the majority of yd T cells expressed the IL-2 receptor within 8 hr
following the start of culture with Con A. In contrast, the data
in Table 3 show that the maximal number of CD4and CDS 1
cells which expressed the IL-2 receptor was not seen until 24 hr
after the start of culture with mitogen. It can also be seen that
not all the CD4+ and CD8+ T cells expressed CD25 after
activation. Figure 1 shows that the rapid expression of IL-2
receptors by yd T cells was not restricted to this activation
molecule. MFIC class II expression by yd T cells, detected by the
monoclonal antibody SW73.2, showed a rapid rise in
expression similar to that seen for CD25. Higher percentages
of CD4 1 and CD8+ T cells, compared to yd T cells, expressed
MHC class II molecules before activation with Con A.
Expression of MHC class II molecules by CD4+ and CD8 +
T cells which were negative for these molecules, at the start of
culture, occurred at a slower rate than was seen for yd T cells.
These observations suggest the rate of activation is more rapid
in yd T cells than it is in CD4 1 and CD8+ T cells.
Positive selection of y8 T cells via the T19 molecule
Figure 2 shows the phenotype of ovine peripheral blood yd
TcR+ cells with respect to the expression of the cell-surface
molecules CD2, CD4, CD8 and T19. The data show that the
majority of yd T cells express the T19 molecule, while less than
5% of yd T cells express either CD2, CD4 and CD8. The
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Figure 1. PBMC from Grey Faced x Suffolk sheep were cultured with 5/rg/ml Con A for 24 hr. At time 0 and at the times shown
viable cells were harvested over Lymphoprep and stained with CC15 (to detect y<5 T cells), and either 1L-A111 or SW73.2. Monoclonal
antibodies were detected by isotype-specific second-layer reagents. Background gates were set with use of irrelevant IgGl and IgG2a
monoclonal antibodies.
expression of the T19 molecule by almost all ovine peripheral
blood yd T cells allowed the purification of these cells to be
attempted by negative and positive selection techniques. Of the
procedures investigated, positive selection using anti-T19
monoclonal antibodies and MACS resulted in the highest
purity and highest recovery of yd T cells. Figure 3 shows a
typical immunofluorescence profile of unfractionated PBMC
and purified cells. yS T cells were routinely purified to >93%
purity from a starting level of approximately 15% in
unfractionated PBMC. Less than 3% of the T19 positively
selected cells expressed either CD4, CD8 or surface immuno¬
globulin. Routinely, the recovery of yd T cells was more than
55% of starting population. Viability of the purified yd T cells
was shown by their ability to proliferate in the presence of
Con A. After 3 days of culture with Con A the purified cell:
incorporated [3H]thymidine to a level of 100,000 c.p.m
compared to a background proliferation of 2000 c.p.m. fo:
cells cultured in media alone. In the bovine species, purified y<
T cells responded poorly to Con A in the absence of exogenou:
IL-2.17
Purified yd T cells were used in antigen-presentation assay:
using proliferation of cells as a measure of antigen recognition
To show that there was no selective outgrowth of contaminat
ing cells within the population of purified yd T cells, Con A
cultured cells were re-examined by immunofluorescenct
analysis for the presence of different T-cell subsets. As showr
in Fig. 3 the percentage of cells which expressed the yd TcB
following stimulation of purified populations of yd T cells witf
Table 3. PBMC from Grey Faced x Suffolk sheep were cultured with 5 ng/m\ Con A for 24 hr. At time 0 and at the times shown viable
cells were harvested over Lymphoprep and stained with CC15 (to detect yd T cells), SBU-T4 or SBU-T8, and either IL-A111 or
SW73.2. The values shown are the mean percentages (n = 3) of each T-cell subset co-expressing activation molecules. Standard
deviations are shown in brackets
Time after Con A stimulation (hr)
24 0 8 24
CD25 MHC class II
yd 17-5 (3-6) 95-4(2-5) 97-2 (1-2) 33-2 (2-2) 87-5 (2-5) 94-5 (2-7)
CD4 32-2 (2-5) 69-9 (4-5) 92-0 (3-3) 60-3 (5-8) 86-2 (6-7) 88-4 (1-9)
CD8 9-6 (1-6) 47-9 (4-3) 78-4 (7-0) 83-6 (5-4) 88-2 (4-1) 95-4 (1-0)
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CD2 CD4 CD8 T19
igure 2. Two-colour immunofluorescence analysis of sheep PBMC were prepared from a Grey Face x Dorset sheep. Cells were stained with either
!C15, 36F, SBU-T4 and SBU-T8, and in all cases biotinylated 86D. These were followed with sheep anti-mouse IgG2a or anti-IgG2b-FITC and
reptavidin-phycoerythrin. Cells were analysed by flow cytometry.
"on A was routinely greater than 95%. Less than 1% of these
ultured cells expressed either CD4, CD8 or surface immuno-
lobulin. This suggests that the purity of the yd T-cell
opulation is maintained upon culture in vitro. To show that
le purification technique did not activate yd T cells, positively
selected cells were cultured in media for 3 days and
subsequently analysed for CD25 expression. As a control,
unfractionated PBMC were cultured in an identical manner. Of
the purified yd T cells 13-8% were CD25+ while 12-8% of yd T























Figure 3. PBMC were prepared from a Grey Face x Suffolk sheep. T19+ cells were immunolabelled with biotinylated ST197 and
CC15 followed by streptavidin and finally MACS biotin microbeads. T19+ cells were isolated by MACS separation and subsequently
stained with either 86D, ST4, ST8 or VPM8 followed accordingly by either anti-mouse IgG or anti-mouse IgM isotype-specific FITC
and analysed by flow cytometry. Some of the purified cells were cultured with 5 jug/ml Con A for 3 days and the phenotype of viable
cells subsequently harvested over Lymphoprep determined.
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Figure 4. yd T cells were purified from peripheral blood of non-primed (a) or antigen-primed (b) Grey Face x Suffolk lambs (n = 8) by
MACS using T19+ selection as described in the Materials and Methods. 105 yd T cells/well were cultured with 105/well autologous
irradiated PBMC and various concentrations of ovalbumin (o) or M. tuberculosis antigen (■) in flat-bottom plates for 5 days and
proliferation was measured by the uptake of [3H]thymidine over the last 5hr. The results shown are data from one experiment.
culturing isolated yd T cells for 3 days the percentage of CD25 +
cells rose to 21-7%. A similar rise in the percentage of CD25 +
yd T cells in cultured unfractionated PBMC was seen. These
observations suggest that the increase in CD25 expression
observed on the purified population of ovine yd T cells was a
general consequence of in vitro culture as yd T cells within
unfractionated PBMC showed a similar percentage increase in
CD25 expression.
Proliferation by yd T cells to Mycobacterium and ovalbumin
antigen
The recognition and response by yd T cells to antigen may be
assumed to occur in a manner analogous to that by a/? T cells;
namely the receptors for antigen on these cells bind a complex
comprising processed antigen and presentational element
promoting clonal expansion of activated cells. Direct evidence
that yd T cells were capable of proliferating to exogenous
antigen was obtained by using MACS-purified populations of
these cells. Purified yd T cells were tested for their ability t
respond in a primary and secondary in vitro proliferativ
response to Mycobacterium antigen and ovalbumin usin
autologous irradiated PBMC as antigen-presenting cells a
shown in Fig. 4. Significant proliferative responses (P ^ 0TC
by purified yd T cells were seen in both cases to Mycobacterial
antigen, yd T cells showed no significant (P > 0T0) prolif
eration in a primary response to ovalbumin but did shot
significant (P ^ 0T0) secondary response to this antigen. Ther
was no difference between stimulation indices of culture
harvested after 3 or 5 days of culture (data not shown). Whil
yd T cells showed a response to the antigens tested, in particula
during a secondary in vitro proliferation assay, the magnitud
of proliferation was regarded as low. This may reflect ai
inability of yd T cells to provide all the lymphokines requirei
for a proliferative response in an autocrine manner, that i
without the help of a/1 T cells, or it might reflect at








Ratio of stimulator to responder cells
Figure 5. yd T-cell and yd T-cell-depleted populations were purified from peripheral blood of Grey Face x Suffolk lambs (n = 3) by MACS usinj
T19 selection as described in the Materials and Methods. 10 responding cells/well, either unfractionated PBMC (#), a/1 T cells (■) or yd T cells (□)
were cultured with various numbers of autologous irradiated PBMC (a) or two different allogeneic PBMC (b and c) in round-bottom plates for :
days. Proliferation was measured by the uptake of [3H]thymidine over the last 5 hr. The results shown are data from one experiment.
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oliferative responses by y5 T cells to allogeneic cells
T cells from mice and humans are reported not to respond to
logeneic stimulator cells6'25 suggesting they do not recognize
tssical MHC molecules. Sheep have a higher percentage of yd
cells in their circulation and have a broader expressed
pertoire of y and <5 genes compared to these cells in mice and
imans.14 This suggests that ovine yd T cells as a population
,n respond to a broader array of presentational elements,
igure 5 shows a typical response by purified ovine yd T cells to
logeneic stimulator cells derived from two different sheep. In
5th experiments the response by fractionated yS T cells was
5t significantly (P > OT) different from response by the
ime cells to equivalent concentrations of autologous
radiated PBMC. The response seen by unfractionated
-BMC was less than the response seen by a/? T cells. This
thanced proliferation by afi T cells was also seen when
tils were cultured in the presence of irradiated autologous
BMC alone. The data suggest that the majority of ovine yd T
:11s, like those in other species, does not recognize and
roliferate to polymorphic molecules presented by allogeneic
irget cells.
DISCUSSION
t is valid to assume that cell populations which express
omologous molecules show a conservation of function across
'ide species barriers. With this in mind it is reasonable to
xpect a greater understanding of yd T-cell function by analysis
f these cells in species which show a high reliance on this
■articular T-cell subset, yd T cells in the peripheral blood of
heep, and other ruminants, may comprise up to 50% of all
'
cells present which is in marked contrast to humans and mice
/here yd T cells constitute only 1-5% of T cells. The greater
■rominence of yd T cells in young ruminants compared to other
pecies may reflect a greater reliance by these animals on
he function of yd rather than CD4 and CD8 T cells at this
tage of their development. During the early part of a
heep's life yd T cells must display a sufficiently diverse
epertoire of both antigen specificity and effector function to
elp deal with the particular pathogen load to which the
nimal is subjected. The expressed yd T-cell repertoire of
umans and mice is very small, with T cells expressing distinct
Ty and Vd pairings populating particular sites such as skin and
ut tissue. In sheep the greater prevalence of yd T cells in
eripheral blood is accompanied by a greater diversity of the
xpressed repertoire for these cells compared to humans and
lice.14
We have utilized the expression of the T19 molecule by
vine yd T cells to purify these lymphocytes from the peripheral
lood of sheep, yd T cells were purified by positive selection
trough the binding of immunomagnetic beads to the T19
tolecule and adhering labelled cells to a magnetic ferrous
alumn. Routeinly, populations of yd T cells of more than 93%
urity and 55% yield were obtained. Our aim in attempting to
urity ovine yd T cells was to investigate antigen recognition by
tese cells. The ability of ovine yd T cells to respond to
oogenous antigen was suggested by the expansion of these cells
i cultures of PBMC with either Mycobacterium antigen or
valbumin. The use of polyclonal populations of purified ovine
5 T cells confirmed that these cells do indeed respond by
proliferation to these antigens. Ovine yd T cells were shown to
respond to heat-killed Mycobaterium antigen in a primary and
a secondary in vitro proliferative response, and to ovalbumin in
only a secondary response. The relatively weak responses made
by yd T cells to these exogenous antigens may reflect an inherent
poor ability of these cells to proliferate in the absence of an
interaction with a/J T cells, possibly for the supply of
interleukins in a paracrine manner. Alternatively, the
responses may be a reflection of the choice of antigen-
presenting cells in the assays. It is not known what presen¬
tational elements are recognized by ovine yd T cells and
therefore which cells act as their principal antigen-presenting
cell. In the mixed lymphocyte reactions reported here purified
ovine yd T cells responded less vigorously than did ap T cells.
This suggests that polymorphic MHC molecules may not be the
principal presentational elements recognized by the majority of
yd T cells in sheep.
A comparison of the rate of activation in vitro reported here
has shown that ovine yd T cells were activated by Con A prior
to CD4 or CD8 T cells as assessed by expression of IL-2
receptor a chain, CD25, and expression of MHC class II
molecules. The expression of IL-2 receptors by yd T cells
has been described in other species. Human yd T cells
constitutively express the /J chain of the IL-2 receptor26 which
is believed to bind IL-2 and initiate the expression of CD25,27
yielding an IL-2 receptor of high affinity. The constitutive
expression of the [i chain of the IL-2 receptor would allow
a population of cells a faster rate of activation compared to
those which require the induction and synthesis of this
molecule. Several other explanations may exist for the
difference in activation between the two T-cell subsets.
Firstly, different signal transduction pathways may exist
between the two T-cell lineages as the majority of ovine yd T
cells lack the CD4 and CDS molecules which in up T cells
associate with the tyrosine kinase p56lck,s and fail to express
CD2 which is also functionally associated with p56lck.2S
Secondly, the two T-cell subsets may have different trans¬
criptional and translational control of CD25 expression.
Ovine yd T cells differ from their counterparts in other species
in that they lack expression of the activation and adhesion
molecule CD2. The functions of CD2 may be replaced on ovine
yd T cells by molecules such as T19. The T19 molecule might
therefore serve as a co-receptor molecule for ovine yd T cells,
like CD4 and CD8 for aft T cells.
The putative role of this molecule in the activation/
maturation of yd T cells is supported by the recent cloning
and sequencing of three different cDNAs which share
approximately 80% homology and encode the bovine T19
molecule.29 The predicted amino acid sequence of the T19
molecule is that of a type I integral membrane protein with an
extracellular domain consisting of 11 scavenger receptor
cysteine-rich repeats. Membrane molecules with similar
repeat units include the prototypic macrophage scavenger
type I receptors. Significantly, the T19 protein has sequence
similarity with CD5 and CD6 which have been shown to be
involved in T-cell activation.30
In humans and rodents the 190,000-200,000 MW CD45RA
molecules are found on naive T cells which, when activated,
lose expression of this isoform of CD45 and express the low Mr
180,000 isoform CD45RO. The majority of ovine peripheral
blood yd T cells lack expression of CD45RA. In the absence of
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a monoclonal antibody to the low Mx isoform of CD45 we
cannot confirm that these cells express CD45RO and whether
they display a memory phenotype which has been described for
T cells in other species. However, the rapid appearance of
CD25 on the surface of ovine yb T cells reported here is similar
to that described for memory T cells in other species.24 In
experiments to be reported elsewhere we have found that while
less than 10% of yd T cells in ovine peripheral blood express
CD25, 50% of yb T cells in afferent lymph express the IL-2
receptor. This supports the notion that yb T cells mediate a
functional role at epithelial sites31 and as a consequence of
recognition of antigen at these sites drain to peripheral lymph
nodes in an activated state. As the percentage of CD25+ yb T
cells in efferent lymph is equal to the percentage found in
peripheral blood, and as the lymphocyte composition of
efferent lymph is derived mainly from peripheral blood32 it
would appear that activated yb T cells which enter the node do
not leave this site. The function of yd T cells at epithelial sites is
proposed to be the elimination of autologous transformed or
stressed cells.33 If this is the case two features of yb T cells
may be expected. Firstly, activated yb T cells should be
present in lymph fluid draining epithelial sites. Our unpub¬
lished observations that show approximately 50% of yb T cells
in afferent lymph express CD25 suggests these cells have
been activated at peripheral sites. Secondly, yb T cells
should display a cytotoxic function. Published data by others
suggest ovine yb T cells are capable of killing allogeneic cells via
MHC class I molecules,34 although the MHC restriction
pattern of these cells was subsequently reported to be
inconsistent.12
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